Imagion Biosystems (ASX:IBX) receives positive feedback from the US FDA for the MagSense HER2 Breast Cancer Phase II clinical trial
🩺Imagion is developing new imaging technology with the aim of early cancer detection with higher specificity
⚕️The FDA has provided Imagion with positive feedback and input regarding the MagSense HER2 study plans
🗓️Expected to file the Investigational New Drug (IND) application for the Phase II study in the third quarter of 2025 calendar year
“I’m very pleased with the trajectory of our communications with the FDA. We view the feedback from the FDA as very encouraging and can now confidently press forward with the formal submission and plans for undertaking the Phase II clinical study knowing we are in good shape regarding the regulatory path.” – Bob Proulx, Executive Chairman of Imagion

Imagion Biosystems (ASX:IBX) receives positive feedback from the US FDA for the MagSense HER2 Breast Cancer Phase II clinical trial
🩺Imagion is developing new imaging technology with the aim of early cancer detection with higher specificity
⚕️The FDA has provided Imagion with positive feedback and input regarding the MagSense HER2 study plans
🗓️Expected to file the Investigational New Drug (IND) application for the Phase II study in the third quarter of 2025 calendar year
“I’m very pleased with the trajectory of our communications with the FDA. We view the feedback from the FDA as very encouraging and can now confidently press forward with the formal submission and plans for undertaking the Phase II clinical study knowing we are in good shape regarding the regulatory path.” – Bob Proulx, Executive Chairman of Imagion
👉 It’s time! The Stock Network`s ASX Gems Investment Conference is officially kicking off this morning -
This is your invitation to tap into fresh ideas and sharp market insights. We’re spotlighting standout ASX-listed companies from energy innovators and tech leaders to financial strategists and resource explorers. Let’s dive into ASX Gems.
📅 Friday 11 July
🕛 11AM - 1PM AEST
💻 Watch live on The Stock Network youtube channel

👉 It’s time! The Stock Network`s ASX Gems Investment Conference is officially kicking off this morning -
This is your invitation to tap into fresh ideas and sharp market insights. We’re spotlighting standout ASX-listed companies from energy innovators and tech leaders to financial strategists and resource explorers. Let’s dive into ASX Gems.
📅 Friday 11 July
🕛 11AM - 1PM AEST
💻 Watch live on The Stock Network youtube channel
Since the Trump-tariff induced falls in March, we’ve seen a remarkable rebound in equity markets in April that’s caught many investors by surprise, especially given the weakening global economy and corporate earnings.
To help make sense of this, TSN speaks with Jun Bei Liu, Co Founder and Portfolio Manager of Ten Cap Alpha Plus, a leading long-short equity fund. Jun Bei will help us understand why stocks have bounced back despite challenging fundamentals, what role policy rate cuts play, and how investors can navigate this uncertain environment.
Stocks mentioned include Pro Medicus Limited (PME), REA Group Limited (REA), SEEK Limited (SEK) JB Hi-Fi Limited (JBH) and Adairs Limited (ADH).
📈 Why stocks are rallying despite weak economic data
🛍️ The opportunity to buy quality stocks on weakness
💡 How investment strategies are shifting and which stocks are driving returns

Since the Trump-tariff induced falls in March, we’ve seen a remarkable rebound in equity markets in April that’s caught many investors by surprise, especially given the weakening global economy and corporate earnings.
To help make sense of this, TSN speaks with Jun Bei Liu, Co Founder and Portfolio Manager of Ten Cap Alpha Plus, a leading long-short equity fund. Jun Bei will help us understand why stocks have bounced back despite challenging fundamentals, what role policy rate cuts play, and how investors can navigate this uncertain environment.
Stocks mentioned include Pro Medicus Limited (PME), REA Group Limited (REA), SEEK Limited (SEK) JB Hi-Fi Limited (JBH) and Adairs Limited (ADH).
📈 Why stocks are rallying despite weak economic data
🛍️ The opportunity to buy quality stocks on weakness
💡 How investment strategies are shifting and which stocks are driving returns
EBR Systems (ASX:EBR) Chief Corporate Development Officer, Andrew Shute will present at The Stock Network`s ASX Gems investor event tomorrow, Friday, 11 July 💡 Register on eventbrite to watch and learn

EBR Systems (ASX:EBR) Chief Corporate Development Officer, Andrew Shute will present at The Stock Network`s ASX Gems investor event tomorrow, Friday, 11 July 💡 Register on eventbrite to watch and learn
Praemium (ASX:PPS) has announced that Bell Financial Group has chosen Praemium’s administration solution, Scope+ to support its business. The leading stockbroking and investment
management firm will utilise Praemium to administer over 2,200 client portfolios. The partnership results in:
🔹An increase of $6bn in funds under administration (FUA)
🔹Acceleration of the Scope+ total FUA by 19%
🔹A 23% increase in Scope+ portfolios
🔹A 10% increase in the group total FUA, to approximately $68bn post onboarding
“This is a milestone moment for our Scope+ offering, and one that reaffirms the calibre of our solution, and the trust leading firms are placing in our capability, we continue to see exceptionally strong growth in this area as firms seek to streamline operations while delivering an exceptional experience to their clients.” Anthony Wamsteker, CEO at Praemium
“Our focus is on delivering high-value, client-centric wealth advice. By partnering with a specialist provider like Praemium for administration, we’re able to free up our team to do what they do best - spend more time with clients, and develop tailored strategies, to help them achieve their financial goals.” Arnie Selvarajah, Co-CEO of Bell Potter

Praemium (ASX:PPS) has announced that Bell Financial Group has chosen Praemium’s administration solution, Scope+ to support its business. The leading stockbroking and investment
management firm will utilise Praemium to administer over 2,200 client portfolios. The partnership results in:
🔹An increase of $6bn in funds under administration (FUA)
🔹Acceleration of the Scope+ total FUA by 19%
🔹A 23% increase in Scope+ portfolios
🔹A 10% increase in the group total FUA, to approximately $68bn post onboarding
“This is a milestone moment for our Scope+ offering, and one that reaffirms the calibre of our solution, and the trust leading firms are placing in our capability, we continue to see exceptionally strong growth in this area as firms seek to streamline operations while delivering an exceptional experience to their clients.” Anthony Wamsteker, CEO at Praemium
“Our focus is on delivering high-value, client-centric wealth advice. By partnering with a specialist provider like Praemium for administration, we’re able to free up our team to do what they do best - spend more time with clients, and develop tailored strategies, to help them achieve their financial goals.” Arnie Selvarajah, Co-CEO of Bell Potter
Tennant Minerals (ASX:TMS) Chief Executive Officer, Vincent Algar will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on eventbrite to watch and learn

Tennant Minerals (ASX:TMS) Chief Executive Officer, Vincent Algar will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on eventbrite to watch and learn
1414 Degrees (ASX:14D) Executive Chairman, Kevin Moriarty will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on eventbrite to watch and learn

1414 Degrees (ASX:14D) Executive Chairman, Kevin Moriarty will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on eventbrite to watch and learn
Green Critical Minerals Limited (ASX:GCM) has delivered successful results from computational modelling performed by the Centre for Advanced Material Technology (CAMT) at the University of Sydney
🌏 Testing led by Professor Qing Li, a world leading expert in computational mechanics
🧊 Commissioned to perform finite element (FE) modelling on the very high density (VHD) technology heat sink to compare heat dissipation between materials
🔥 Results showed VHD heat sink can accommodate microchip power demands of 300-400W in comparison to 200-250W from other materials
“These modelling results led by Professor Li, demonstrate the unique and outstanding capabilities of our innovative VHD graphite technology. These findings demonstrate the significant advantages our product can offer rapidly growing sectors such as data centres, where microchip power demands are now frequently starting at 300W and above.” – Clinton Booth, Managing Director of Green Critical Minerals

Green Critical Minerals Limited (ASX:GCM) has delivered successful results from computational modelling performed by the Centre for Advanced Material Technology (CAMT) at the University of Sydney
🌏 Testing led by Professor Qing Li, a world leading expert in computational mechanics
🧊 Commissioned to perform finite element (FE) modelling on the very high density (VHD) technology heat sink to compare heat dissipation between materials
🔥 Results showed VHD heat sink can accommodate microchip power demands of 300-400W in comparison to 200-250W from other materials
“These modelling results led by Professor Li, demonstrate the unique and outstanding capabilities of our innovative VHD graphite technology. These findings demonstrate the significant advantages our product can offer rapidly growing sectors such as data centres, where microchip power demands are now frequently starting at 300W and above.” – Clinton Booth, Managing Director of Green Critical Minerals
Activeport Group (ASX:ATV) has secured a strategically significant contract with leading Indian ICT provider Ishan Technologies
🛜 Activeport to deliver its software-defined networking and network orchestration technology to Ishan’s network infrastructure
👥 Ishan Technologies connects more than 10,000 businesses, 75,000 retail customers and 40+ data centres across India
🌏 The project marks Activeport’s first large-scale deployment of its new network operations centre module
“We are proud to partner with Ishan Technologies to streamline network operations and enhance their customer service. Our software will empower Ishan to optimise their business network automation and self-service features. This project will demonstrate Activeport’s capability as a global leader in network orchestration and strengthen Ishan’s leadership in India’s ICT sector.” – Peter Christie, Chairman & CEO of Activeport

Activeport Group (ASX:ATV) has secured a strategically significant contract with leading Indian ICT provider Ishan Technologies
🛜 Activeport to deliver its software-defined networking and network orchestration technology to Ishan’s network infrastructure
👥 Ishan Technologies connects more than 10,000 businesses, 75,000 retail customers and 40+ data centres across India
🌏 The project marks Activeport’s first large-scale deployment of its new network operations centre module
“We are proud to partner with Ishan Technologies to streamline network operations and enhance their customer service. Our software will empower Ishan to optimise their business network automation and self-service features. This project will demonstrate Activeport’s capability as a global leader in network orchestration and strengthen Ishan’s leadership in India’s ICT sector.” – Peter Christie, Chairman & CEO of Activeport
Nickel Industries (ASX:NIC) Managing Director, Justin Werner will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on evenbrite to watch and learn

Nickel Industries (ASX:NIC) Managing Director, Justin Werner will present at The Stock Network`s ASX Gems investor event tomorrow, 11 July 💡 Register on evenbrite to watch and learn
BPH Energy (ASX:BPH) Executive Chairman, David Breeze will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on evenbrite to watch and learn

BPH Energy (ASX:BPH) Executive Chairman, David Breeze will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on evenbrite to watch and learn
OncoSil Medical (ASX:OSL) Managing Director & CEO, Nigel Lange will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

OncoSil Medical (ASX:OSL) Managing Director & CEO, Nigel Lange will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
@sunrice Group (ASX:SGLLV) Chief Financial Officer, Dimitri Courtelis will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

@sunrice Group (ASX:SGLLV) Chief Financial Officer, Dimitri Courtelis will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
AML3D (ASX:AL3) Managing Director, Sean Ebert will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

AML3D (ASX:AL3) Managing Director, Sean Ebert will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
FBR (ASX:FBR) CEO & Managing Director, Mark Pivac will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

FBR (ASX:FBR) CEO & Managing Director, Mark Pivac will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
Kincora Copper (ASX:KCC) President & CEO, Sam Spring will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

Kincora Copper (ASX:KCC) President & CEO, Sam Spring will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
Impact Minerals (ASX:IPT) Managing Director, Mike Jones will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

Impact Minerals (ASX:IPT) Managing Director, Mike Jones will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
TIP Group (ASX:TIP) Chief Executive Officer, Andrew Coleman will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn

TIP Group (ASX:TIP) Chief Executive Officer, Andrew Coleman will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register on eventbrite to watch and learn
Kincora Copper (ASX:KCC, TSXV:KCC) has announced a non-brokered private placement corner-stoned by leading North American natural resource sector investors, including Rick Rule and Jeff Phillips.
The placement raises up to $4 million Canadian dollars, or around $4.6 million Australian dollars, with a lock-up period on the stock for a full 12-months. The cap raise also received strong support from existing and new investors.
Kincora operates under a project generator model where it leverages strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to advance multiple exploration projects simultaneously.
Kincora Copper President and CEO, Sam Spring, joins Lel Smits from The Stock Network to discuss how the company plans to deploy the funds to drive growth.
🍁 Strategic North American investors Rick Rule and Jeff Phillips
🪨 Non-brokered placement with a year lock-up and 1:10 Consolidation
⚒️ Proceeds will be used to support ongoing project generation strategy and exploration drilling

Kincora Copper (ASX:KCC, TSXV:KCC) has announced a non-brokered private placement corner-stoned by leading North American natural resource sector investors, including Rick Rule and Jeff Phillips.
The placement raises up to $4 million Canadian dollars, or around $4.6 million Australian dollars, with a lock-up period on the stock for a full 12-months. The cap raise also received strong support from existing and new investors.
Kincora operates under a project generator model where it leverages strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to advance multiple exploration projects simultaneously.
Kincora Copper President and CEO, Sam Spring, joins Lel Smits from The Stock Network to discuss how the company plans to deploy the funds to drive growth.
🍁 Strategic North American investors Rick Rule and Jeff Phillips
🪨 Non-brokered placement with a year lock-up and 1:10 Consolidation
⚒️ Proceeds will be used to support ongoing project generation strategy and exploration drilling
Asian Battery Metals PLC (ASX:AZ9) Managing Director, Gan-Ochir Zunduisuren will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register to eventbrite watch and learn

Asian Battery Metals PLC (ASX:AZ9) Managing Director, Gan-Ochir Zunduisuren will present at The Stock Network`s ASX Gems investor event on Friday, 11 July 💡 Register to eventbrite watch and learn
AML3D (ASX:AL3) has announced that the US Navy plans to collaborate with AML3D on several key additive manufacturing initiatives.
🔹AML3D’s ARCEMY® technology identified as ‘pivotal’ to meeting US Navy forecasts for 100 additive manufacturing system installations.
🔹AML3D identified as key to the overall supply of around 400 components in 2026, rising to 1,600 by 2030, to the US Navy Maritime industrial Base.
🔹US Department of the Navy Letter of Intent outlines plans to regularly brief AML3D on US Navy demand forecasts for additive manufacturing.
🔹Access to US Navy demand intelligence will support future plans to more than double AML3D’s US manufacturing capability.
“We are excited about the prospect of working together to drive advancements in AM for the Navy. We look forward to discussing these opportunities in more detail and exploring how we can leverage AML3D`s expertise to achieve mutual success. Thank you for the excellent collaboration to date.” Matthew D Evans, Deputy Program Manager for Ships, US Navy, Maritime Industrial Base
“Key to AML3D’s successful US growth strategy is our ability to support the US Navy’s Additive Manufacturing needs and our strong relationships within the US Navy Maritime Industrial Base. We are looking forward to continuing to build these relationships, to working with the US Navy to meet the surging demand for additive manufacturing identified in the Letter of Intent and continuing our strong investment in our US manufacturing capability." Sean Ebert, AML3D CEO

AML3D (ASX:AL3) has announced that the US Navy plans to collaborate with AML3D on several key additive manufacturing initiatives.
🔹AML3D’s ARCEMY® technology identified as ‘pivotal’ to meeting US Navy forecasts for 100 additive manufacturing system installations.
🔹AML3D identified as key to the overall supply of around 400 components in 2026, rising to 1,600 by 2030, to the US Navy Maritime industrial Base.
🔹US Department of the Navy Letter of Intent outlines plans to regularly brief AML3D on US Navy demand forecasts for additive manufacturing.
🔹Access to US Navy demand intelligence will support future plans to more than double AML3D’s US manufacturing capability.
“We are excited about the prospect of working together to drive advancements in AM for the Navy. We look forward to discussing these opportunities in more detail and exploring how we can leverage AML3D`s expertise to achieve mutual success. Thank you for the excellent collaboration to date.” Matthew D Evans, Deputy Program Manager for Ships, US Navy, Maritime Industrial Base
“Key to AML3D’s successful US growth strategy is our ability to support the US Navy’s Additive Manufacturing needs and our strong relationships within the US Navy Maritime Industrial Base. We are looking forward to continuing to build these relationships, to working with the US Navy to meet the surging demand for additive manufacturing identified in the Letter of Intent and continuing our strong investment in our US manufacturing capability." Sean Ebert, AML3D CEO
GemLife Communities Group has listed on the ASX with a ticker code of GLF. The company is one of Australia’s largest residential pureplay Land Lease Communities developers, builders, owners and operators. Its core focus is building an Australia-based portfolio of premium Land Lease Communities assets that provide quality resort-style living for homeowners aged 50 and over. GemLife offers investors site rental Income from long‑term owner‑occupied sites plus home settlement revenue from the development and sale of homes.
@gemlife_resorts

GemLife Communities Group has listed on the ASX with a ticker code of GLF. The company is one of Australia’s largest residential pureplay Land Lease Communities developers, builders, owners and operators. Its core focus is building an Australia-based portfolio of premium Land Lease Communities assets that provide quality resort-style living for homeowners aged 50 and over. GemLife offers investors site rental Income from long‑term owner‑occupied sites plus home settlement revenue from the development and sale of homes.
@gemlife_resorts
The Stock Network is pleased to support the Sydney Mining Club and interview Resources & Energy Group (ASX:REZ) CEO and Managing Director Daniel Moore, who will be presenting at the Sydney Mining Club Event.
Hear about Resources & Energy Group on transitioning from explorer to producer at its flagship Menzies Gold Project in Western Australia. With recent drilling upgrades, gold pours underway, and a self-managed vat leach processing facility operating onsite, Resources & Energy Group is gaining momentum. The company has also strengthened its balance sheet with the sale of Mt Mackenzie in Queensland for $2.5 million, plus a recently completed $1.1 million capital raise, ensuring it is well funded for its next phase of growth.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Resources & Energy Group (ASX:REZ) CEO and Managing Director Daniel Moore.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Resources & Energy Group (ASX:REZ) CEO and Managing Director Daniel Moore, who will be presenting at the Sydney Mining Club Event.
Hear about Resources & Energy Group on transitioning from explorer to producer at its flagship Menzies Gold Project in Western Australia. With recent drilling upgrades, gold pours underway, and a self-managed vat leach processing facility operating onsite, Resources & Energy Group is gaining momentum. The company has also strengthened its balance sheet with the sale of Mt Mackenzie in Queensland for $2.5 million, plus a recently completed $1.1 million capital raise, ensuring it is well funded for its next phase of growth.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Resources & Energy Group (ASX:REZ) CEO and Managing Director Daniel Moore.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney
The Stock Network is pleased to support the @sydneyminingclub and interview @flagshipminerals (ASX:FLG) Chairman & Managing Director @pauldavidlock, who will be presenting at the Sydney Mining Club Event.
Hear about Flagship Minerals on becoming a low-cost producer of gold and copper through large-scale oxide projects in Chile, a country rich in mining history and infrastructure with projects located in areas close to major mines and surrounded by industry giants like Barrick, Newmont, and Kinross. The company is developing its Pantanillo Gold and Rosario Copper projects to tap into strong global demand.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Flagship Minerals (ASX:FLG) Chairman & Managing Director Paul Lock.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney

The Stock Network is pleased to support the @sydneyminingclub and interview @flagshipminerals (ASX:FLG) Chairman & Managing Director @pauldavidlock, who will be presenting at the Sydney Mining Club Event.
Hear about Flagship Minerals on becoming a low-cost producer of gold and copper through large-scale oxide projects in Chile, a country rich in mining history and infrastructure with projects located in areas close to major mines and surrounded by industry giants like Barrick, Newmont, and Kinross. The company is developing its Pantanillo Gold and Rosario Copper projects to tap into strong global demand.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Flagship Minerals (ASX:FLG) Chairman & Managing Director Paul Lock.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney
Vection Technologies Limited (ASX:VR1) has scored a supply contract worth $4.4 million from a top ten global defence contractor
💻 The $4.4 million contract is for the supply of ICT infrastructure and AI-enabled analytics
🤝 Cumulative revenue from the same customer is now approximately $10 million with further works planned for FY26-FY30
🌎 Demand for Vection’s AI-powered monitoring solutions is accelerating due to heightened geopolitical tensions
“Achieving ~$10m in orders strongly validates our technology and is a strong indication that the client will continue with the full program for the additional $21m scheduled for FY26-FY30. Increasing geopolitical instability is prompting militaries to implement AI-driven, XR-enhanced workflows that can handle extensive data sets in real-time. INTEGRATEDXR® is exceptionally equipped to address this demand.” – Gianmarco Biagi, Managing Director of Vection Technologies

Vection Technologies Limited (ASX:VR1) has scored a supply contract worth $4.4 million from a top ten global defence contractor
💻 The $4.4 million contract is for the supply of ICT infrastructure and AI-enabled analytics
🤝 Cumulative revenue from the same customer is now approximately $10 million with further works planned for FY26-FY30
🌎 Demand for Vection’s AI-powered monitoring solutions is accelerating due to heightened geopolitical tensions
“Achieving ~$10m in orders strongly validates our technology and is a strong indication that the client will continue with the full program for the additional $21m scheduled for FY26-FY30. Increasing geopolitical instability is prompting militaries to implement AI-driven, XR-enhanced workflows that can handle extensive data sets in real-time. INTEGRATEDXR® is exceptionally equipped to address this demand.” – Gianmarco Biagi, Managing Director of Vection Technologies
Tetratherix has listed on the ASX with a ticker code of TTX. The company is at the forefront of regenerative medicine, having developed a biopolymer platform designed for a future where healing is enabled, not hindered, by the materials placed inside bodies. Tetratherix is targeting three initial clinical applications for its platform, namely bone regeneration, tissue spacing, and tissue healing. The company has already clinically validated its first product in bone regeneration, and is presently moving through regulatory approvals and toward commercialisation in oral surgery.

Tetratherix has listed on the ASX with a ticker code of TTX. The company is at the forefront of regenerative medicine, having developed a biopolymer platform designed for a future where healing is enabled, not hindered, by the materials placed inside bodies. Tetratherix is targeting three initial clinical applications for its platform, namely bone regeneration, tissue spacing, and tissue healing. The company has already clinically validated its first product in bone regeneration, and is presently moving through regulatory approvals and toward commercialisation in oral surgery.
LinQ Minerals has listed on the ASX with a ticker code of LNQ. The company is a copper-gold explorer and owner of the Gilmore Project, located in the western limb of the world class Macquarie Arc in New South Wales, Australia. LinQ Minerals’ immediate priority is to drill test the significant exploration potential existing within the Gilmore Project, where at least 20 porphyry and epithermal related prospects have been identified. The company also plans to advance development of its brownfield gold project within the Gilmore Project, comprising the Gidginbung gold deposit and an adjacent porphyry gold copper The Dam deposit.

LinQ Minerals has listed on the ASX with a ticker code of LNQ. The company is a copper-gold explorer and owner of the Gilmore Project, located in the western limb of the world class Macquarie Arc in New South Wales, Australia. LinQ Minerals’ immediate priority is to drill test the significant exploration potential existing within the Gilmore Project, where at least 20 porphyry and epithermal related prospects have been identified. The company also plans to advance development of its brownfield gold project within the Gilmore Project, comprising the Gidginbung gold deposit and an adjacent porphyry gold copper The Dam deposit.
La Trobe Private Credit Fund has listed on the ASX with a ticker code of LF1. The Fund provides complementary exposure to La Trobe Financial’s two best-in-class private credit strategies in one convenient vehicle. These two strategies entail a balanced and defensive exposure to both Australian real estate private credit, and U.S. mid-market corporate private credit.

La Trobe Private Credit Fund has listed on the ASX with a ticker code of LF1. The Fund provides complementary exposure to La Trobe Financial’s two best-in-class private credit strategies in one convenient vehicle. These two strategies entail a balanced and defensive exposure to both Australian real estate private credit, and U.S. mid-market corporate private credit.
DroneShield Limited (ASX:DRO) has secured three standalone contracts worth $61.6 million from an undisclosed European military customer
📡 The contracts are for handheld detection, counterdrone systems and accessories
⚙️ The order is the biggest single order in DroneShield history and is larger than its entire revenue for 2024 ($57.5 million)
🤝 DroneShield previously received a single contract from the same customer in April 2024 worth $0.5 million
“In succession to the $32.2 million repeat order announced on 14 April 2025 for another customer, DroneShield products are now being purchased in material quantities. The scale and frequency of orders has been increasing as leading Military customers are moving from testing hardware to broader rollouts. DroneShield is well placed to meet the increasing demand.” – Oleg Vornik, CEO of @droneshield_official

DroneShield Limited (ASX:DRO) has secured three standalone contracts worth $61.6 million from an undisclosed European military customer
📡 The contracts are for handheld detection, counterdrone systems and accessories
⚙️ The order is the biggest single order in DroneShield history and is larger than its entire revenue for 2024 ($57.5 million)
🤝 DroneShield previously received a single contract from the same customer in April 2024 worth $0.5 million
“In succession to the $32.2 million repeat order announced on 14 April 2025 for another customer, DroneShield products are now being purchased in material quantities. The scale and frequency of orders has been increasing as leading Military customers are moving from testing hardware to broader rollouts. DroneShield is well placed to meet the increasing demand.” – Oleg Vornik, CEO of @droneshield_official
The Stock Network is pleased to support the Sydney Mining Club and interview Flynn Gold (ASX:FG1) Managing Director & CEO Neil Marston, who will be presenting at the Sydney Mining Club Event.
Hear about Flynn Gold’s exploration potential at its flagship Golden Ridge project in Tasmania, including its greenfields discovery at the Grenadier prospect where recent bulk sample results returned over 10 grams per tonne gold with 95% recovery. The company is now gearing up for an upcoming drilling campaign at Grenadier.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Flynn Gold (ASX:FG1) Managing Director & CEO Neil Marston.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Flynn Gold (ASX:FG1) Managing Director & CEO Neil Marston, who will be presenting at the Sydney Mining Club Event.
Hear about Flynn Gold’s exploration potential at its flagship Golden Ridge project in Tasmania, including its greenfields discovery at the Grenadier prospect where recent bulk sample results returned over 10 grams per tonne gold with 95% recovery. The company is now gearing up for an upcoming drilling campaign at Grenadier.
Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Flynn Gold (ASX:FG1) Managing Director & CEO Neil Marston.
🗓 Thursday 3 July 2025
🕛 5:15 PM
📍 Establishment Ballroom, 252 George Street, Sydney
Infragreen Group Limited has listed on the ASX with a ticker code of IFN. The company owns, operates and holds interests in sustainable infrastructure businesses in Australia and New Zealand. These operations have a strong focus on recycling and waste recovery alongside clean energy and energy transition. Infragreen’s business model is built on strategic asset ownership, active management and growth, collaborative partnerships, sustainable infrastructure solutions and value creation and long-term stability. Longer term, Infragreen aims to broaden its diversified platform by strategically expanding into additional business pillars.

Infragreen Group Limited has listed on the ASX with a ticker code of IFN. The company owns, operates and holds interests in sustainable infrastructure businesses in Australia and New Zealand. These operations have a strong focus on recycling and waste recovery alongside clean energy and energy transition. Infragreen’s business model is built on strategic asset ownership, active management and growth, collaborative partnerships, sustainable infrastructure solutions and value creation and long-term stability. Longer term, Infragreen aims to broaden its diversified platform by strategically expanding into additional business pillars.
Alliance Aviation Services Limited (ASX:AQZ) has secured a $62.3 million binding sale of 12 General Electric CF34-10E engines to US-based BeauTech Power Systems.
🗓️ Ten of the engines are set to be delivered by the end of FY25, and the other two by early FY26
✈️ BeauTech is a leading provider of aviation solutions, specialising in leasing and trading of aircraft engines
🛫 Alliance Aviation is Australasia’s leading provider of contract, charter and allied aviation and maintenance services
“We are delighted with this outcome where we have again been able to monetise inventory at values commensurate with current market prices and take advantage of the low AUD/USD exchange rate.” – Scott McMillan, MD of Alliance
“Over the course of our recent negotiations with Alliance, we have developed a strong and collaborative relationship, supported by several visits to Brisbane by myself and the BeauTech team. We hold Alliance’s commercial approach in high regard and are particularly impressed by the strength and uniqueness of their business model.” – Lee Beaumont, Founder, President and CEO of BeauTech

Alliance Aviation Services Limited (ASX:AQZ) has secured a $62.3 million binding sale of 12 General Electric CF34-10E engines to US-based BeauTech Power Systems.
🗓️ Ten of the engines are set to be delivered by the end of FY25, and the other two by early FY26
✈️ BeauTech is a leading provider of aviation solutions, specialising in leasing and trading of aircraft engines
🛫 Alliance Aviation is Australasia’s leading provider of contract, charter and allied aviation and maintenance services
“We are delighted with this outcome where we have again been able to monetise inventory at values commensurate with current market prices and take advantage of the low AUD/USD exchange rate.” – Scott McMillan, MD of Alliance
“Over the course of our recent negotiations with Alliance, we have developed a strong and collaborative relationship, supported by several visits to Brisbane by myself and the BeauTech team. We hold Alliance’s commercial approach in high regard and are particularly impressed by the strength and uniqueness of their business model.” – Lee Beaumont, Founder, President and CEO of BeauTech
Greatland Resources Limited has listed on the ASX with a ticker code of GGP. The company is an Australian gold-copper producer owning and operating the Telfer gold-copper mine and the adjacent world-class brownfield Havieron gold-copper project in Western Australia’s Paterson region. The company says the positioning of Telfer’s existing infrastructure and processing capacity in the Paterson region effectively de-risks, expedites and reduces the cost of completing the planned development of Havieron.

Greatland Resources Limited has listed on the ASX with a ticker code of GGP. The company is an Australian gold-copper producer owning and operating the Telfer gold-copper mine and the adjacent world-class brownfield Havieron gold-copper project in Western Australia’s Paterson region. The company says the positioning of Telfer’s existing infrastructure and processing capacity in the Paterson region effectively de-risks, expedites and reduces the cost of completing the planned development of Havieron.
Virgin Australia Holdings has listed on the ASX with a ticker code of VGN. The company owns the second largest airline group operating in the Australian aviation market. Virgin Australia’s fleet of more than 100 aircraft fly routes across its domestic and short-haul international business. The company also boasts a world class suite of international airline partners, which provide a comprehensive ‘capital light’ long-haul international network. These partners include Qatar Airways, which recently acquired a 25% stake in Virgin Australia. The company’s airline business is supported by Velocity, an award-winning loyalty program with around 80 commercial partners and 13 million members.

Virgin Australia Holdings has listed on the ASX with a ticker code of VGN. The company owns the second largest airline group operating in the Australian aviation market. Virgin Australia’s fleet of more than 100 aircraft fly routes across its domestic and short-haul international business. The company also boasts a world class suite of international airline partners, which provide a comprehensive ‘capital light’ long-haul international network. These partners include Qatar Airways, which recently acquired a 25% stake in Virgin Australia. The company’s airline business is supported by Velocity, an award-winning loyalty program with around 80 commercial partners and 13 million members.
Nimy Resources (ASX:NIM) has recently announced high grade gallium in its first assays from its high grade gallium discovery at its Block 3 prospect in Western Australia. The gallium drilling campaign has been completed Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network to discuss what lies ahead for Nimy Resources.
🪨 High grade Gallium in first assays
⛏️ Set for maiden resource with drilling campaign finished and further assays pending
⚒️ Rio Tinto’s (ASX:RIO) push into the gallium market

Nimy Resources (ASX:NIM) has recently announced high grade gallium in its first assays from its high grade gallium discovery at its Block 3 prospect in Western Australia. The gallium drilling campaign has been completed Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network to discuss what lies ahead for Nimy Resources.
🪨 High grade Gallium in first assays
⛏️ Set for maiden resource with drilling campaign finished and further assays pending
⚒️ Rio Tinto’s (ASX:RIO) push into the gallium market
Smartpay Holdings Limited (ASX:SMP, NZSX:SPY) has entered into a Scheme Implementation Agreement under which US-based payment company Shift4 Payments will acquire all Smartpay shares for NZ$1.20 per share in cash
🌎 Shift4 processes over US$260 billion in payment transactions each year across 45 countries and 200,000 customers
🇦🇺 Smartpay is Australia and New Zealand’s largest independent full-service EFTPOS provider, serving over 39,000 merchants
🤝 The proposed acquisition has an implied equity value of A$274 million
“Smartpay remains focused on being the payments partner of choice, investing and adding scale to our existing Australian and New Zealand business. The proposed transaction, if completed, will see Shift4 partner with Smartpay to deliver an enhanced value proposition to our customers, employees and other stakeholders while delivering immediate and derisked value to our current shareholders.” – Marty Pomeroy, CEO of Smartpay

Smartpay Holdings Limited (ASX:SMP, NZSX:SPY) has entered into a Scheme Implementation Agreement under which US-based payment company Shift4 Payments will acquire all Smartpay shares for NZ$1.20 per share in cash
🌎 Shift4 processes over US$260 billion in payment transactions each year across 45 countries and 200,000 customers
🇦🇺 Smartpay is Australia and New Zealand’s largest independent full-service EFTPOS provider, serving over 39,000 merchants
🤝 The proposed acquisition has an implied equity value of A$274 million
“Smartpay remains focused on being the payments partner of choice, investing and adding scale to our existing Australian and New Zealand business. The proposed transaction, if completed, will see Shift4 partner with Smartpay to deliver an enhanced value proposition to our customers, employees and other stakeholders while delivering immediate and derisked value to our current shareholders.” – Marty Pomeroy, CEO of Smartpay
4DMedical (ASX:4DX) has expanded its existing contract with Stanford University’s 3DQ Lab to include CT:VQ imaging technology for research and evaluation
🤝Stanford has renewed the license for a suite of 4DMedical products, and upgraded its package to include CT:VQ, among others
🧪CT:VQ is an imaging solution that provides ventilation and perfusion information without the need for radioactive tracers or contrast agents
🩺Stanford University’s 3DQ Lab is globally recognised for its role in evaluating, validating and operationalising medical imaging technologies
“Stanford’s 3DQ Lab is one of the most influential medical imaging research centres in the world, and the renewal and expansion of their contract shows the value they see in 4DMedical’s technology.” Andreas Fouras, MD and CEO of 4DMedical

4DMedical (ASX:4DX) has expanded its existing contract with Stanford University’s 3DQ Lab to include CT:VQ imaging technology for research and evaluation
🤝Stanford has renewed the license for a suite of 4DMedical products, and upgraded its package to include CT:VQ, among others
🧪CT:VQ is an imaging solution that provides ventilation and perfusion information without the need for radioactive tracers or contrast agents
🩺Stanford University’s 3DQ Lab is globally recognised for its role in evaluating, validating and operationalising medical imaging technologies
“Stanford’s 3DQ Lab is one of the most influential medical imaging research centres in the world, and the renewal and expansion of their contract shows the value they see in 4DMedical’s technology.” Andreas Fouras, MD and CEO of 4DMedical
FBR (ASX:FBR, OTCQB:FBRKF) is a robotic technology company that builds dynamically stabilised construction robots and has just signed a non-binding Memorandum of Understanding with Darwin-based builder Habitat NT for the sale of Hadrian X units. The deal, valued at A$7.8 million, marks FBR’s entry into the Northern Territory market, where a critical shortage of housing and trades is driving demand for innovation in construction. FBR Co-Founder, CEO, and primary inventor of FBR`s technology Mark Pivac joins Lel Smits from The Stock Network.
🤝 FBR $7.8M Northern Territory machine deal with Habitat NT
🏠 Addressing the housing and defence build boom
🚛 A potential long-term rollout of Hadrian X
🤖 FBR and Samsung Heavy Industries deal and development of commercialisation business models

FBR (ASX:FBR, OTCQB:FBRKF) is a robotic technology company that builds dynamically stabilised construction robots and has just signed a non-binding Memorandum of Understanding with Darwin-based builder Habitat NT for the sale of Hadrian X units. The deal, valued at A$7.8 million, marks FBR’s entry into the Northern Territory market, where a critical shortage of housing and trades is driving demand for innovation in construction. FBR Co-Founder, CEO, and primary inventor of FBR`s technology Mark Pivac joins Lel Smits from The Stock Network.
🤝 FBR $7.8M Northern Territory machine deal with Habitat NT
🏠 Addressing the housing and defence build boom
🚛 A potential long-term rollout of Hadrian X
🤖 FBR and Samsung Heavy Industries deal and development of commercialisation business models
Nimy Resources (ASX: NIM) has reported high-grade gallium assay results from the first four holes of the Phase 2 drilling program at its Block 3 Gallium Project in WA.
⚒️ The results confirm the potential for Block 3 to emerge as a standalone gallium project, with consistent near-surface and deeper mineralisation intersected across all initial holes.
⛏️ The Phase 2 drill program has delivered outstanding gallium assay results, including multiple high-grade intercepts from near-surface, highlighting the scale and continuity of mineralisation at Block 3.
"The first assays received from phase 2 drilling at Block 3 indicate a continuation of high-grade gallium immediately east, west and south of our previously drilled high grade holes, including high-grade intervals outside of our current exploration target.
“These results give us confidence in our drilling strategy targeting a substantial high-grade gallium JORC resource, importantly drilling is demonstrating an extensive and coherent mineralised system.
“With Phase 3 nearing completion and remaining Phase 2 assays due shortly, we are defining a globally significant gallium project capable of supporting in part the supply needs of the Western world”. - Luke Hampson, Nimy Resources Managing Director

Nimy Resources (ASX: NIM) has reported high-grade gallium assay results from the first four holes of the Phase 2 drilling program at its Block 3 Gallium Project in WA.
⚒️ The results confirm the potential for Block 3 to emerge as a standalone gallium project, with consistent near-surface and deeper mineralisation intersected across all initial holes.
⛏️ The Phase 2 drill program has delivered outstanding gallium assay results, including multiple high-grade intercepts from near-surface, highlighting the scale and continuity of mineralisation at Block 3.
"The first assays received from phase 2 drilling at Block 3 indicate a continuation of high-grade gallium immediately east, west and south of our previously drilled high grade holes, including high-grade intervals outside of our current exploration target.
“These results give us confidence in our drilling strategy targeting a substantial high-grade gallium JORC resource, importantly drilling is demonstrating an extensive and coherent mineralised system.
“With Phase 3 nearing completion and remaining Phase 2 assays due shortly, we are defining a globally significant gallium project capable of supporting in part the supply needs of the Western world”. - Luke Hampson, Nimy Resources Managing Director
Mineral exploration business Tennant Minerals (ASX:TMS) is focused on its 100%-owned Barkly copper-gold project in the Northern Territory.
A review of historical drilling, geochemical data, and gravity surveys has now uncovered two high-priority copper-gold targets, Babbler and Wedge, in proximity to the group’s high-grade Bluebird copper-gold discovery.
Tennant Minerals CEO Vincent Algar joins Lel Smits from The Stock Network.
⚒️ Two large-scale gold-copper targets identified
⛏️ Historical drilling shows kilometre-scale gold anomaly
🪨 Pathway to drilling and regional processing

Mineral exploration business Tennant Minerals (ASX:TMS) is focused on its 100%-owned Barkly copper-gold project in the Northern Territory.
A review of historical drilling, geochemical data, and gravity surveys has now uncovered two high-priority copper-gold targets, Babbler and Wedge, in proximity to the group’s high-grade Bluebird copper-gold discovery.
Tennant Minerals CEO Vincent Algar joins Lel Smits from The Stock Network.
⚒️ Two large-scale gold-copper targets identified
⛏️ Historical drilling shows kilometre-scale gold anomaly
🪨 Pathway to drilling and regional processing
The Stock Network is pleased to support the Noosa Mining Conference and interview Pantoro Gold (ASX:PNR) Managing Director Paul Cmrlec, who will be presenting at the Noosa Mining conference. Hear about why Pantoro Gold`s shares are up around 130% over the last year, as the Western Australian based gold producer ramps up operations in one of the state`s highest grate goldfields. The miner is also debt free and boasts cash growth while building new mines and advancing growth activities. Ahead of appearing at the Noosa Mining Conference, Pantoro Gold Managing Director Paul Cmrlec , joins Lel Smits from The Stock Network.
🗓 Wednesday 23 July 2025 - Friday 25 July 2025
🕛 11:30 AM
📍 Peppers Noosa Resort, Queensland

The Stock Network is pleased to support the Noosa Mining Conference and interview Pantoro Gold (ASX:PNR) Managing Director Paul Cmrlec, who will be presenting at the Noosa Mining conference. Hear about why Pantoro Gold`s shares are up around 130% over the last year, as the Western Australian based gold producer ramps up operations in one of the state`s highest grate goldfields. The miner is also debt free and boasts cash growth while building new mines and advancing growth activities. Ahead of appearing at the Noosa Mining Conference, Pantoro Gold Managing Director Paul Cmrlec , joins Lel Smits from The Stock Network.
🗓 Wednesday 23 July 2025 - Friday 25 July 2025
🕛 11:30 AM
📍 Peppers Noosa Resort, Queensland
Asian Battery Metals PLC (ASX: AZ9) starts the regional exploration program at its Yambat Project.
⛰️ New ultramafic - gabbroic intrusion with weak sulphide mineralisation was intersected at MS1, located 6km southeast of the main Oval Cu-Ni discovery.
⛏️ A conductive plate identified via downhole electromagnetic (EM) supports the possibility of lateral and deeper mineralised zones.
🔎A SAMSON EM survey will be designed and completed at the MS1 target to further delineate potential conductors.
⚒️ MS2 drilling intersects gabbroic rock, visually similar to un-mineralised zones at Oval, suggesting a potential structural linkage and potential for mineralisation in this area.
🪨 The ground-based deep penetrating SAMSON EM survey has commenced on the Oval Cu-Ni prospect and will be expanded to the MS1 area.
“These early scout holes at MS1 and MS2 show we are onto a broader mineralised system. The discovery of new mafic-ultramafic intrusions at MS1 and MS2 — with mineralisation and EM conductors at MS1 — supports the view that Yambat is a district-scale system. These new targets could represent a parallel mineralised trend to Oval, offering multiple potential pipelines for discovery. We will continue EM surveys and planning of follow-up drilling to most efficiently unlock the potential of these regional targets.” - Gan-Ochir Zunduisuren, Managing Director of Asian Battery Metals PLC

Asian Battery Metals PLC (ASX: AZ9) starts the regional exploration program at its Yambat Project.
⛰️ New ultramafic - gabbroic intrusion with weak sulphide mineralisation was intersected at MS1, located 6km southeast of the main Oval Cu-Ni discovery.
⛏️ A conductive plate identified via downhole electromagnetic (EM) supports the possibility of lateral and deeper mineralised zones.
🔎A SAMSON EM survey will be designed and completed at the MS1 target to further delineate potential conductors.
⚒️ MS2 drilling intersects gabbroic rock, visually similar to un-mineralised zones at Oval, suggesting a potential structural linkage and potential for mineralisation in this area.
🪨 The ground-based deep penetrating SAMSON EM survey has commenced on the Oval Cu-Ni prospect and will be expanded to the MS1 area.
“These early scout holes at MS1 and MS2 show we are onto a broader mineralised system. The discovery of new mafic-ultramafic intrusions at MS1 and MS2 — with mineralisation and EM conductors at MS1 — supports the view that Yambat is a district-scale system. These new targets could represent a parallel mineralised trend to Oval, offering multiple potential pipelines for discovery. We will continue EM surveys and planning of follow-up drilling to most efficiently unlock the potential of these regional targets.” - Gan-Ochir Zunduisuren, Managing Director of Asian Battery Metals PLC
FOS Capital (ASX:FOS) is acquiring the street lighting assets of Aldridge Traffic Systems from ASX-listed Traffic Technologies Ltd (ASX:TTI) for a total consideration of $3.1m
🤝The total consideration of $3.1 million includes $0.9 million in plant and equipment, $0.5 million in inventory and $1.7 million in intellectual property
🚦ATS designs, manufactures and distributes data-enabled LED road lighting
👥 The acquisition will be funded via a $3.7 million equity raising placement at $0.30 per share

FOS Capital (ASX:FOS) is acquiring the street lighting assets of Aldridge Traffic Systems from ASX-listed Traffic Technologies Ltd (ASX:TTI) for a total consideration of $3.1m
🤝The total consideration of $3.1 million includes $0.9 million in plant and equipment, $0.5 million in inventory and $1.7 million in intellectual property
🚦ATS designs, manufactures and distributes data-enabled LED road lighting
👥 The acquisition will be funded via a $3.7 million equity raising placement at $0.30 per share
Specialist metal technology business AML3D (ASX: AL3) is shaping the future of manufacturing by redefining how critical metal components are produced.
Its ARCEMY 3D printing systems utilise the company’s patented Wire Additive Manufacturing (WAM) technology to provide an all-in-one digital advanced manufacturing solution for multiple high-performance sectors.
ARCEMY builds stronger parts with shorter lead times that can be certified and manufactured, whilst delivering a lower carbon footprint compared to traditional processes.
AML3D’s technology is applicable to a wide array on industries such as aerospace, defence, maritime, oil and gas, with key benefits including:
⚙️ Faster lead times compared to machining from billet and exotic material casting or forging
🌿 Reduced waste and material costs
🧩 Enhanced design freedom and customisation
💪 Proven strength and durability for mission-critical use
🔗On-demand, scalable manufacturing anywhere in the world
ARCEMY enables industries to move from supply chain constraints to supply chain resilience - all while meeting performance, safety, and environmental standards.

Specialist metal technology business AML3D (ASX: AL3) is shaping the future of manufacturing by redefining how critical metal components are produced.
Its ARCEMY 3D printing systems utilise the company’s patented Wire Additive Manufacturing (WAM) technology to provide an all-in-one digital advanced manufacturing solution for multiple high-performance sectors.
ARCEMY builds stronger parts with shorter lead times that can be certified and manufactured, whilst delivering a lower carbon footprint compared to traditional processes.
AML3D’s technology is applicable to a wide array on industries such as aerospace, defence, maritime, oil and gas, with key benefits including:
⚙️ Faster lead times compared to machining from billet and exotic material casting or forging
🌿 Reduced waste and material costs
🧩 Enhanced design freedom and customisation
💪 Proven strength and durability for mission-critical use
🔗On-demand, scalable manufacturing anywhere in the world
ARCEMY enables industries to move from supply chain constraints to supply chain resilience - all while meeting performance, safety, and environmental standards.
icetana AI (ASX:ICE) has secured an A$3.6 million strategic partnership with Singapore-based SoftBank Robotics Group
🤖 The partnership includes a three-year joint product development program to integrate icetana’s AI analytics with SoftBank’s automation and security solutions
👥 SoftBank Robotics will acquire a 17.6% stake in icetana for A$1.87 million
Under the agreement, SoftBank has been appointed as exclusive distributor for icetana AI in Japan
“Adding to our existing partnership with Macnica, this agreement with SoftBank Robotics Group represents a major step forward for icetana AI in Japan. Their global leadership in AI and commercial scale in Japan create an ideal launchpad for our next phase of growth. This partnership not only accelerates our expansion into key markets but also integrates our technology into some of the world’s most advanced security platforms.” – Kevin Brown, CEO of icetana AI

icetana AI (ASX:ICE) has secured an A$3.6 million strategic partnership with Singapore-based SoftBank Robotics Group
🤖 The partnership includes a three-year joint product development program to integrate icetana’s AI analytics with SoftBank’s automation and security solutions
👥 SoftBank Robotics will acquire a 17.6% stake in icetana for A$1.87 million
Under the agreement, SoftBank has been appointed as exclusive distributor for icetana AI in Japan
“Adding to our existing partnership with Macnica, this agreement with SoftBank Robotics Group represents a major step forward for icetana AI in Japan. Their global leadership in AI and commercial scale in Japan create an ideal launchpad for our next phase of growth. This partnership not only accelerates our expansion into key markets but also integrates our technology into some of the world’s most advanced security platforms.” – Kevin Brown, CEO of icetana AI
FBR Limited (ASX: FBR) is a robotic technology business that builds dynamically stabilised robots which utilise the company’s Dynamic Stabilisation Technology (DST) to effectively operate in an outdoor environment. The group is advancing the commercialisation push for its Hadrian X fully automated robotic bricklaying system, designed to build structural walls faster, safer, more accurately, and with less wastage than traditional manual methods. FBR Co Founder, CEO and primary inventor of FBR technology, Mark Pivac, joins Lel Smits from The Stock Network.
🤖 Overview Hadrian X and globally unique technology
🚧 Commercialisation push for Hadrian X
🧑💻 Adjacent applications of the DST technology

FBR Limited (ASX: FBR) is a robotic technology business that builds dynamically stabilised robots which utilise the company’s Dynamic Stabilisation Technology (DST) to effectively operate in an outdoor environment. The group is advancing the commercialisation push for its Hadrian X fully automated robotic bricklaying system, designed to build structural walls faster, safer, more accurately, and with less wastage than traditional manual methods. FBR Co Founder, CEO and primary inventor of FBR technology, Mark Pivac, joins Lel Smits from The Stock Network.
🤖 Overview Hadrian X and globally unique technology
🚧 Commercialisation push for Hadrian X
🧑💻 Adjacent applications of the DST technology
Asian Battery Metals (ASX:AZ9) is a mineral explorer targeting the discovery of critical battery mineral deposits in Mongolia, including at its wholly owned Yambat project where drilling has already unveiled a significant copper and nickel discovery at the Oval prospect. The company recently launched a follow-up drilling campaign at Oval, whilst also commencing a broader regional exploration program at its Yambat tenure. Asian Battery Metals Managing Director, Gan-Ochir Zunduisuren, joins Lel Smits from The Stock Network.
⛰️ Overview of the Oval discovery
⚒️ Follow-up drilling at Oval and recent news
⛏️ Regional exploration campaign at Yambat

Asian Battery Metals (ASX:AZ9) is a mineral explorer targeting the discovery of critical battery mineral deposits in Mongolia, including at its wholly owned Yambat project where drilling has already unveiled a significant copper and nickel discovery at the Oval prospect. The company recently launched a follow-up drilling campaign at Oval, whilst also commencing a broader regional exploration program at its Yambat tenure. Asian Battery Metals Managing Director, Gan-Ochir Zunduisuren, joins Lel Smits from The Stock Network.
⛰️ Overview of the Oval discovery
⚒️ Follow-up drilling at Oval and recent news
⛏️ Regional exploration campaign at Yambat
Kincora Copper (ASX:KCC) is an emerging Australia-focused project generator and copper-gold explorer now successfully proving up the prospectivity of its extensive project portfolio. Kincora Chief Executive Officer, Sam Spring joins The Stock Network`s Lel Smits.
⛏️ Reasons for the second extension to the ongoing drilling program at the Nyngan project funded by AngloGold Ashanti
⚒️ Drilling to transition from Nyngan to the highly rated Nevertire and Nevertire South projects
🪨 Kincora receives fees for managing these drill programs
🤝 Shareholder overhang has been removed

Kincora Copper (ASX:KCC) is an emerging Australia-focused project generator and copper-gold explorer now successfully proving up the prospectivity of its extensive project portfolio. Kincora Chief Executive Officer, Sam Spring joins The Stock Network`s Lel Smits.
⛏️ Reasons for the second extension to the ongoing drilling program at the Nyngan project funded by AngloGold Ashanti
⚒️ Drilling to transition from Nyngan to the highly rated Nevertire and Nevertire South projects
🪨 Kincora receives fees for managing these drill programs
🤝 Shareholder overhang has been removed
Robex Resources Inc has listed on the ASX with a ticker code of RXR. The Company is also listed on the TSX Venture Exchange (TSX-V) and is a West African gold explorer, developer and producer. Robex Resources currently has two assets in the Birimian Greenstone belt: the Nampala Project, a mine located in southern Mali; and, the advanced Kiniéro Project, which is located in Guinea. While Kiniéro Project is currently Robex Resources’ major focus, the Mali-based Nampala asset includes a producing gold mine.

Robex Resources Inc has listed on the ASX with a ticker code of RXR. The Company is also listed on the TSX Venture Exchange (TSX-V) and is a West African gold explorer, developer and producer. Robex Resources currently has two assets in the Birimian Greenstone belt: the Nampala Project, a mine located in southern Mali; and, the advanced Kiniéro Project, which is located in Guinea. While Kiniéro Project is currently Robex Resources’ major focus, the Mali-based Nampala asset includes a producing gold mine.
Nimy Resources Limited (ASX:NIM) has extended strong potential gallium mineralisation at the Block 3 Gallium Project, part of its broader Mons Critical Minerals Project in Western Australia.
🪨 Preliminary logging from ongoing Phase 2 drilling has confirmed the presence of extensive gallium-hosting lithologies across the newly delineated Central Zone located in Nimy Resources’ Block 3 Gallium Project, with the system remaining open along strike and at depth.
⚒️ Drilling completed within the Central Zone has intersected zones of chlorite schist, which has been independently validated by CSIRO as the primary host rock for potential high-grade gallium mineralisation at Block 3.
⛏️ Reconnaissance fieldwork continues across the broader Block 3 prospect area, focussing on mapping and sampling additional occurrences of chlorite schist along strike.
“The consistent intersection of mafic schist across all Central Zone drillholes indicates the continuity of the primary gallium host unit and supports our interpretation of a large, coherent mineralised system at Block 3.
“With mineralisation remaining open along strike and at depth, and step-out drilling now testing newly identified outcropping zones, the project continues to demonstrate the hallmarks of a high-grade, critical metal discovery.
“As gallium emerges as a priority metal for semiconductors and defence technologies, securing supply is now a strategic imperative for Western economies. Block 3 positions Nimy at the forefront of the Western World’s response to this challenge.
“Looking ahead, Nimy is actively progressing discussions with downstream partners to ensure optimising future processing pathways” - Luke Hampson, Nimy Resources Managing Director

Nimy Resources Limited (ASX:NIM) has extended strong potential gallium mineralisation at the Block 3 Gallium Project, part of its broader Mons Critical Minerals Project in Western Australia.
🪨 Preliminary logging from ongoing Phase 2 drilling has confirmed the presence of extensive gallium-hosting lithologies across the newly delineated Central Zone located in Nimy Resources’ Block 3 Gallium Project, with the system remaining open along strike and at depth.
⚒️ Drilling completed within the Central Zone has intersected zones of chlorite schist, which has been independently validated by CSIRO as the primary host rock for potential high-grade gallium mineralisation at Block 3.
⛏️ Reconnaissance fieldwork continues across the broader Block 3 prospect area, focussing on mapping and sampling additional occurrences of chlorite schist along strike.
“The consistent intersection of mafic schist across all Central Zone drillholes indicates the continuity of the primary gallium host unit and supports our interpretation of a large, coherent mineralised system at Block 3.
“With mineralisation remaining open along strike and at depth, and step-out drilling now testing newly identified outcropping zones, the project continues to demonstrate the hallmarks of a high-grade, critical metal discovery.
“As gallium emerges as a priority metal for semiconductors and defence technologies, securing supply is now a strategic imperative for Western economies. Block 3 positions Nimy at the forefront of the Western World’s response to this challenge.
“Looking ahead, Nimy is actively progressing discussions with downstream partners to ensure optimising future processing pathways” - Luke Hampson, Nimy Resources Managing Director
BetMakers Technology Group (ASX:BET) has struck a binding heads of agreement to acquire the Las Vegas Dissemination Company (LVDC), Nevada’s only approved provider of pari-mutuel wagering.
🗓️ The proposed acquisition is expected to generate approximately A$4 million in annualised revenue
🐎 LVDC is Las Vegas’ only approved supplied of Horse and Greyhound pari-mutuel wagering
🎰 BetMakers plans to use its technology to help modernise and improve the horse racing wagering experience in Las Vegas both digitally and in-venue
“We are excited to announce the potential acquisition of LVDC. A strategic step that strengthens our position within the North American market and expands connectivity with world-class global wagering operators through the BetMakers network. This acquisition would not only give us access to the dynamic Nevada gaming market but also creates a strong platform to showcase innovation in horse racing technology and retail wagering experiences.” – Jake Henson, CEO of BetMakers

BetMakers Technology Group (ASX:BET) has struck a binding heads of agreement to acquire the Las Vegas Dissemination Company (LVDC), Nevada’s only approved provider of pari-mutuel wagering.
🗓️ The proposed acquisition is expected to generate approximately A$4 million in annualised revenue
🐎 LVDC is Las Vegas’ only approved supplied of Horse and Greyhound pari-mutuel wagering
🎰 BetMakers plans to use its technology to help modernise and improve the horse racing wagering experience in Las Vegas both digitally and in-venue
“We are excited to announce the potential acquisition of LVDC. A strategic step that strengthens our position within the North American market and expands connectivity with world-class global wagering operators through the BetMakers network. This acquisition would not only give us access to the dynamic Nevada gaming market but also creates a strong platform to showcase innovation in horse racing technology and retail wagering experiences.” – Jake Henson, CEO of BetMakers
DXN Limited (ASX:DXN) secured a $4.6 million contract with Globalstar, a leading US-based telecommunications company that operates a low earth orbit (LEO) satellite constellation
🔧 DXN’s core business is designing, engineering, manufacturing, maintaining and operating data centres in Asia Pacific
📡 Under the contract, DXN will deliver three prefabricated modular data centre units to Globalstar
🌎 The units are set to be deployed in Maui, Hawaii by the end of 2025
“This contract is more than a commercial milestone – it affirms DXN’s unique value in delivering mission-critical infrastructure. We are excited about the positive impact this project will have on our business and look forward to executing it with the same dedication and precision that defines our brand. We remain focused on executing our scale-up strategy, strengthening our global delivery capabilities, and delivering exceptional outcomes for our customers.” – Shalini Lagrutta, CEO and MD of DXN

DXN Limited (ASX:DXN) secured a $4.6 million contract with Globalstar, a leading US-based telecommunications company that operates a low earth orbit (LEO) satellite constellation
🔧 DXN’s core business is designing, engineering, manufacturing, maintaining and operating data centres in Asia Pacific
📡 Under the contract, DXN will deliver three prefabricated modular data centre units to Globalstar
🌎 The units are set to be deployed in Maui, Hawaii by the end of 2025
“This contract is more than a commercial milestone – it affirms DXN’s unique value in delivering mission-critical infrastructure. We are excited about the positive impact this project will have on our business and look forward to executing it with the same dedication and precision that defines our brand. We remain focused on executing our scale-up strategy, strengthening our global delivery capabilities, and delivering exceptional outcomes for our customers.” – Shalini Lagrutta, CEO and MD of DXN
The Stock Network is pleased to support the Noosa Mining Conference and interview Southern Cross Gold (ASX:SX2, TSX:SXGC) President & CEO / Managing Director Michael Hudson, who will be presenting at the Noosa Mining conference. Hear about Southern Cross Gold`s flagship asset Sunday Creek gold and antimony project which could represent one of the most significant exploration discoveries to come out of Australia in recent times. Ahead of appearing at the Noosa Mining Conference, Southern Cross Gold President & CEO / Managing Director Michael Hudson, joins Lel Smits from The Stock Network.
🗓 Wednesday 23 July 2025 - Friday 25 July 2025
🕛 11:30 AM
📍 Peppers Noosa Resort, Queensland

The Stock Network is pleased to support the Noosa Mining Conference and interview Southern Cross Gold (ASX:SX2, TSX:SXGC) President & CEO / Managing Director Michael Hudson, who will be presenting at the Noosa Mining conference. Hear about Southern Cross Gold`s flagship asset Sunday Creek gold and antimony project which could represent one of the most significant exploration discoveries to come out of Australia in recent times. Ahead of appearing at the Noosa Mining Conference, Southern Cross Gold President & CEO / Managing Director Michael Hudson, joins Lel Smits from The Stock Network.
🗓 Wednesday 23 July 2025 - Friday 25 July 2025
🕛 11:30 AM
📍 Peppers Noosa Resort, Queensland
The Stock Network is pleased to support the Sydney Mining Club and interview New Hope Group (ASX:NHC) Chief Executive Officer, Rob Bishop, who will be presenting at the Sydney Mining Club Event. Hear about New Hope’s flagship assets including the 80 per cent owned Bengalla coal mine in the Hunter Valley of New South Wales, and the New Acland coal mine in Queensland. Ahead of appearing at Sydney Mining Club, New Hope Chief Executive Officer, Rob Bishop, joins Lel Smits from The Stock Network.
🗓 Thursday 5 June 2025
🕛 12:15 PM
📍 Ivy Ballroom, 320 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview New Hope Group (ASX:NHC) Chief Executive Officer, Rob Bishop, who will be presenting at the Sydney Mining Club Event. Hear about New Hope’s flagship assets including the 80 per cent owned Bengalla coal mine in the Hunter Valley of New South Wales, and the New Acland coal mine in Queensland. Ahead of appearing at Sydney Mining Club, New Hope Chief Executive Officer, Rob Bishop, joins Lel Smits from The Stock Network.
🗓 Thursday 5 June 2025
🕛 12:15 PM
📍 Ivy Ballroom, 320 George Street, Sydney
Neurotech International Limited (ASX:NTI) has delivered positive results from a human study of its new treatment, NTI164, designed to treat neurological and inflammatory brain disorders in children.
🌱NTI164 is a drug formulation derived from unique cannabis strains and demonstrates positive treatment effects on human neuroinflammatory disorders
👶Minimal Tetrahydrocannabinol (THC) exposure in NTI164 treatment confirms a non-intoxicating profile suitable for paediatric use
✅The positive results support NTI164’s advancement toward regulatory approval across both the US FDA and Australian TGA
"The results of our first-in-human PK study represent another important clinical milestone for NTI164. The clear validation of systemic stability, safety and targeted therapeutic action highlights NTI164`s potential as a disease-modifying therapy. We are eager to advance NTI164 rapidly into the next stages of its development and regulatory progress, while actively pursuing commercial opportunities." – Dr Anthony Filippis, CEO and MD of Neurotech

Neurotech International Limited (ASX:NTI) has delivered positive results from a human study of its new treatment, NTI164, designed to treat neurological and inflammatory brain disorders in children.
🌱NTI164 is a drug formulation derived from unique cannabis strains and demonstrates positive treatment effects on human neuroinflammatory disorders
👶Minimal Tetrahydrocannabinol (THC) exposure in NTI164 treatment confirms a non-intoxicating profile suitable for paediatric use
✅The positive results support NTI164’s advancement toward regulatory approval across both the US FDA and Australian TGA
"The results of our first-in-human PK study represent another important clinical milestone for NTI164. The clear validation of systemic stability, safety and targeted therapeutic action highlights NTI164`s potential as a disease-modifying therapy. We are eager to advance NTI164 rapidly into the next stages of its development and regulatory progress, while actively pursuing commercial opportunities." – Dr Anthony Filippis, CEO and MD of Neurotech
The Stock Network is pleased to support the Sydney Mining Club and interview TerraCom (ASX:TER) Managing Director Danny McCarthy, who will be presenting at the Sydney Mining Club Event. Hear about TerraCom’s operations headlined by its flagship Blair Athol coal mine in Queensland’s Bowen Basin. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is TerraCom (ASX:TER) Managing Director Danny McCarthy.
🗓 Thursday 5 June 2025
🕛 12:15 PM
📍 Ivy Ballroom, 320 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview TerraCom (ASX:TER) Managing Director Danny McCarthy, who will be presenting at the Sydney Mining Club Event. Hear about TerraCom’s operations headlined by its flagship Blair Athol coal mine in Queensland’s Bowen Basin. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is TerraCom (ASX:TER) Managing Director Danny McCarthy.
🗓 Thursday 5 June 2025
🕛 12:15 PM
📍 Ivy Ballroom, 320 George Street, Sydney
ASX-listed investment house TIP Group (ASX:TIP) implements a disciplined investment philosophy based on a systematic approach which combines fundamentals, valuation, and risk assessment to uncover long-term wealth-building opportunities for investors.
It believes that smart investing isn’t just about buying at the right time, but also about disciplined exit decisions.
💾 Lets data guide its decisions and sells companies that no longer meet the group’s investment criteria
👥 Relies on collective wisdom of experienced members in its TeamInvest community to spot red flags in management, hidden risks, or weakening competitive advantages
📊 Sells stocks with negative projected returns that show greater likelihood of losing money than gaining money over five years
🥁 Reinvests with discipline after selling, targeting companies that meet TIP Group’s investment filters showing higher expected returns or lower risk
This rational, data-driven selling strategy enables TIP Group to generate a better long-term performance by removing emotional attachment to its investments.
Gain further insight from TIP Group’s ‘TIP Wealth Builder’ podcast ⚡

ASX-listed investment house TIP Group (ASX:TIP) implements a disciplined investment philosophy based on a systematic approach which combines fundamentals, valuation, and risk assessment to uncover long-term wealth-building opportunities for investors.
It believes that smart investing isn’t just about buying at the right time, but also about disciplined exit decisions.
💾 Lets data guide its decisions and sells companies that no longer meet the group’s investment criteria
👥 Relies on collective wisdom of experienced members in its TeamInvest community to spot red flags in management, hidden risks, or weakening competitive advantages
📊 Sells stocks with negative projected returns that show greater likelihood of losing money than gaining money over five years
🥁 Reinvests with discipline after selling, targeting companies that meet TIP Group’s investment filters showing higher expected returns or lower risk
This rational, data-driven selling strategy enables TIP Group to generate a better long-term performance by removing emotional attachment to its investments.
Gain further insight from TIP Group’s ‘TIP Wealth Builder’ podcast ⚡
Mineral exploration business Kincora Copper (ASX:KCC) is targeting the discovery of globally significant copper-gold systems through a project generator model, where it enters strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to progress its portfolio of projects.
These partnerships enable Kincora to conduct partner-funded drilling and other exploration works across multiple projects simultaneously, whilst generating an income stream as the operator of the earn-in agreements.
🤝 Kincora’s partners include globally renowned gold producer AngloGold Ashanti (NYSE:AU), with two joint venture (JV) agreements covering five licenses in the Northern Junee-Narromine Belt in NSW
⚒️ Kincora is the operator of the AngloGold Ashanti JV agreements and is receiving a 10% management fee on expenditures, with the deal supporting up to $100 million in cumulative exploration spending
⛏️ Other partners include private geophysics and space tech business Fleet Space Technologies, which raised $150 million to support maiden drilling and geophysics at the Wongarbon project in NSW
🏔️ Kincora has also teamed up with artificial intelligence-focused exploration outfit Earth AI, which recently raised $20 million for ongoing drilling and geophysics at the Cundumbul project in NSW
🟠 In Mongolia, Kincora has partnered with Orbminco Ltd: an explorer and operator of the Bronze Fox project in the Southern Gobi copper-gold belt

Mineral exploration business Kincora Copper (ASX:KCC) is targeting the discovery of globally significant copper-gold systems through a project generator model, where it enters strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to progress its portfolio of projects.
These partnerships enable Kincora to conduct partner-funded drilling and other exploration works across multiple projects simultaneously, whilst generating an income stream as the operator of the earn-in agreements.
🤝 Kincora’s partners include globally renowned gold producer AngloGold Ashanti (NYSE:AU), with two joint venture (JV) agreements covering five licenses in the Northern Junee-Narromine Belt in NSW
⚒️ Kincora is the operator of the AngloGold Ashanti JV agreements and is receiving a 10% management fee on expenditures, with the deal supporting up to $100 million in cumulative exploration spending
⛏️ Other partners include private geophysics and space tech business Fleet Space Technologies, which raised $150 million to support maiden drilling and geophysics at the Wongarbon project in NSW
🏔️ Kincora has also teamed up with artificial intelligence-focused exploration outfit Earth AI, which recently raised $20 million for ongoing drilling and geophysics at the Cundumbul project in NSW
🟠 In Mongolia, Kincora has partnered with Orbminco Ltd: an explorer and operator of the Bronze Fox project in the Southern Gobi copper-gold belt
Aurora Labs (ASX:A3D) has secured a non-binding partnership with US-based aircraft developer Mayman Aerospace to explore the development of 3D-printed propulsion technologies
🤝 The partnership falls under a Memorandum of Understanding (MoU), meaning it is a non-binding contract
🛩️ Mayman Aerospace is a US-based developer of Vertical Take-Off and Landing (VTOL) aircraft
✈️ The companies will collaboratively explore the development of 3D-printed micro gas turbines and advanced propulsion systems
“As we expand our presence into the United States—a market renowned for its scale, innovation, and appetite for advanced aerospace technology—this MoU is a key milestone in our growth strategy. The U.S. offers unparalleled opportunities for Aurora Labs to demonstrate the strength of our metal additive manufacturing and propulsion systems in a world-leading aerospace environment.” – Rebekah Letheby, CEO of Aurora Labs

Aurora Labs (ASX:A3D) has secured a non-binding partnership with US-based aircraft developer Mayman Aerospace to explore the development of 3D-printed propulsion technologies
🤝 The partnership falls under a Memorandum of Understanding (MoU), meaning it is a non-binding contract
🛩️ Mayman Aerospace is a US-based developer of Vertical Take-Off and Landing (VTOL) aircraft
✈️ The companies will collaboratively explore the development of 3D-printed micro gas turbines and advanced propulsion systems
“As we expand our presence into the United States—a market renowned for its scale, innovation, and appetite for advanced aerospace technology—this MoU is a key milestone in our growth strategy. The U.S. offers unparalleled opportunities for Aurora Labs to demonstrate the strength of our metal additive manufacturing and propulsion systems in a world-leading aerospace environment.” – Rebekah Letheby, CEO of Aurora Labs
Nimy Resources (ASX:NIM) completes phase 2 drilling campaign at its Block 3 Gallium project, with nine holes intercepting chlorite/mafic schist.
⚒️ This schist has been identified by CSIRO as the host rock for high grade gallium mineralisation at Block 3.
🪨 The highly successful phase 2 drilling program opens the way for an immediate commencement of phase 3 drilling.
⛏️ Phase 3 drilling will test for gallium mineralisation beyond the original exploration target as well as the recently discovered outcropping schist.
“The consistent intersections of schistose material across completed drill holes at Block 3 is an exciting development that continues to reinforce the scale and potential of this high-grade gallium prospect.
“Assays are pending and phase 3 drilling has commenced, we are well positioned to rapidly advance what is a significant critical minerals discovery in Western Australia.” - Luke Hampson, Managing Director

Nimy Resources (ASX:NIM) completes phase 2 drilling campaign at its Block 3 Gallium project, with nine holes intercepting chlorite/mafic schist.
⚒️ This schist has been identified by CSIRO as the host rock for high grade gallium mineralisation at Block 3.
🪨 The highly successful phase 2 drilling program opens the way for an immediate commencement of phase 3 drilling.
⛏️ Phase 3 drilling will test for gallium mineralisation beyond the original exploration target as well as the recently discovered outcropping schist.
“The consistent intersections of schistose material across completed drill holes at Block 3 is an exciting development that continues to reinforce the scale and potential of this high-grade gallium prospect.
“Assays are pending and phase 3 drilling has commenced, we are well positioned to rapidly advance what is a significant critical minerals discovery in Western Australia.” - Luke Hampson, Managing Director
InFocus Group (ASX:IFG), a data analytics and software solutions company, has secured an exclusive partnership deal with TG Solutions Consulting on the development of an end-to-end iGaming platform.
🗓️The contract is potentially valued at US$3.25 million over the next 24 months
🎮 InFocus will develop an integrated white-label iGaming platform as part of TG’s end-to-end digital gaming service
🤖 The contract reflects InFocus’s position at the intersection of big data, data analytics, fintech and cyber security
“We are excited to have secured another substantial contract – this time with the potential to generate revenues of US$3.25 million over the next 24 months – within the digital gaming sector. This sector sits at the intersection of big data, data analytics, and fintech, whilst also requiring a strict cybersecurity discipline, which are all areas of focus and expertise for InFocus Group.” – Ken Tovich, CEO of InFocus

InFocus Group (ASX:IFG), a data analytics and software solutions company, has secured an exclusive partnership deal with TG Solutions Consulting on the development of an end-to-end iGaming platform.
🗓️The contract is potentially valued at US$3.25 million over the next 24 months
🎮 InFocus will develop an integrated white-label iGaming platform as part of TG’s end-to-end digital gaming service
🤖 The contract reflects InFocus’s position at the intersection of big data, data analytics, fintech and cyber security
“We are excited to have secured another substantial contract – this time with the potential to generate revenues of US$3.25 million over the next 24 months – within the digital gaming sector. This sector sits at the intersection of big data, data analytics, and fintech, whilst also requiring a strict cybersecurity discipline, which are all areas of focus and expertise for InFocus Group.” – Ken Tovich, CEO of InFocus
Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has received firm commitments for an $8.7m capital raise supported by existing and new shareholders, including strong support from several Australian institutional investors.
🩺 Existing substantial shareholder, Pengana High Conviction Equities Fund was a cornerstone investor in the capital raise and will increase their holding in Oncosil following completion of the transaction.
⚕️ Post transaction the Company will have a pro-forma cash balance of $14.1m which will fund the company through H2 CY26 when it is expected to start generating positive operating cash flow
🔬 The landmark PANCOSIL study is now ~95% recruited. If successful, OncoSil intends to seek label expansion for the OncoSil™ Device for use by Interventional Radiology in existing jurisdictions
💉 TRIPP-FFX study now ~99% recruited. If successful, OncoSil intends to seek label expansion for the OncoSil™ Device for use in addition to FOLFIRINOX chemotherapy in existing jurisdictions.🏥 120 Hospitals across Germany are now eligible to seek reimbursement for the commercial sale of the OncoSil™ device for the G-BA approved trial
“We are thrilled by the strong investor support afforded our capital raise from new and existing investors. I want to personally welcome the new investors joining our share register by virtue of the Placement. I also want to thank Pengana Capital Group for both being a cornerstone investor in the Placement and their ongoing support. The accompanying SPP gives our existing shareholders an opportunity to add to their holding in the Company as its commercialisation strategy continues to be delivered. A significant portion of the new equity received through the raise will fund ongoing commercialisation which is forecast to take OncoSil to cashflow breakeven by H2 CY26.” Nigel Lange, CEO & Managing Director of OncoSil Medical

Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has received firm commitments for an $8.7m capital raise supported by existing and new shareholders, including strong support from several Australian institutional investors.
🩺 Existing substantial shareholder, Pengana High Conviction Equities Fund was a cornerstone investor in the capital raise and will increase their holding in Oncosil following completion of the transaction.
⚕️ Post transaction the Company will have a pro-forma cash balance of $14.1m which will fund the company through H2 CY26 when it is expected to start generating positive operating cash flow
🔬 The landmark PANCOSIL study is now ~95% recruited. If successful, OncoSil intends to seek label expansion for the OncoSil™ Device for use by Interventional Radiology in existing jurisdictions
💉 TRIPP-FFX study now ~99% recruited. If successful, OncoSil intends to seek label expansion for the OncoSil™ Device for use in addition to FOLFIRINOX chemotherapy in existing jurisdictions.🏥 120 Hospitals across Germany are now eligible to seek reimbursement for the commercial sale of the OncoSil™ device for the G-BA approved trial
“We are thrilled by the strong investor support afforded our capital raise from new and existing investors. I want to personally welcome the new investors joining our share register by virtue of the Placement. I also want to thank Pengana Capital Group for both being a cornerstone investor in the Placement and their ongoing support. The accompanying SPP gives our existing shareholders an opportunity to add to their holding in the Company as its commercialisation strategy continues to be delivered. A significant portion of the new equity received through the raise will fund ongoing commercialisation which is forecast to take OncoSil to cashflow breakeven by H2 CY26.” Nigel Lange, CEO & Managing Director of OncoSil Medical
Nimy Resources (ASX:NIM) has uncovered outcropping chlorite schist material approximately 480 metres east of the initial gallium discovery, highlighting the potential for additional near-surface mineralisation along trend and presenting an exciting opportunity to expand known mineralised zones.
🪨 Chlorite schist, which has been previously intersected in earlier drilling, is notably associated with high-grade gallium mineralisation.
⛏️ Phase II drilling of the Block 3 East Prospect is nearing completion
⚒️ Once the data from Phase II drilling has been fully interpreted, Nimy Resources will promptly commence Phase III drilling.
"The discovery of chlorite schist 480m to the east of 25PH024 has the potential to add significantly to the Block 3 gallium resource once confirmed and drill tested.
Our immediate task is to incorporate the area to the Phase III drill program and confirm the observations of our geologists on the ground that the schist is mineralised and expands our gallium footprint significantly to the east.
“Nimy remains focused on delivering a JORC compliant gallium resource to underpin the development of our high-grade gallium discovery at Block 3.” Luke Hampson, Nimy Managing Director

Nimy Resources (ASX:NIM) has uncovered outcropping chlorite schist material approximately 480 metres east of the initial gallium discovery, highlighting the potential for additional near-surface mineralisation along trend and presenting an exciting opportunity to expand known mineralised zones.
🪨 Chlorite schist, which has been previously intersected in earlier drilling, is notably associated with high-grade gallium mineralisation.
⛏️ Phase II drilling of the Block 3 East Prospect is nearing completion
⚒️ Once the data from Phase II drilling has been fully interpreted, Nimy Resources will promptly commence Phase III drilling.
"The discovery of chlorite schist 480m to the east of 25PH024 has the potential to add significantly to the Block 3 gallium resource once confirmed and drill tested.
Our immediate task is to incorporate the area to the Phase III drill program and confirm the observations of our geologists on the ground that the schist is mineralised and expands our gallium footprint significantly to the east.
“Nimy remains focused on delivering a JORC compliant gallium resource to underpin the development of our high-grade gallium discovery at Block 3.” Luke Hampson, Nimy Managing Director
TIP Group (ASX:TIP) is an ASX-listed investment house using proprietary, research driven insights to help investors create long-term wealth. It implements investment strategies akin to those championed by some of the world’s most successful investors such as Warren Buffett, Benjamin Graham, and Peter Lynch.
The company’s ‘SMaRT’ methodology has been honed over decades, empowering its investments to achieve exceptional performance by focusing on the key pillars of Strategy, Moats, Risks, and Trustworthiness.
🧠 Strategy: Targets investment in businesses with sustainable competitive advantages to determine how they can win in their respective markets
🧱 Moats: Seeks strong barriers to entry and defensibility to determine what protects its investments from competitors
🛡️ Risks: Identifies capital killers to mitigate potential downside that could derail the success of the companies it invests in
🔒 Trustworthiness: Seeks confidence in management to facilitate consistent and reliable performance for its investments
This systematic approach has enabled TIP Group to generate unique insights and measurable successes across its funds and educational programs, helping to drive long-term value creation for investors.

TIP Group (ASX:TIP) is an ASX-listed investment house using proprietary, research driven insights to help investors create long-term wealth. It implements investment strategies akin to those championed by some of the world’s most successful investors such as Warren Buffett, Benjamin Graham, and Peter Lynch.
The company’s ‘SMaRT’ methodology has been honed over decades, empowering its investments to achieve exceptional performance by focusing on the key pillars of Strategy, Moats, Risks, and Trustworthiness.
🧠 Strategy: Targets investment in businesses with sustainable competitive advantages to determine how they can win in their respective markets
🧱 Moats: Seeks strong barriers to entry and defensibility to determine what protects its investments from competitors
🛡️ Risks: Identifies capital killers to mitigate potential downside that could derail the success of the companies it invests in
🔒 Trustworthiness: Seeks confidence in management to facilitate consistent and reliable performance for its investments
This systematic approach has enabled TIP Group to generate unique insights and measurable successes across its funds and educational programs, helping to drive long-term value creation for investors.
Nickel mining and processing business Nickel Industries (ASX:NIC) is committed to providing a safe and inclusive workplace for women with its business characterised by established policies against bullying, discrimination, and harassment.
The company actively implements multiple campaigns to improve employee wellbeing, to create a respectful workplace for women, and to promote the retention of female staff across its Indonesian operations.
🌍 Strong commitment to diversity with a focus on attracting and retaining personnel with different backgrounds, knowledge, experiences, and abilities
🧕 Maintaining gender diversity and an inclusive workplace is vital in sustaining business growth as demand for female employees grows within the industry
🤝 Diversity contributes to the company’s success and benefits individuals, clients, teams, shareholders and stakeholders
🫶 Nickel Industries’ commitment to diversity and inclusion is reflected through on-site visual campaigns on respecting and protecting women`s rights
👷♀️ Implements numerous initiatives for female staff including support for pregnant employees and separate transport options to create an inclusive workplace

Nickel mining and processing business Nickel Industries (ASX:NIC) is committed to providing a safe and inclusive workplace for women with its business characterised by established policies against bullying, discrimination, and harassment.
The company actively implements multiple campaigns to improve employee wellbeing, to create a respectful workplace for women, and to promote the retention of female staff across its Indonesian operations.
🌍 Strong commitment to diversity with a focus on attracting and retaining personnel with different backgrounds, knowledge, experiences, and abilities
🧕 Maintaining gender diversity and an inclusive workplace is vital in sustaining business growth as demand for female employees grows within the industry
🤝 Diversity contributes to the company’s success and benefits individuals, clients, teams, shareholders and stakeholders
🫶 Nickel Industries’ commitment to diversity and inclusion is reflected through on-site visual campaigns on respecting and protecting women`s rights
👷♀️ Implements numerous initiatives for female staff including support for pregnant employees and separate transport options to create an inclusive workplace
Renergen Limited (ASX:RLT) has struck a merger deal with US-based ASP Isotopes Inc (ASPI) to create a global critical materials production house specialising in electronic and isotopically-enriched gases.
🧪ASPI is listed on the NASDAQ and is an advanced materials company specialising in development and production of isotopes
🌱 Isotopes and helium are critically and strategically important materials in medicine, semiconductors, green energy and space exploration
🌍 The companies plan to provide geographic diversification across US, South Africa, UK, Europe and the Middle East

Renergen Limited (ASX:RLT) has struck a merger deal with US-based ASP Isotopes Inc (ASPI) to create a global critical materials production house specialising in electronic and isotopically-enriched gases.
🧪ASPI is listed on the NASDAQ and is an advanced materials company specialising in development and production of isotopes
🌱 Isotopes and helium are critically and strategically important materials in medicine, semiconductors, green energy and space exploration
🌍 The companies plan to provide geographic diversification across US, South Africa, UK, Europe and the Middle East
How and where are technological advancements expanding the opportunities with robotic surgery? Dr. Camile Farah is an expert in robotic surgery and the CEO of Optiscan Imaging (ASX:OIL) and outlines why the future of robotic surgery is evolving rapidly and what lies ahead...
#FinTok #Tech #stocks #MedTech #TechStocks #ASX #AI #robots #finance

How and where are technological advancements expanding the opportunities with robotic surgery? Dr. Camile Farah is an expert in robotic surgery and the CEO of Optiscan Imaging (ASX:OIL) and outlines why the future of robotic surgery is evolving rapidly and what lies ahead...
#FinTok #Tech #stocks #MedTech #TechStocks #ASX #AI #robots #finance
Economic chaos has reared its head as global stock markets react to the latest developments from President Trump’s tariffs, headlined by rates on Chinese imports into the USA being cut from 145% to 30%.
TIP Group (ASX:TIP) CEO Andrew Coleman outlines the potential implications for Australian businesses and how current share market fluctuations can benefit investor portfolios.
🥩 Australian businesses: TIP believes the White House tariffs could lead to a new market opportunity for Australia, as already evidenced with beef and cattle exports
🏦 Investment opportunity: Share market fluctuations could allow investors to purchase shares in quality businesses at a discount, or dispose of overvalued stocks

Economic chaos has reared its head as global stock markets react to the latest developments from President Trump’s tariffs, headlined by rates on Chinese imports into the USA being cut from 145% to 30%.
TIP Group (ASX:TIP) CEO Andrew Coleman outlines the potential implications for Australian businesses and how current share market fluctuations can benefit investor portfolios.
🥩 Australian businesses: TIP believes the White House tariffs could lead to a new market opportunity for Australia, as already evidenced with beef and cattle exports
🏦 Investment opportunity: Share market fluctuations could allow investors to purchase shares in quality businesses at a discount, or dispose of overvalued stocks
Nimy Resources (ASX:NIM) completes $2.75m share placement to fund exploration at WA gallium discovery.
🪨 The Placement was strongly supported by strategic shareholders and therefore required scaling.
⚒️ Funds raised will advance the Block 3 gallium discovery by accelerating drilling, progressing resource definition and offtake discussions, and supporting metallurgical test work.
⛰️ Upcoming newsflows will include a drilling update from the Block 3 program, assay results, maiden JORC resource progress, metallurgical test work outcomes and potential offtake discussions.
⛏️ Gallium prices have surged to $1,012/kg, driven by China’s export ban that has squeezed global semiconductor supply chains.
“We are very pleased with the positive market response received. Nimy is focused on delivering a JORC compliant gallium resource to underpin the development of our high
grade gallium discovery at Block 3. Nimy is positioning to be a major player supplying high grade gallium into high growth markets as the US and the EU seek security of supply into gallium reliant industries such as semi-conductor manufacture and defence force applications”. Luke Hampson, Nimy Managing Director

Nimy Resources (ASX:NIM) completes $2.75m share placement to fund exploration at WA gallium discovery.
🪨 The Placement was strongly supported by strategic shareholders and therefore required scaling.
⚒️ Funds raised will advance the Block 3 gallium discovery by accelerating drilling, progressing resource definition and offtake discussions, and supporting metallurgical test work.
⛰️ Upcoming newsflows will include a drilling update from the Block 3 program, assay results, maiden JORC resource progress, metallurgical test work outcomes and potential offtake discussions.
⛏️ Gallium prices have surged to $1,012/kg, driven by China’s export ban that has squeezed global semiconductor supply chains.
“We are very pleased with the positive market response received. Nimy is focused on delivering a JORC compliant gallium resource to underpin the development of our high
grade gallium discovery at Block 3. Nimy is positioning to be a major player supplying high grade gallium into high growth markets as the US and the EU seek security of supply into gallium reliant industries such as semi-conductor manufacture and defence force applications”. Luke Hampson, Nimy Managing Director
Optiscan Imaging (ASX:OIL) is a commercial stage medical technology company advancing its suite of digital pathology and precision surgery hardware and software solutions. Optiscan is focused on the development, manufacturing, and commercialisation of imaging technologies for medical, translational and pre-clinical applications. Optiscan Imaging’s CEO and Managing Director, Dr Camile Farah speaks with The Stock Network`s Lel Smits.
🤝 Collaboration with US academic medical center, Mayo Clinic
🏥 Mayo Clinic development milestones and next steps
🩻 Versatility of Optiscan`s imaging platform

Optiscan Imaging (ASX:OIL) is a commercial stage medical technology company advancing its suite of digital pathology and precision surgery hardware and software solutions. Optiscan is focused on the development, manufacturing, and commercialisation of imaging technologies for medical, translational and pre-clinical applications. Optiscan Imaging’s CEO and Managing Director, Dr Camile Farah speaks with The Stock Network`s Lel Smits.
🤝 Collaboration with US academic medical center, Mayo Clinic
🏥 Mayo Clinic development milestones and next steps
🩻 Versatility of Optiscan`s imaging platform
AML3D (ASX: AL3) is a specialist metal technology business applying its patented Wire Additive Manufacturing technology known as ARCEMY to produce 3D prints of complex industrial parts for the defence, oil & gas, and aerospace industries. The company is targeting significant growth in the US after its manufacturing hub in Ohio became fully operational late last year. AML3D Chief Executive Officer, Sean Ebert, joins Lel Smits from The Stock Network.
⚙️Overview of patented ARCEMY technology for 3D printing
🗽The company`s growth strategy in the US market
🛡️Expansion in the US Defense sector

AML3D (ASX: AL3) is a specialist metal technology business applying its patented Wire Additive Manufacturing technology known as ARCEMY to produce 3D prints of complex industrial parts for the defence, oil & gas, and aerospace industries. The company is targeting significant growth in the US after its manufacturing hub in Ohio became fully operational late last year. AML3D Chief Executive Officer, Sean Ebert, joins Lel Smits from The Stock Network.
⚙️Overview of patented ARCEMY technology for 3D printing
🗽The company`s growth strategy in the US market
🛡️Expansion in the US Defense sector
Electro Optic Systems Holdings Limited (ASX:EOS) has secured a new order for its Remote Weapons Systems (RWS) amounting to approximately A$53 million.
🚢 The A$53 million deal is EOS’s largest-ever order for both Counter-Drone and naval RWS
🌍 The order is funded by a Western European government to meet its urgent operational requirements
🗓️The contract is set for delivery in 2025-2026

Electro Optic Systems Holdings Limited (ASX:EOS) has secured a new order for its Remote Weapons Systems (RWS) amounting to approximately A$53 million.
🚢 The A$53 million deal is EOS’s largest-ever order for both Counter-Drone and naval RWS
🌍 The order is funded by a Western European government to meet its urgent operational requirements
🗓️The contract is set for delivery in 2025-2026
Domino’s Pizza (ASX:DMP) Australia and New Zealand CEO, Kerri Hayman, will be stepping down in August 2025 after a 37-year career with Domino’s.
🍕 Hayman spent her entire working life with the Domino’s brand across Australia, the UK and the USA
👥Former franchise partner and current Head of Operations Greg Steenson has been appointed as the new Chief Operating Officer
🍕Domino’s has begun an international recruitment process for the new CEO, including internal candidates
“Working with Domino’s has given me some of the most rewarding experiences of my life — both professionally and personally — and I’ve developed lifelong friendships with passionate pizza people around the world.” – Kerri Hayman, CEO of Domino’s ANZ

Domino’s Pizza (ASX:DMP) Australia and New Zealand CEO, Kerri Hayman, will be stepping down in August 2025 after a 37-year career with Domino’s.
🍕 Hayman spent her entire working life with the Domino’s brand across Australia, the UK and the USA
👥Former franchise partner and current Head of Operations Greg Steenson has been appointed as the new Chief Operating Officer
🍕Domino’s has begun an international recruitment process for the new CEO, including internal candidates
“Working with Domino’s has given me some of the most rewarding experiences of my life — both professionally and personally — and I’ve developed lifelong friendships with passionate pizza people around the world.” – Kerri Hayman, CEO of Domino’s ANZ
Mineral explorer Kincora Copper (ASX:KCC) is focused on discovering and advancing globally significant copper-gold systems in ‘tier-one’ geological regions, including the Macquarie Arc in New South Wales which is regarded as Australia’s premier copper-gold porphyry belt.
The company operates under a project generator model where it leverages strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to advance multiple exploration projects simultaneously.
⚒️ Kincora holds twelve licenses in Australia and two in Mongolia covering approximately 3,500 sq km across six major project areas
🪨 Core focus is the Macquarie Arc, which has recently attracted more than $16 billion in M&A for producing mines and over $385 million in ‘earn-in’ deals
⛏️ Executed six separate asset-level deals that collectively unlock more than $110 million in potential partner funding for eight projects across four major portfolios
🟠 These partnerships enable Kincora to conduct partner-funded drilling and other exploration works across multiple projects, with an income stream for being operator of the earn-in agreements
🤝 Partner funded exploration kicked off in late 2024 with more than 7,000 meters of drilling and $3.5 million of expenditures, utilising four drill rigs across three projects
🟡 Negotiations for new partnerships across Kincora’s three remaining projects remain ongoing, which are situated within porphyry complexes in NSW already known to host a gold equivalent resource inventory of more than 20 million ounces

Mineral explorer Kincora Copper (ASX:KCC) is focused on discovering and advancing globally significant copper-gold systems in ‘tier-one’ geological regions, including the Macquarie Arc in New South Wales which is regarded as Australia’s premier copper-gold porphyry belt.
The company operates under a project generator model where it leverages strategic partnerships with mining majors and ‘cashed up’ new generation tech explorers to advance multiple exploration projects simultaneously.
⚒️ Kincora holds twelve licenses in Australia and two in Mongolia covering approximately 3,500 sq km across six major project areas
🪨 Core focus is the Macquarie Arc, which has recently attracted more than $16 billion in M&A for producing mines and over $385 million in ‘earn-in’ deals
⛏️ Executed six separate asset-level deals that collectively unlock more than $110 million in potential partner funding for eight projects across four major portfolios
🟠 These partnerships enable Kincora to conduct partner-funded drilling and other exploration works across multiple projects, with an income stream for being operator of the earn-in agreements
🤝 Partner funded exploration kicked off in late 2024 with more than 7,000 meters of drilling and $3.5 million of expenditures, utilising four drill rigs across three projects
🟡 Negotiations for new partnerships across Kincora’s three remaining projects remain ongoing, which are situated within porphyry complexes in NSW already known to host a gold equivalent resource inventory of more than 20 million ounces
Chimeric Therapeutics (ASX:CHM) has delivered promising results in its Phase 1B clinical trial in treating Acute Myeloid Leukemia (AML).
🧬In the Phase 1B clinical trial, two of the three evaluable patients have achieved remission in AML
🩸AML is a cancer of the myeloid line of blood cells, building up in the bone marrow and blood and interfering with normal blood cell production
🩺The clinical trial is expected to be completed in December, and is designed to enrol 20 newly diagnosed AML patients who are ineligible for other treatments
“This is great news for newly diagnosed AML patients who may benefit from our CORE-NK cells as their initial AML therapy. We are excited to be pioneers in the cell therapy sector, with the first frontline cell therapy study in AML led by MD Anderson Cancer Center.” – Dr Rebecca McQualter, CEO of Chimeric Therapeutics

Chimeric Therapeutics (ASX:CHM) has delivered promising results in its Phase 1B clinical trial in treating Acute Myeloid Leukemia (AML).
🧬In the Phase 1B clinical trial, two of the three evaluable patients have achieved remission in AML
🩸AML is a cancer of the myeloid line of blood cells, building up in the bone marrow and blood and interfering with normal blood cell production
🩺The clinical trial is expected to be completed in December, and is designed to enrol 20 newly diagnosed AML patients who are ineligible for other treatments
“This is great news for newly diagnosed AML patients who may benefit from our CORE-NK cells as their initial AML therapy. We are excited to be pioneers in the cell therapy sector, with the first frontline cell therapy study in AML led by MD Anderson Cancer Center.” – Dr Rebecca McQualter, CEO of Chimeric Therapeutics
Babylon Pump & Power (ASX:BPP) has struck a deal to acquire 100% of groundwater management specialist Matrix Hydro Services to strengthen its water management capabilities.
💧Babylon is a provider of mining and power generation services, specialising in high-pressure pumping, dewatering and project water management
👥 Matrix founders will join Babylon’s management team following the acquisition, adding technical expertise
💧The acquisition will be funded through a $3.5 million Accelerated Non-Renounceable Entitlement Offer (ANREO)
“I am very pleased to announce the Matrix acquisition which will significantly enhance our ability to serve our clients - bringing together highly specialised diagnostic services with our existing rental and maintenance platforms.” – Michael Shelby, CEO and Managing Director of Babylon

Babylon Pump & Power (ASX:BPP) has struck a deal to acquire 100% of groundwater management specialist Matrix Hydro Services to strengthen its water management capabilities.
💧Babylon is a provider of mining and power generation services, specialising in high-pressure pumping, dewatering and project water management
👥 Matrix founders will join Babylon’s management team following the acquisition, adding technical expertise
💧The acquisition will be funded through a $3.5 million Accelerated Non-Renounceable Entitlement Offer (ANREO)
“I am very pleased to announce the Matrix acquisition which will significantly enhance our ability to serve our clients - bringing together highly specialised diagnostic services with our existing rental and maintenance platforms.” – Michael Shelby, CEO and Managing Director of Babylon
Nimy Resources (ASX:NIM) has launched a follow-up drilling campaign targeting a maiden resource at its high-grade Block 3 gallium discovery in the Yilgarn Craton of Western Australia. The drilling is designed to test an already defined exploration target at Block 3, and to extend known high-grade mineralisation along strike and down dip. The Block 3 prospect covers an area of 3km x 1.5km with the current exploration target only encompassing the eastern segment of this zone.
Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network.
⚒️ Drilling to support development of a maiden gallium JORC resource
🪨 Collaboration with CSIRO and Curtin University on metallurgical processes at Block 3

Nimy Resources (ASX:NIM) has launched a follow-up drilling campaign targeting a maiden resource at its high-grade Block 3 gallium discovery in the Yilgarn Craton of Western Australia. The drilling is designed to test an already defined exploration target at Block 3, and to extend known high-grade mineralisation along strike and down dip. The Block 3 prospect covers an area of 3km x 1.5km with the current exploration target only encompassing the eastern segment of this zone.
Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network.
⚒️ Drilling to support development of a maiden gallium JORC resource
🪨 Collaboration with CSIRO and Curtin University on metallurgical processes at Block 3
Kincora Copper (ASX:KCC) has just released its March quarterly report, highlighting an active exploration and project generation strategy successfully executed, with drilling and management fees increasing, a sixth asset level partnership executed and further asset level agreements under discussion with multiple major miners and parties. Kincora Copper President and CEO, Sam Spring, joins Lel Smits from The Stock Network.
💡 Quarterly highlights - a three legged stool
🪨 Field work at three projects - results to date and near term plans
⛏️ Vindication of our project generator funding model
⚒️ Increasing liquidity and market recognition

Kincora Copper (ASX:KCC) has just released its March quarterly report, highlighting an active exploration and project generation strategy successfully executed, with drilling and management fees increasing, a sixth asset level partnership executed and further asset level agreements under discussion with multiple major miners and parties. Kincora Copper President and CEO, Sam Spring, joins Lel Smits from The Stock Network.
💡 Quarterly highlights - a three legged stool
🪨 Field work at three projects - results to date and near term plans
⛏️ Vindication of our project generator funding model
⚒️ Increasing liquidity and market recognition
Nimy Resources (ASX: NIM) has commenced a drilling program underway targeting Maiden Gallium Resource.
⚒️ The drill program will support the development of a Maiden JORC Resource.
⛏️ Drilling is aimed at testing the Block 3 gallium exploration target, defined on the 28th of January, extending the known high-grade mineralisation along strike and down dip.
🪨 The Phase 2 program includes - Drill testing of the new Block 3 Central Target.
“The commencement of this round of drilling at the Block 3 Gallium discovery is significant as we move forward in defining a world class JORC compliant high grade gallium deposit. Concurrently, Curtin University are working on metallurgical testing following CSIRO identification of high grade 400-800 g/t gallium in chlorite. These exploration milestones move Nimy closer to meeting the need of gallium customers who have made initial enquiries as to our progress”. Luke Hampson, Nimy Managing Director

Nimy Resources (ASX: NIM) has commenced a drilling program underway targeting Maiden Gallium Resource.
⚒️ The drill program will support the development of a Maiden JORC Resource.
⛏️ Drilling is aimed at testing the Block 3 gallium exploration target, defined on the 28th of January, extending the known high-grade mineralisation along strike and down dip.
🪨 The Phase 2 program includes - Drill testing of the new Block 3 Central Target.
“The commencement of this round of drilling at the Block 3 Gallium discovery is significant as we move forward in defining a world class JORC compliant high grade gallium deposit. Concurrently, Curtin University are working on metallurgical testing following CSIRO identification of high grade 400-800 g/t gallium in chlorite. These exploration milestones move Nimy closer to meeting the need of gallium customers who have made initial enquiries as to our progress”. Luke Hampson, Nimy Managing Director
Trigg Minerals (ASX:TMG) is a mineral exploration business focused on advancing its portfolio of high-grade antimony projects in New South Wales, including its wholly owned Achilles project which hosts Australia’s highest-grade undeveloped antimony deposit known as Wild Cattle Creek. Trigg Minerals Managing Director, Andre Boison Booyzen, joins Lel Smits from The Stock Network.
🪨 Strategic nature of antimony
⚒️ Overview of Wild Cattle Creek deposit
⛏️ Project portfolio expansion

Trigg Minerals (ASX:TMG) is a mineral exploration business focused on advancing its portfolio of high-grade antimony projects in New South Wales, including its wholly owned Achilles project which hosts Australia’s highest-grade undeveloped antimony deposit known as Wild Cattle Creek. Trigg Minerals Managing Director, Andre Boison Booyzen, joins Lel Smits from The Stock Network.
🪨 Strategic nature of antimony
⚒️ Overview of Wild Cattle Creek deposit
⛏️ Project portfolio expansion
Pilot Energy (ASX:PGY) has sealed up to $1.8 million in convertible note funding to support its ongoing work programme associated with transitioning the Cliff Head facilities from oil production to carbon injection and storage, which represents a key pillar in the group’s flagship ‘Mid West Clean Energy Project’ (MWCEP).
The company is leveraging its extensive energy industry experience and existing oil and gas assets, including infrastructure, to take a leading role in Western Australia’s energy transition by developing competitive, clean energy projects.
🥁 Pilot seeks to develop Australia`s first offshore carbon storage project at Cliff Head, with planned storage capacity of 5 million metric tonnes per annum (mmtpa) by 2030
⛓️ Could generate high-quality Australian Carbon Credit Units (ACCUs) and Safeguard Mechanism carbon offset credits for the company, which are projected to be in high demand in the future
🔥 Cliff Head is situated in proximity to wide range of potential customers including corporates and gas producers
🌱 Could deliver a material reduction in carbon emissions in Western Australia
🤝 Pilot holds a 21.25% stake in the Cliff Head oil field and associated infrastructure, which will increase to 100% on completion of the acquisition of Triangle Energy’s interest through an already agreed vendor financing arrangement
📢 The company recently received a non-binding proposal from a state-owned enterprise to acquire a minority interest in the project, on terms consistent with its commercial expectations for joint venture participation

Pilot Energy (ASX:PGY) has sealed up to $1.8 million in convertible note funding to support its ongoing work programme associated with transitioning the Cliff Head facilities from oil production to carbon injection and storage, which represents a key pillar in the group’s flagship ‘Mid West Clean Energy Project’ (MWCEP).
The company is leveraging its extensive energy industry experience and existing oil and gas assets, including infrastructure, to take a leading role in Western Australia’s energy transition by developing competitive, clean energy projects.
🥁 Pilot seeks to develop Australia`s first offshore carbon storage project at Cliff Head, with planned storage capacity of 5 million metric tonnes per annum (mmtpa) by 2030
⛓️ Could generate high-quality Australian Carbon Credit Units (ACCUs) and Safeguard Mechanism carbon offset credits for the company, which are projected to be in high demand in the future
🔥 Cliff Head is situated in proximity to wide range of potential customers including corporates and gas producers
🌱 Could deliver a material reduction in carbon emissions in Western Australia
🤝 Pilot holds a 21.25% stake in the Cliff Head oil field and associated infrastructure, which will increase to 100% on completion of the acquisition of Triangle Energy’s interest through an already agreed vendor financing arrangement
📢 The company recently received a non-binding proposal from a state-owned enterprise to acquire a minority interest in the project, on terms consistent with its commercial expectations for joint venture participation
Tennant Minerals (ASX:TMS) is a mineral exploration business advancing its highly prospective Barkly copper and gold project in the Northern Territory, which already hosts the high-grade copper discovery known as Bluebird. The company recently identified a significant copper-in-ironstone anomaly from a review of historical drilling that shows geological similarities to Bluebird. Tennant Minerals CEO, Vincent Algar, joins Lel Smits from The Stock Network.
🪨 Significance of the Bluebird East Anomaly
⚒️ Historical drilling at Bluebird East
⛏️ Exploration focus in 2025

Tennant Minerals (ASX:TMS) is a mineral exploration business advancing its highly prospective Barkly copper and gold project in the Northern Territory, which already hosts the high-grade copper discovery known as Bluebird. The company recently identified a significant copper-in-ironstone anomaly from a review of historical drilling that shows geological similarities to Bluebird. Tennant Minerals CEO, Vincent Algar, joins Lel Smits from The Stock Network.
🪨 Significance of the Bluebird East Anomaly
⚒️ Historical drilling at Bluebird East
⛏️ Exploration focus in 2025
Tennant Minerals (ASX:TMS) has identified a significant copper-in-ironstone anomaly below surface at Bluebird East, extending over a strike length of at least 250m. The anomaly is similar to that over the Bluebird high-grade copper-gold discovery.
⚒️ Historical drilling results show potential for Bluebird lookalike discovery
🪨 The Bluebird East Anomaly lies NE of the Bluebird high-grade copper-gold body, which has been extensively drilled and previously reported by the Company
⛏️ Tennant Minerals is planning a follow-up drilling program across the anomaly and areas of subsurface iron enrichment further east, with hole depths to extend below the base of oxidation.
“A review of the historical shallow drilling data east of the main Bluebird copper-gold mineralisation, has identified a significant subsurface copper anomaly extending over 250m. It is located 350m NE of the Bluebird high-grade mineralisation, presenting a very attractive near-term drill target.
Composite five metre samples from Slimline reverse circulation drilling results indicate subsurface iron enrichment further to the east, extending the new area of interest to over 600m in total, presenting a significant target for future exploration.
The Bluebird deposit is considered a “blind” discovery, which means there is no indication at surface of its presence at depth. This is common throughout the Tennant Creek field and at Bluebird, where the upper 50 metres below the surface is weathered and leached of copper. Our analysis has identified a very good comparison between the level of copper anomalism seen above the high-grade Bluebird body of mineralisation and shallow geo-chemical drilling previously conducted at Bluebird East." Vincent Algar, Tennant Minerals CEO

Tennant Minerals (ASX:TMS) has identified a significant copper-in-ironstone anomaly below surface at Bluebird East, extending over a strike length of at least 250m. The anomaly is similar to that over the Bluebird high-grade copper-gold discovery.
⚒️ Historical drilling results show potential for Bluebird lookalike discovery
🪨 The Bluebird East Anomaly lies NE of the Bluebird high-grade copper-gold body, which has been extensively drilled and previously reported by the Company
⛏️ Tennant Minerals is planning a follow-up drilling program across the anomaly and areas of subsurface iron enrichment further east, with hole depths to extend below the base of oxidation.
“A review of the historical shallow drilling data east of the main Bluebird copper-gold mineralisation, has identified a significant subsurface copper anomaly extending over 250m. It is located 350m NE of the Bluebird high-grade mineralisation, presenting a very attractive near-term drill target.
Composite five metre samples from Slimline reverse circulation drilling results indicate subsurface iron enrichment further to the east, extending the new area of interest to over 600m in total, presenting a significant target for future exploration.
The Bluebird deposit is considered a “blind” discovery, which means there is no indication at surface of its presence at depth. This is common throughout the Tennant Creek field and at Bluebird, where the upper 50 metres below the surface is weathered and leached of copper. Our analysis has identified a very good comparison between the level of copper anomalism seen above the high-grade Bluebird body of mineralisation and shallow geo-chemical drilling previously conducted at Bluebird East." Vincent Algar, Tennant Minerals CEO
Aurora Labs (ASX:A3D) has achieved the design freeze milestone under their contract with the Australian Defence Force to develop a 3D-printed propulsion system.
⚙️Aurora Labs secured a $319,000 contract with the Australian Defence Force in December 2024
🌱The contract included the development of a novel 3D-printed propulsion system targeting low fuel consumption
🛠️Following this achievement, Aurora Labs will proceed to fabrication and testing activities
“We are extremely proud of the progress made under this groundbreaking project. Achieving the design freeze phase marks a major technical achievement and validates the power of our advanced additive manufacturing technologies. We remain focused on delivering a sovereign propulsion solution for Defence, showcasing Aurora’s capacity for innovation, rapid development, and sovereign capability contribution.” – Rebekah Letheby, CEO of Aurora Labs

Aurora Labs (ASX:A3D) has achieved the design freeze milestone under their contract with the Australian Defence Force to develop a 3D-printed propulsion system.
⚙️Aurora Labs secured a $319,000 contract with the Australian Defence Force in December 2024
🌱The contract included the development of a novel 3D-printed propulsion system targeting low fuel consumption
🛠️Following this achievement, Aurora Labs will proceed to fabrication and testing activities
“We are extremely proud of the progress made under this groundbreaking project. Achieving the design freeze phase marks a major technical achievement and validates the power of our advanced additive manufacturing technologies. We remain focused on delivering a sovereign propulsion solution for Defence, showcasing Aurora’s capacity for innovation, rapid development, and sovereign capability contribution.” – Rebekah Letheby, CEO of Aurora Labs
XPON Technologies (ASX:XPN), an Australian AI marketing technology business, has secured a deal to acquire 100% of Alpha Digital to accelerate its AI-powered growth strategy.
🤖 XPON uses an integration of data and AI to power tools which predict consumer behaviour and automate marketing processes
🏬 Alpha Digital has worked with several big-name clients including Target, Kmart, QUT and Stone & Wood
🤝 The deal boosts XPON’s revenue, profitability and access to Alpha Digital’s major clients

XPON Technologies (ASX:XPN), an Australian AI marketing technology business, has secured a deal to acquire 100% of Alpha Digital to accelerate its AI-powered growth strategy.
🤖 XPON uses an integration of data and AI to power tools which predict consumer behaviour and automate marketing processes
🏬 Alpha Digital has worked with several big-name clients including Target, Kmart, QUT and Stone & Wood
🤝 The deal boosts XPON’s revenue, profitability and access to Alpha Digital’s major clients
Teaminvest Private Group (ASX:TIP), known as TIP Group, is an ASX-listed investment house using proprietary, research driven insights to create better investors and better businesspeople through its three operating divisions. The first of these three verticals is education and advice. Secondly, funds management and finally equity in which the company takes direct ownership or a partial position in medium sized businesses. TIP Group CEO, Andrew Coleman, joins Lel Smits from The Stock Network.
💡 Overview of TIP Group’s investment strategy
🧑🤝🧑 Teaminvest investment community and education
💰 TIP Wealth funds management business
💼 TIP Equity active investments division

Teaminvest Private Group (ASX:TIP), known as TIP Group, is an ASX-listed investment house using proprietary, research driven insights to create better investors and better businesspeople through its three operating divisions. The first of these three verticals is education and advice. Secondly, funds management and finally equity in which the company takes direct ownership or a partial position in medium sized businesses. TIP Group CEO, Andrew Coleman, joins Lel Smits from The Stock Network.
💡 Overview of TIP Group’s investment strategy
🧑🤝🧑 Teaminvest investment community and education
💰 TIP Wealth funds management business
💼 TIP Equity active investments division
What happens when the President of the United States calls out your project? Dateline Resources (ASX:DTR) found out on Friday when its stock jumped 200%, that’s when Donald Trump mentioned its Colosseum Project located in California. On his official Truth Social weekly update Trump said, “The Colosseum Mine, America’s second rare earths mine, has been approved after years of stalled permitting. Dateline shared the news and also revealed its pursuing an OTCQB listing in the U.S. to improve market access and engagement with U.S. investors.
#finktok #mining #finance #stocks #miners #trump #rareearths #us #mining #donaldtrump

What happens when the President of the United States calls out your project? Dateline Resources (ASX:DTR) found out on Friday when its stock jumped 200%, that’s when Donald Trump mentioned its Colosseum Project located in California. On his official Truth Social weekly update Trump said, “The Colosseum Mine, America’s second rare earths mine, has been approved after years of stalled permitting. Dateline shared the news and also revealed its pursuing an OTCQB listing in the U.S. to improve market access and engagement with U.S. investors.
#finktok #mining #finance #stocks #miners #trump #rareearths #us #mining #donaldtrump
Consumer electronics eCommerce business Harris Technology (ASX:HT8) continued to build momentum during the third quarter of the 2025 financial year (Q3 FY25) after locking in a $1.5 million investment from Taiwanese tech giant FSP Technology to facilitate expansion into new product categories for its emerging ‘Refurbished Tech’ division.
💻 Funds being used to increase the group’s presence in high-growth product segments which include the refurbishment of pre-owned electronics
🔌 Seeks to generate significant scale by exploring new product opportunities and capitalising on its strong infrastructure and established market presence
📻 Targeting more stock that is suitable for refurbishment, whilst also market testing new product ranges including IT goods, devices, and household appliances
📱 Such offerings could represent a significant opportunity to diversify the company’s revenue streams, expand retail channels, and enhance overall margins
“Over the coming months, we see a substantial opportunity to leverage Harris Technology’s global supply chain infrastructure to solidify our position as a leading seller of refurbished tech products which will enable us to expand our product range in FY26 and beyond.” - Garrison Huang, Harris Technology Chief Executive Officer

Consumer electronics eCommerce business Harris Technology (ASX:HT8) continued to build momentum during the third quarter of the 2025 financial year (Q3 FY25) after locking in a $1.5 million investment from Taiwanese tech giant FSP Technology to facilitate expansion into new product categories for its emerging ‘Refurbished Tech’ division.
💻 Funds being used to increase the group’s presence in high-growth product segments which include the refurbishment of pre-owned electronics
🔌 Seeks to generate significant scale by exploring new product opportunities and capitalising on its strong infrastructure and established market presence
📻 Targeting more stock that is suitable for refurbishment, whilst also market testing new product ranges including IT goods, devices, and household appliances
📱 Such offerings could represent a significant opportunity to diversify the company’s revenue streams, expand retail channels, and enhance overall margins
“Over the coming months, we see a substantial opportunity to leverage Harris Technology’s global supply chain infrastructure to solidify our position as a leading seller of refurbished tech products which will enable us to expand our product range in FY26 and beyond.” - Garrison Huang, Harris Technology Chief Executive Officer
Oil and gas exploration and production business Metgasco Limited (ASX:MEL) has improved its financial performance during the March quarter of the 2025 financial year after recording solid gas production from its 25% owned Vali and Odin gas fields in the Cooper Eromanga Basin. The company and its partners are now targeting a further boost in production, sales, and cash generation after recently approving a ‘Production Uplift Program’ for the Vali and Odin wells.
🥁 Generates profit following surface pressure de-bottlenecking work which successfully moderated natural gas production decline at Vali-1 and Odin-1 wells
🔥 Odin field average gross raw gas production during the quarter of 2.73 million standard cubic feet per day (MMscfd)
🛢️ Vali field raw gas production of 0.81 MMscfd during the quarter
⚒️ Identifies production optimisation opportunities to increase output at Odin and the adjacent Vali gas field
“I am happy to report an improved financial performance by Metgasco during the March 2025 quarter, with the Company delivering a modest quarterly profit. This profit recovery was attributable to both surface pressure de-bottlenecking work, which successfully moderated the natural gas production decline of Vali-1 and Odin-1, and our focus on controlling joint venture and in-house costs.” - Ken Aitken, Metgasco Managing Director

Oil and gas exploration and production business Metgasco Limited (ASX:MEL) has improved its financial performance during the March quarter of the 2025 financial year after recording solid gas production from its 25% owned Vali and Odin gas fields in the Cooper Eromanga Basin. The company and its partners are now targeting a further boost in production, sales, and cash generation after recently approving a ‘Production Uplift Program’ for the Vali and Odin wells.
🥁 Generates profit following surface pressure de-bottlenecking work which successfully moderated natural gas production decline at Vali-1 and Odin-1 wells
🔥 Odin field average gross raw gas production during the quarter of 2.73 million standard cubic feet per day (MMscfd)
🛢️ Vali field raw gas production of 0.81 MMscfd during the quarter
⚒️ Identifies production optimisation opportunities to increase output at Odin and the adjacent Vali gas field
“I am happy to report an improved financial performance by Metgasco during the March 2025 quarter, with the Company delivering a modest quarterly profit. This profit recovery was attributable to both surface pressure de-bottlenecking work, which successfully moderated the natural gas production decline of Vali-1 and Odin-1, and our focus on controlling joint venture and in-house costs.” - Ken Aitken, Metgasco Managing Director
Wide Open Agriculture (ASX:WOA) has secured an exclusive marketing and distribution deal with Univar Solutions China for the sale of its functional lupin protein products in China.
🌱 Univar has committed to purchase a minimum of 50 tonnes of lupin protein over a 12-month period
🌏 Univar is the world’s second-largest chemical and ingredient distributor
♻️ Wide Open Agriculture is working with Univar to support sustainable, clean-label, high functionality food innovation in China
“Univar Solutions China is a powerhouse in the global ingredient distribution landscape. Partnering with their China team gives us not only a strong local presence, but also the strategic capability to unlock real growth in one of the world’s most dynamic markets for plant-based protein.” – Yaxi Zhan, Executive Chair of WOA

Wide Open Agriculture (ASX:WOA) has secured an exclusive marketing and distribution deal with Univar Solutions China for the sale of its functional lupin protein products in China.
🌱 Univar has committed to purchase a minimum of 50 tonnes of lupin protein over a 12-month period
🌏 Univar is the world’s second-largest chemical and ingredient distributor
♻️ Wide Open Agriculture is working with Univar to support sustainable, clean-label, high functionality food innovation in China
“Univar Solutions China is a powerhouse in the global ingredient distribution landscape. Partnering with their China team gives us not only a strong local presence, but also the strategic capability to unlock real growth in one of the world’s most dynamic markets for plant-based protein.” – Yaxi Zhan, Executive Chair of WOA
Mineral exploration business Nimy Resources (ASX:NIM) has moved closer to defining a maiden gallium resource at its high-grade Block 3 discovery in WA after reporting a “highly favourable” mineralogy assessment conducted by CSIRO. The findings pave the way for metallurgical testing which will underpin a JORC resource estimate at Block 3, in conjunction with follow-up drilling.
⛏️ Results suggest that chlorite is the primary host for gallium at Block 3, with gallium grades within chlorite ranging between 400 parts per million (ppm) and 800 ppm
⚒️ Metallurgical evaluation for Block 3 now set to commence at Curtin University’s Kalgoorlie Campus
🏔️ Drilling to grow the mineralised horizon due to commence in early May
📢 Maiden gallium resource for Block 3 projected for release in 2025
🪨 Gallium is a strategic metal utilised in semiconductors, solar panels, and other high-tech industries
“Metallurgical tests will play a key role in calculating a maiden JORC 2012-compliant Resource for Block 3. This work will all be done in parallel with the next round of drilling, which is set to start in early May. We are pushing hard to expedite progress at Block 3 on several fronts at the same time, enabling us to capitalise on the huge worldwide demand for gallium stemming from China’s recent export controls on critical minerals ” - Christian Price, Nimy Resources Technical Director

Mineral exploration business Nimy Resources (ASX:NIM) has moved closer to defining a maiden gallium resource at its high-grade Block 3 discovery in WA after reporting a “highly favourable” mineralogy assessment conducted by CSIRO. The findings pave the way for metallurgical testing which will underpin a JORC resource estimate at Block 3, in conjunction with follow-up drilling.
⛏️ Results suggest that chlorite is the primary host for gallium at Block 3, with gallium grades within chlorite ranging between 400 parts per million (ppm) and 800 ppm
⚒️ Metallurgical evaluation for Block 3 now set to commence at Curtin University’s Kalgoorlie Campus
🏔️ Drilling to grow the mineralised horizon due to commence in early May
📢 Maiden gallium resource for Block 3 projected for release in 2025
🪨 Gallium is a strategic metal utilised in semiconductors, solar panels, and other high-tech industries
“Metallurgical tests will play a key role in calculating a maiden JORC 2012-compliant Resource for Block 3. This work will all be done in parallel with the next round of drilling, which is set to start in early May. We are pushing hard to expedite progress at Block 3 on several fronts at the same time, enabling us to capitalise on the huge worldwide demand for gallium stemming from China’s recent export controls on critical minerals ” - Christian Price, Nimy Resources Technical Director
1414 Degrees Ltd (ASX:14D) has advanced its strategic shift toward becoming a full-service provider of decarbonised energy solutions, with multiple development milestones recently advanced.
🧑💻 Delivered 20-year SiBox unit sales forecast to Woodside, targeting up to 20% of the accessible industrial heat market
💡 Deloitte engaged to develop a Heat-as-a-Service financial model to assist 1414 Degrees in delivering integrated renewable electricity–gas heat contracts
🪫Generator due diligence for Aurora BESS progressed, clearing the path for the utility to commence network impact assessments
⚡ Pre-commissioning tests underway on SiPHyR Stage 1 prototype reactor, with it set to go online in Q4 FY25
"The March 2025 quarter saw 1414 Degrees further progress its plans to transform from a pure technology developer to a full-service provider of decarbonised energy solutions. A key deliverable over the quarter was further work on a wide-ranging Heat-as-a-Service framework, underpinned by the financial model being developed by Deloitte. Another notable achievement was the continued progress in delivering on our 2021 SiBox Development Agreement with Woodside, with a detailed commercialisation model created. While this model currently targets just 20% of the accessible industrial heat market, the potential revenue that could be generated from it is significant." Dr Kevin Moriarty, 1414 Degrees Executive Chair

1414 Degrees Ltd (ASX:14D) has advanced its strategic shift toward becoming a full-service provider of decarbonised energy solutions, with multiple development milestones recently advanced.
🧑💻 Delivered 20-year SiBox unit sales forecast to Woodside, targeting up to 20% of the accessible industrial heat market
💡 Deloitte engaged to develop a Heat-as-a-Service financial model to assist 1414 Degrees in delivering integrated renewable electricity–gas heat contracts
🪫Generator due diligence for Aurora BESS progressed, clearing the path for the utility to commence network impact assessments
⚡ Pre-commissioning tests underway on SiPHyR Stage 1 prototype reactor, with it set to go online in Q4 FY25
"The March 2025 quarter saw 1414 Degrees further progress its plans to transform from a pure technology developer to a full-service provider of decarbonised energy solutions. A key deliverable over the quarter was further work on a wide-ranging Heat-as-a-Service framework, underpinned by the financial model being developed by Deloitte. Another notable achievement was the continued progress in delivering on our 2021 SiBox Development Agreement with Woodside, with a detailed commercialisation model created. While this model currently targets just 20% of the accessible industrial heat market, the potential revenue that could be generated from it is significant." Dr Kevin Moriarty, 1414 Degrees Executive Chair
The Stock Network is pleased to support the Sydney Mining Club and interview Legacy Minerals (ASX: LGM) CEO & Managing Director Christopher Byrne, who will be presenting at Sydney Mining Club`s Leading Edge event.
Hear about Legacy Minerals` outstanding economics confirm Drake Project potential and drilling large gold-copper targets at the Thomson Project.
Ahead of appearing at Sydney Mining Club`s Leading Edge event CEO & Managing Director Chris Byrne speaks with Lel Smits on The Stock Network.
🗓 Thursday 1 May 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Legacy Minerals (ASX: LGM) CEO & Managing Director Christopher Byrne, who will be presenting at Sydney Mining Club`s Leading Edge event.
Hear about Legacy Minerals` outstanding economics confirm Drake Project potential and drilling large gold-copper targets at the Thomson Project.
Ahead of appearing at Sydney Mining Club`s Leading Edge event CEO & Managing Director Chris Byrne speaks with Lel Smits on The Stock Network.
🗓 Thursday 1 May 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
WAM Income Maximiser has listed on the ASX with a ticker code of WMX. This listed investment company’s investment process involves fundamental research, macroeconomic analysis and market positioning, enabling it to invest in an actively managed portfolio of prime quality Australian companies and corporate debt instruments. WAM Income Maximiser will be led by Matthew Haupt as Lead Portfolio Manager.

WAM Income Maximiser has listed on the ASX with a ticker code of WMX. This listed investment company’s investment process involves fundamental research, macroeconomic analysis and market positioning, enabling it to invest in an actively managed portfolio of prime quality Australian companies and corporate debt instruments. WAM Income Maximiser will be led by Matthew Haupt as Lead Portfolio Manager.
Optiscan Imaging Ltd (ASX:OIL) advanced its product development strategy during the March quarter by revealing its next generation microscopic medical imaging device known as InForm, which is specifically designed for pathology workflows. The company also progressed its broader product development pipeline, its clinical studies, and its sales and marketing initiatives.
⚕️ InForm could transform digital pathology by delivering real-time digital insights across the full pathology workflow at point of contact with a tissue sample
🩺 The device includes several new features that facilitate precision sampling and review of data, as well as enhancing the visual familiarity of confocal endomicroscopy images
🥼 InForm is designed to be connected to hospital or laboratory archiving systems, allowing for seamless integration into the wider healthcare system
🔬 It also integrates with Optiscan’s cloud-based telepathology streaming platform which enables remote consultation in real time anywhere in the world
🌎 Optiscan also appointed veteran medical sales executive, Belinda Williamson, as Chief Commercial Officer to drive its commercialisation strategy in the US, Europe, and China
"The reveal of our InForm™ device, a realisation of the hard work put in by our scientific team, represents a watershed moment in the Company’s product development strategy. The device significantly advances the evolution of digital pathology, and has the ability to massively improve the entire pathology workflow from bedside to laboratory and beyond from multiple perspectives - speed, accuracy and the flexibility of testing, analysis and diagnosis included". - Dr Camile Farah, Optiscan Imaging Chief Executive Officer and Managing Director

Optiscan Imaging Ltd (ASX:OIL) advanced its product development strategy during the March quarter by revealing its next generation microscopic medical imaging device known as InForm, which is specifically designed for pathology workflows. The company also progressed its broader product development pipeline, its clinical studies, and its sales and marketing initiatives.
⚕️ InForm could transform digital pathology by delivering real-time digital insights across the full pathology workflow at point of contact with a tissue sample
🩺 The device includes several new features that facilitate precision sampling and review of data, as well as enhancing the visual familiarity of confocal endomicroscopy images
🥼 InForm is designed to be connected to hospital or laboratory archiving systems, allowing for seamless integration into the wider healthcare system
🔬 It also integrates with Optiscan’s cloud-based telepathology streaming platform which enables remote consultation in real time anywhere in the world
🌎 Optiscan also appointed veteran medical sales executive, Belinda Williamson, as Chief Commercial Officer to drive its commercialisation strategy in the US, Europe, and China
"The reveal of our InForm™ device, a realisation of the hard work put in by our scientific team, represents a watershed moment in the Company’s product development strategy. The device significantly advances the evolution of digital pathology, and has the ability to massively improve the entire pathology workflow from bedside to laboratory and beyond from multiple perspectives - speed, accuracy and the flexibility of testing, analysis and diagnosis included". - Dr Camile Farah, Optiscan Imaging Chief Executive Officer and Managing Director
The Stock Network is pleased to support the Sydney Mining Club and interview Fenix Resources Limited (ASX:FEX) Chairman John Welborn, who will be presenting at Sydney Mining Club`s Leading Edge event.
Hear about Fenix Resources` plans to open its third iron ore mine in the Mid-West region of Western Australia, and the company’s unique business model centred on mining, haulage and logistics, and port services.
Ahead of appearing at Sydney Mining Club`s Leading Edge event Fenix Resources Chairman John Welborn joins Lel Smits from The Stock Network.
🗓 Thursday 1 May 2025
🕛5:15 PM
📍The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Fenix Resources Limited (ASX:FEX) Chairman John Welborn, who will be presenting at Sydney Mining Club`s Leading Edge event.
Hear about Fenix Resources` plans to open its third iron ore mine in the Mid-West region of Western Australia, and the company’s unique business model centred on mining, haulage and logistics, and port services.
Ahead of appearing at Sydney Mining Club`s Leading Edge event Fenix Resources Chairman John Welborn joins Lel Smits from The Stock Network.
🗓 Thursday 1 May 2025
🕛5:15 PM
📍The Establishment Rooms, 252 George Street, Sydney
DY6 Metals (ASX:DY6) soared 292% yesterday after reporting a review of historical assay results. The results highlighted high grade gallium potential from the junior miner’s Tundulu Project located in Malawi.

DY6 Metals (ASX:DY6) soared 292% yesterday after reporting a review of historical assay results. The results highlighted high grade gallium potential from the junior miner’s Tundulu Project located in Malawi.
Orthocell (ASX:OCC) has secured regulatory approval from Thailand’s FDA to commence sales of its nerve repair product RemplirTM, expanding into the significant global nerve repair market.
❤️🩹RemplirTM is a collagen wrap used in nerve repair surgery to assist surgeons to improve outcomes in regeneration of damaged nerves
🇹🇭Thailand’s growing nerve repair market is valued at US$84 million, and has a high quality and well-developed healthcare system boosted by medical tourism
⚕️Orthocell plans to partner with an exclusive distributor and expects first sales in second half of 2025
“We are delighted to receive regulatory approval for Remplir in Thailand far sooner than we expected which shows the quality of the product and our clinical data. Thailand is an influential medical market in the Asian region and the second largest market for Remplir, after the US, that we have received approval for.” – Paul Anderson, CEO and MD of Orthocell

Orthocell (ASX:OCC) has secured regulatory approval from Thailand’s FDA to commence sales of its nerve repair product RemplirTM, expanding into the significant global nerve repair market.
❤️🩹RemplirTM is a collagen wrap used in nerve repair surgery to assist surgeons to improve outcomes in regeneration of damaged nerves
🇹🇭Thailand’s growing nerve repair market is valued at US$84 million, and has a high quality and well-developed healthcare system boosted by medical tourism
⚕️Orthocell plans to partner with an exclusive distributor and expects first sales in second half of 2025
“We are delighted to receive regulatory approval for Remplir in Thailand far sooner than we expected which shows the quality of the product and our clinical data. Thailand is an influential medical market in the Asian region and the second largest market for Remplir, after the US, that we have received approval for.” – Paul Anderson, CEO and MD of Orthocell
Metgasco (ASX:MEL) is a growing onshore Australia-focussed oil / gas exploration and production company with a 25% interest in the Odin and Vali gas fields located in Licences in the Southern Flank of Australia’s Cooper Eromanga Basin. The company has progressed appraisal drilling and production programs for these assets to the point where they now generate gas and gas liquids-derived sales revenues through long-term gas contracts to blue-chip gas customers. Metgasco Managing Director, Ken Aitken joins Lel Smits from The Stock Network.
⛽ Over 2 yrs of contracted gas production to blue chip customers
🪨 Near Term Plans to boost gas production from Odin and Vali fields
🛢️MEL’s gas reserves provides small-cap exposure to undersupplied East Cost Markets

Metgasco (ASX:MEL) is a growing onshore Australia-focussed oil / gas exploration and production company with a 25% interest in the Odin and Vali gas fields located in Licences in the Southern Flank of Australia’s Cooper Eromanga Basin. The company has progressed appraisal drilling and production programs for these assets to the point where they now generate gas and gas liquids-derived sales revenues through long-term gas contracts to blue-chip gas customers. Metgasco Managing Director, Ken Aitken joins Lel Smits from The Stock Network.
⛽ Over 2 yrs of contracted gas production to blue chip customers
🪨 Near Term Plans to boost gas production from Odin and Vali fields
🛢️MEL’s gas reserves provides small-cap exposure to undersupplied East Cost Markets
TruScreen Group (NZX/ASX:TRU) has launched a 5-year program to screen 260,000 women for cervical cancer using its AI-enabled, real time, non-invasive, cervical cancer screening device.
🩺The 5-year cervical cancer screening program was launched in Ho Chi Minh City on 12 April 2025, aiming to screen 260,000 women.
🩺 The program uses TruScreen’s AI-enabled, real-time, non-invasive screening device, eliminating the need for lab infrastructure.
🩺 Partnership between TruScreen, Ho Chi Minh City Public Health Association and Gorton Health Services supports Vietnam’s goal to screen 60% of women aged 30-54.
"This program with its target of screening 260,000 women may save the lives of over 2,600 mothers, daughters, sisters, wives and friends.” Marty Dillon, CEO of TruScreen

TruScreen Group (NZX/ASX:TRU) has launched a 5-year program to screen 260,000 women for cervical cancer using its AI-enabled, real time, non-invasive, cervical cancer screening device.
🩺The 5-year cervical cancer screening program was launched in Ho Chi Minh City on 12 April 2025, aiming to screen 260,000 women.
🩺 The program uses TruScreen’s AI-enabled, real-time, non-invasive screening device, eliminating the need for lab infrastructure.
🩺 Partnership between TruScreen, Ho Chi Minh City Public Health Association and Gorton Health Services supports Vietnam’s goal to screen 60% of women aged 30-54.
"This program with its target of screening 260,000 women may save the lives of over 2,600 mothers, daughters, sisters, wives and friends.” Marty Dillon, CEO of TruScreen
NeuroScientific Biopharmaceuticals (ASX:NSB) has acquired the patented StemSmartTMstem cell technology from Isopogen WA to deliver potent and clinically promising cellular medicine for immune-related diseases.
🔬Exclusive rights secured to patented StemSmartTM stem cell technology for treating inflammatory and immune-related diseases
🔬StemSmartTM interacts with immune system to modulate immune responses
🔬Strong early trial results in patients with Crohn’s disease and other serious conditions, with multiple positive clinical responses
“We’re incredibly excited to add mesenchymal stem cell technology to our growing portfolio. This acquisition not only complements our existing pipeline of therapeutic peptides, but also strategically positions us at the forefront of next-generation biologics.” – Dr Anton Uvarov, Founding Director of NeuroScientific

NeuroScientific Biopharmaceuticals (ASX:NSB) has acquired the patented StemSmartTMstem cell technology from Isopogen WA to deliver potent and clinically promising cellular medicine for immune-related diseases.
🔬Exclusive rights secured to patented StemSmartTM stem cell technology for treating inflammatory and immune-related diseases
🔬StemSmartTM interacts with immune system to modulate immune responses
🔬Strong early trial results in patients with Crohn’s disease and other serious conditions, with multiple positive clinical responses
“We’re incredibly excited to add mesenchymal stem cell technology to our growing portfolio. This acquisition not only complements our existing pipeline of therapeutic peptides, but also strategically positions us at the forefront of next-generation biologics.” – Dr Anton Uvarov, Founding Director of NeuroScientific
AML3D Limited (ASX:AL3) has announced the largest custom ARCEMY® system ever built. The system was installed at the US Navy’s AM Center of Excellence in Danville VA, that has been setup and operated by Austal USA. Bringing the system online triggers payment of the final 50% of the contract value.
🇺🇲 The custom ARCEMY® system supports Austal USA’s drive to further embed additive manufacturing into the U.S. Navy’s supply chain.
🇺🇲 Austal USA leads and operates the Navy’s Additive Manufacturing Center of Excellence in Danville, Virginia, which currently operates a large scale ARCEMY® 6700 system delivered in early 2024.
🇺🇲 A second custom ARCEMY® system was recently installed, featuring a massive 11,000kg positioner and over four meters of linear rail, enabling a build volume of approximately 35 cubic meters—making it the largest of its kind
“The successful delivery the custom ARCEMY® system to Austal USA (refer to ASX announcement November 20,2023) aligns with our ambitions to expand the range of U.S.
defense work we do. AML3D already has a track record of deploying our WAM Additive Manufacturing technology in support of the U.S. Navy submarine industrial base. Those successes are translating to an adoption of additive manufacturing technology in the wider U.S. Marine Industrial Base, covering shipbuilding and munitions". - Sean Ebert, AML3D CEO

AML3D Limited (ASX:AL3) has announced the largest custom ARCEMY® system ever built. The system was installed at the US Navy’s AM Center of Excellence in Danville VA, that has been setup and operated by Austal USA. Bringing the system online triggers payment of the final 50% of the contract value.
🇺🇲 The custom ARCEMY® system supports Austal USA’s drive to further embed additive manufacturing into the U.S. Navy’s supply chain.
🇺🇲 Austal USA leads and operates the Navy’s Additive Manufacturing Center of Excellence in Danville, Virginia, which currently operates a large scale ARCEMY® 6700 system delivered in early 2024.
🇺🇲 A second custom ARCEMY® system was recently installed, featuring a massive 11,000kg positioner and over four meters of linear rail, enabling a build volume of approximately 35 cubic meters—making it the largest of its kind
“The successful delivery the custom ARCEMY® system to Austal USA (refer to ASX announcement November 20,2023) aligns with our ambitions to expand the range of U.S.
defense work we do. AML3D already has a track record of deploying our WAM Additive Manufacturing technology in support of the U.S. Navy submarine industrial base. Those successes are translating to an adoption of additive manufacturing technology in the wider U.S. Marine Industrial Base, covering shipbuilding and munitions". - Sean Ebert, AML3D CEO
Neuren Pharmaceuticals (ASX:NEU) has secured FDA confirmation of primary endpoints for its Phase 3 clinical trial of a new drug therapy to treat Phelan-McDermid Syndrome (PMS).
🧬 Between 8,000-15,000 have PMS, and there are no medication, drugs or therapies to treat it, causing an overwhelming unmet medical need
🧬 PMS affects a region of chromosome 22 that supports synapses in the brain, severely impacting quality of life
🧬 Neuren’s trial which commences in mid-2025 marks the first ever Phase 3 trial for PMS in children
“We are very pleased with the outcome of another constructive discussion with the FDA and are now excited to be able to move forward as planned with the first ever Phase 3 trial in children with Phelan-McDermid syndrome.” – Jon Pilcher, CEO of Neuren

Neuren Pharmaceuticals (ASX:NEU) has secured FDA confirmation of primary endpoints for its Phase 3 clinical trial of a new drug therapy to treat Phelan-McDermid Syndrome (PMS).
🧬 Between 8,000-15,000 have PMS, and there are no medication, drugs or therapies to treat it, causing an overwhelming unmet medical need
🧬 PMS affects a region of chromosome 22 that supports synapses in the brain, severely impacting quality of life
🧬 Neuren’s trial which commences in mid-2025 marks the first ever Phase 3 trial for PMS in children
“We are very pleased with the outcome of another constructive discussion with the FDA and are now excited to be able to move forward as planned with the first ever Phase 3 trial in children with Phelan-McDermid syndrome.” – Jon Pilcher, CEO of Neuren
Australian game developer Streamplay Studio (ASX:SP8) has reported strong first-quarter performance, with its subsidiary Noodlecake generating $2.7M in revenue and preparing to launch several high-profile games.
Subsidiary Noodlecake generated $2.7M revenue in Q1 following acquisition by Streamplay on 1 January 2025
Upcoming mobile title Super Flappy Golf has achieved over 50,000 pre-orders
Over 30 new game pitches and strategic partnerships explored at Game Developers Conference (GDC) 2025
“We’ve been very pleased with how seamlessly the Noodlecake team has integrated, and we’re now strongly focused on driving growth both organically and through the
identification of complementary assets to bring into the group.” — Bert Mondello, Chairman of Streamplay Studio

Australian game developer Streamplay Studio (ASX:SP8) has reported strong first-quarter performance, with its subsidiary Noodlecake generating $2.7M in revenue and preparing to launch several high-profile games.
Subsidiary Noodlecake generated $2.7M revenue in Q1 following acquisition by Streamplay on 1 January 2025
Upcoming mobile title Super Flappy Golf has achieved over 50,000 pre-orders
Over 30 new game pitches and strategic partnerships explored at Game Developers Conference (GDC) 2025
“We’ve been very pleased with how seamlessly the Noodlecake team has integrated, and we’re now strongly focused on driving growth both organically and through the
identification of complementary assets to bring into the group.” — Bert Mondello, Chairman of Streamplay Studio
Kincora Copper Limited (TSXV:KCC, ASX:KCC) has secured its second major earn-in with AngloGold Ashanti (JSE:ANG; NYSE:AU).The deal opens the way for more extensive exploration in the Northern Junee-Narromine Belt of the Macquarie Arc, Central West NSW, Australia.
⛏️ Multiple-year deal for the Nyngan South, Nevertire South and Mulla projects
⛏️ AngloGold Ashanti may earn a 70% interest by spending $25 million
⛏️Kincora remains the operator, receiving a 10% management fee
“We are very pleased to broaden our partnership with AngloGold Ashanti. It comes as we continue to progress our ongoing exploration program at the Nyngan project, with a ground gravity survey and hole twelve of the scout drilling program recently completed." - Kincora Copper Technical Committee chair, John Holliday and VP of Exploration Peter Leaman

Kincora Copper Limited (TSXV:KCC, ASX:KCC) has secured its second major earn-in with AngloGold Ashanti (JSE:ANG; NYSE:AU).The deal opens the way for more extensive exploration in the Northern Junee-Narromine Belt of the Macquarie Arc, Central West NSW, Australia.
⛏️ Multiple-year deal for the Nyngan South, Nevertire South and Mulla projects
⛏️ AngloGold Ashanti may earn a 70% interest by spending $25 million
⛏️Kincora remains the operator, receiving a 10% management fee
“We are very pleased to broaden our partnership with AngloGold Ashanti. It comes as we continue to progress our ongoing exploration program at the Nyngan project, with a ground gravity survey and hole twelve of the scout drilling program recently completed." - Kincora Copper Technical Committee chair, John Holliday and VP of Exploration Peter Leaman
The USA’s status as a global super-power is under the microscope and Teaminvest Private Group (ASX:TIP) CEO Andrew Coleman identifies where to invest as USA’s economic power wanes:
📉 Recession reality: TIP believes the US recession is no longer looming; it`s arrived and says "Liberation Day" may go down as the moment things truly unraveled.
🛠️ People and productivity: Since the 16th century, growth has come from more workers or more output per worker and TIP says shrinking the workforce and blocking innovation breaks that math.
🌪️ Defying economic gravity: TIP warns policies that ignore fundamentals might seem bold, but gravity doesn’t care if you believe in it, it happens.

The USA’s status as a global super-power is under the microscope and Teaminvest Private Group (ASX:TIP) CEO Andrew Coleman identifies where to invest as USA’s economic power wanes:
📉 Recession reality: TIP believes the US recession is no longer looming; it`s arrived and says "Liberation Day" may go down as the moment things truly unraveled.
🛠️ People and productivity: Since the 16th century, growth has come from more workers or more output per worker and TIP says shrinking the workforce and blocking innovation breaks that math.
🌪️ Defying economic gravity: TIP warns policies that ignore fundamentals might seem bold, but gravity doesn’t care if you believe in it, it happens.
What is the VIX, and why does it spike during a crash?
#finance #fintok #stocks #shares #investing #wallstreet #VIX #fear #trump #trumptariffs

What is the VIX, and why does it spike during a crash?
#finance #fintok #stocks #shares #investing #wallstreet #VIX #fear #trump #trumptariffs
Elsight Limited (ASX:ELS) has secured a US$4.28 million supply deal with its European-based defence OEM (original equipment manufacturer) customer for its AI-powered Halo connectivity platform.
📡 European defence drone OEM customer commits to US$4.28 million in additional purchases over next four months (April-July 2025)
📡 Deal follows the initial production order of US$300,000 last month and signifies an escalation in scale and scope of the engagement
📡 Initial production order allowed customer to conclude an extensive and successful field integration
“This commitment is a major validation of the value, reliability and strategic position of our solution. After a long and extensive period of field testing, the Customer’s fast move to production based on field deployment success, and already progressed to a multi-million-dollar scale-up phase within a few months, highlights just how critical reliable communications are in modern defence operations.” – Yoav Amitai, CEO of Elsight

Elsight Limited (ASX:ELS) has secured a US$4.28 million supply deal with its European-based defence OEM (original equipment manufacturer) customer for its AI-powered Halo connectivity platform.
📡 European defence drone OEM customer commits to US$4.28 million in additional purchases over next four months (April-July 2025)
📡 Deal follows the initial production order of US$300,000 last month and signifies an escalation in scale and scope of the engagement
📡 Initial production order allowed customer to conclude an extensive and successful field integration
“This commitment is a major validation of the value, reliability and strategic position of our solution. After a long and extensive period of field testing, the Customer’s fast move to production based on field deployment success, and already progressed to a multi-million-dollar scale-up phase within a few months, highlights just how critical reliable communications are in modern defence operations.” – Yoav Amitai, CEO of Elsight
Guzman y Gomez (ASX:GYG) has reported a strong quarterly performance across its international fast food network over the third quarter on the back of its mission to, "reinvent fast food and change the way the masses eat".
🌮 Restaurant network expansion continued, with three new GYG restaurants in Australia and two in the US
🌮 Marketing initiatives introduced new menu item Street Corn, and Clean is the New Healthy campaign in the US
🌮 Acceleration of sales recorded during breakfast period and after 9pm

Guzman y Gomez (ASX:GYG) has reported a strong quarterly performance across its international fast food network over the third quarter on the back of its mission to, "reinvent fast food and change the way the masses eat".
🌮 Restaurant network expansion continued, with three new GYG restaurants in Australia and two in the US
🌮 Marketing initiatives introduced new menu item Street Corn, and Clean is the New Healthy campaign in the US
🌮 Acceleration of sales recorded during breakfast period and after 9pm
Challenger (ASX:CGF), an Australian investment management firm focused on retirement income, has announced that Japanese insurance company Dai-ichi Life will become a new strategic shareholder.
🤝Dai-ichi Life, through its Australian subsidiary TAL, is acquiring a minority stake in Challenger Limited.
🤝The deal is subject to regulatory approval and marks Dai-ichi Life as a new strategic shareholder.
🤝Challenger and Dai-ichi Life plan to explore future opportunities together while maintaining existing partnerships.
“Dai-ichi Life is a global leader in life insurance and we look forward to building a relationship that will benefit both our customers and shareholders. We welcome their significant investment in our business and will explore future opportunities that support our strategic objectives.” – Nick Hamilton, CEO and MD of Challenger
ASX Announcement ⚡️https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02933387-2A1589613&v=7bc42bd11d853ed5e8c28f2ffcd6a069ee5cd6b4

Challenger (ASX:CGF), an Australian investment management firm focused on retirement income, has announced that Japanese insurance company Dai-ichi Life will become a new strategic shareholder.
🤝Dai-ichi Life, through its Australian subsidiary TAL, is acquiring a minority stake in Challenger Limited.
🤝The deal is subject to regulatory approval and marks Dai-ichi Life as a new strategic shareholder.
🤝Challenger and Dai-ichi Life plan to explore future opportunities together while maintaining existing partnerships.
“Dai-ichi Life is a global leader in life insurance and we look forward to building a relationship that will benefit both our customers and shareholders. We welcome their significant investment in our business and will explore future opportunities that support our strategic objectives.” – Nick Hamilton, CEO and MD of Challenger
ASX Announcement ⚡️https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02933387-2A1589613&v=7bc42bd11d853ed5e8c28f2ffcd6a069ee5cd6b4
Stocks have been dumped over the last week on Trump’s latest tariff moves, but is the recent rebound just a dead cat bounce, and what is a dead cat bounce?
#finance #stocks #stockmarket #US #wallstreet #wallst #trump #trumptariffs #tradewar #deadcatbounce #trading

Stocks have been dumped over the last week on Trump’s latest tariff moves, but is the recent rebound just a dead cat bounce, and what is a dead cat bounce?
#finance #stocks #stockmarket #US #wallstreet #wallst #trump #trumptariffs #tradewar #deadcatbounce #trading
Globe Metals & Mining (ASX:GBE) has locked in a new offtake agreement for the production of niobium pentoxide and tantalum pentoxide from its Kanyika project in Malawi with NEO Performance Materials – a global manufacturer of industrial minerals for modern-day technologies such as renewable energy, consumer electronics, robotics, and aerospace.
🪨 The MOU with NEO provides a framework to negotiate a binding offtake agreement to supply about 50% of Kanyika’s annual Phase 1 production of high-purity niobium pentoxide
⚒️ Up to 100% of niobium and tantalum from Phase 1 production at Kanyika is now under non-binding offtake agreements
⛏️ Paves the way for binding offtake agreements to support an upcoming updated Bankable Feasibility Study for Kanyika
⛰️ Development of Kanyika could position Globe as a key supplier of in-demand niobium oxide to specialised industries in Europe and North America
“The Neo MOU represents a watershed moment for the Kanyika Project. It means Globe has now signed multiple MOUs and a letter of intent that, as a package, cover offtake for100% of the Kanyika’s Phase 1 production of both Niobium Pentoxide and Tantalum Pentoxide. We are now working to quickly turn these offtake discussions towards binding agreements" - Paul Smith, Globe Metals & Mining Chief Executive Officer

Globe Metals & Mining (ASX:GBE) has locked in a new offtake agreement for the production of niobium pentoxide and tantalum pentoxide from its Kanyika project in Malawi with NEO Performance Materials – a global manufacturer of industrial minerals for modern-day technologies such as renewable energy, consumer electronics, robotics, and aerospace.
🪨 The MOU with NEO provides a framework to negotiate a binding offtake agreement to supply about 50% of Kanyika’s annual Phase 1 production of high-purity niobium pentoxide
⚒️ Up to 100% of niobium and tantalum from Phase 1 production at Kanyika is now under non-binding offtake agreements
⛏️ Paves the way for binding offtake agreements to support an upcoming updated Bankable Feasibility Study for Kanyika
⛰️ Development of Kanyika could position Globe as a key supplier of in-demand niobium oxide to specialised industries in Europe and North America
“The Neo MOU represents a watershed moment for the Kanyika Project. It means Globe has now signed multiple MOUs and a letter of intent that, as a package, cover offtake for100% of the Kanyika’s Phase 1 production of both Niobium Pentoxide and Tantalum Pentoxide. We are now working to quickly turn these offtake discussions towards binding agreements" - Paul Smith, Globe Metals & Mining Chief Executive Officer
Identitii (ASX:ID8) has signed an agreement with Cherry Hub to deliver an anti-money laundering and counter-terrorism (AML/CTF) financing solution tailored to Australia’s hospitality venues, clubs and hotels.
🛡️ Agreement delivers AML/CTF solution for hospitality venues, clubs and hotels
🛡️ Solution offered to industry via the existing Cherry Hub integration
🛡️ Cherry Hub and its related entities service more than 600 industry venues
"We are thrilled to announce this collaboration with Cherry Hub, and look forward to working with them. At a time when AUSTRAC is paying increased attention to hospitality venues, clubs and hotels, our collaboration enables Cherry Hub to make it easier for the industry to manage financial crime risks and realise significant operational and cost efficiencies." - John Rayment, CEO of Identiti

Identitii (ASX:ID8) has signed an agreement with Cherry Hub to deliver an anti-money laundering and counter-terrorism (AML/CTF) financing solution tailored to Australia’s hospitality venues, clubs and hotels.
🛡️ Agreement delivers AML/CTF solution for hospitality venues, clubs and hotels
🛡️ Solution offered to industry via the existing Cherry Hub integration
🛡️ Cherry Hub and its related entities service more than 600 industry venues
"We are thrilled to announce this collaboration with Cherry Hub, and look forward to working with them. At a time when AUSTRAC is paying increased attention to hospitality venues, clubs and hotels, our collaboration enables Cherry Hub to make it easier for the industry to manage financial crime risks and realise significant operational and cost efficiencies." - John Rayment, CEO of Identiti
Markets go up and down in crash and boom cycles. When markets fall, takeovers tend to accelerate - who`s a target on the ASX right now?
#finance #stocks #stockmarket #US #wallstreet #trump #trumptariffs #tradewar #ASX #NYSE #M&A #stockmarkets

Markets go up and down in crash and boom cycles. When markets fall, takeovers tend to accelerate - who`s a target on the ASX right now?
#finance #stocks #stockmarket #US #wallstreet #trump #trumptariffs #tradewar #ASX #NYSE #M&A #stockmarkets
How has the world reacted to Trump’s shock tariff announcement last week, and what comes next amid steep stock market falls?
#finance #stocks #stockmarket #US #wallstreert #trump #trumptariffs #tradewar

How has the world reacted to Trump’s shock tariff announcement last week, and what comes next amid steep stock market falls?
#finance #stocks #stockmarket #US #wallstreert #trump #trumptariffs #tradewar
What has US President Donald Trump said after Wall Street clocked its worst falls since 2020`s pandemic on the back of his latest tariffs?
#finance #stocks #wallstreet #wallst #trump #donaldtrump #US #tariffs

What has US President Donald Trump said after Wall Street clocked its worst falls since 2020`s pandemic on the back of his latest tariffs?
#finance #stocks #wallstreet #wallst #trump #donaldtrump #US #tariffs
How will Aussie markets react now that America has just wrapped up `Liberation Day`?
#US #WallStreet #finance #stocks #tariffs #liberationday #money

How will Aussie markets react now that America has just wrapped up `Liberation Day`?
#US #WallStreet #finance #stocks #tariffs #liberationday #money
Medallion Metals (ASX:MM8) shares are up around 130% over the last year - what`s the latest with the gold and copper focussed mining company?

Medallion Metals (ASX:MM8) shares are up around 130% over the last year - what`s the latest with the gold and copper focussed mining company?
CoreWeave, Inc. (CRWV) listed on US technology exchange Nasdaq last week, but what did the debut tell us about the health of tech IPOs?

CoreWeave, Inc. (CRWV) listed on US technology exchange Nasdaq last week, but what did the debut tell us about the health of tech IPOs?
Orion Minerals (ASX: ORN) has revealed the results from a DFS evaluating a “de-risked” two-stage development strategy with initial shallow underground mining followed by large-scale deeper production on its flagship Prieska copper and zinc project in South Africa.
🪨 Study points to a pre-tax NPV of about $800 million and an IRR of 31%
🟠 Undiscounted free cash flows of nearly $1.8 billion on a pre-tax basis over an estimated 13.2 year mine life
⚒️ Additional upside potential from conversion of more mineral resources into ore reserves
“The outstanding results outlined in the DFS-25 confirm the potential to develop a long-life, financially robust mining operation via a two-phase development plan which substantially de-risks the mine development pathway and fast-tracks initial cash flow.” – Errol Smart, Orion Managing Director and Chief Executive Officer

Orion Minerals (ASX: ORN) has revealed the results from a DFS evaluating a “de-risked” two-stage development strategy with initial shallow underground mining followed by large-scale deeper production on its flagship Prieska copper and zinc project in South Africa.
🪨 Study points to a pre-tax NPV of about $800 million and an IRR of 31%
🟠 Undiscounted free cash flows of nearly $1.8 billion on a pre-tax basis over an estimated 13.2 year mine life
⚒️ Additional upside potential from conversion of more mineral resources into ore reserves
“The outstanding results outlined in the DFS-25 confirm the potential to develop a long-life, financially robust mining operation via a two-phase development plan which substantially de-risks the mine development pathway and fast-tracks initial cash flow.” – Errol Smart, Orion Managing Director and Chief Executive Officer
Asian Battery Metals (ASX:AZ9) is a mineral exploration business seeking to unlock the vast potential for critical battery minerals in Mongolia. The company’s exploration efforts are heating up after recently unveiling a significant copper and nickel discovery at the Oval prospect, located within its wholly owned Yambat project. Asian Battery Metals Managing Director, Gan-Ochir Zunduisuren, joins Lel Smits from The Stock Network to discuss:
🪨 Nickel and copper discovery at its Oval prospect in Mongolia
⚒️ Recently launched drilling campaign at Oval and other nearby targets

Asian Battery Metals (ASX:AZ9) is a mineral exploration business seeking to unlock the vast potential for critical battery minerals in Mongolia. The company’s exploration efforts are heating up after recently unveiling a significant copper and nickel discovery at the Oval prospect, located within its wholly owned Yambat project. Asian Battery Metals Managing Director, Gan-Ochir Zunduisuren, joins Lel Smits from The Stock Network to discuss:
🪨 Nickel and copper discovery at its Oval prospect in Mongolia
⚒️ Recently launched drilling campaign at Oval and other nearby targets
AML3D Limited`s (ASX:AL3) Managing Director Sean Ebert has this month returned from a visit to the US with Pete Goumas, AML3D USA’s CEO and President.
• Sean met with members of U.S. Congress, the Navy, the Australian Embassy
• AML3D can immediately support the U.S. Maritime Industrial Base
• President Trump says it is a priority to increase capacity for building submarines, ships, and other critical industries in the U.S.
AML3D is increasing additive manufacturing in the U.S. and the Indo-Pacific and has just released a new presentation titled, "New US defence markets open to AML3D"
• Large parts of US Defense Market are now more immediately accessible
• Expansion of MIB to shipbuilding, missiles and submarines triples the near-term market opportunity
• Success supporting the US Navy to create pathway to accessing additional defence sectors mid to longer term

AML3D Limited`s (ASX:AL3) Managing Director Sean Ebert has this month returned from a visit to the US with Pete Goumas, AML3D USA’s CEO and President.
• Sean met with members of U.S. Congress, the Navy, the Australian Embassy
• AML3D can immediately support the U.S. Maritime Industrial Base
• President Trump says it is a priority to increase capacity for building submarines, ships, and other critical industries in the U.S.
AML3D is increasing additive manufacturing in the U.S. and the Indo-Pacific and has just released a new presentation titled, "New US defence markets open to AML3D"
• Large parts of US Defense Market are now more immediately accessible
• Expansion of MIB to shipbuilding, missiles and submarines triples the near-term market opportunity
• Success supporting the US Navy to create pathway to accessing additional defence sectors mid to longer term
Nimy Resources (ASX:NIM) is a mineral exploration business targeting the discovery and development of critical mineral deposits at its Mons project in the Yilgarn Craton of Western Australia. The company is fast-tracking exploration efforts after recently unveiling a high-grade gallium discovery at its Block 3 prospect. Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network to discuss:
⛏️ Significance of gallium in the modern-day high-tech world
⚒️ Drilling objectives and its collaboration with US critical minerals supply chain specialist, M2i Global

Nimy Resources (ASX:NIM) is a mineral exploration business targeting the discovery and development of critical mineral deposits at its Mons project in the Yilgarn Craton of Western Australia. The company is fast-tracking exploration efforts after recently unveiling a high-grade gallium discovery at its Block 3 prospect. Nimy Resources Managing Director, Luke Hampson, joins Lel Smits from The Stock Network to discuss:
⛏️ Significance of gallium in the modern-day high-tech world
⚒️ Drilling objectives and its collaboration with US critical minerals supply chain specialist, M2i Global
Mineral exploration business Cannindah Resources (ASX: CAE) has delivered an “outstanding” copper intercept from its first hole in a recently commenced drilling campaign at its Mt Cannindah project in Queensland.
🟠 The 71m hit grading 0.95% copper equivalent extends the known mineralisation at the project
🪨 Contained within a larger 274m mineralised zone grading 0.49% copper equivalent, with parts of the hole returning high-grade gold including 1m at 31 g/t
⚒️ Ongoing drilling campaign seeks to grow the current resource consisting of 14.5Mt at 1.09% copper equivalent, and to test other nearby targets
“These outstanding results further demonstrate the continuity of the high grade zone and support the clear upside potential of the Cannindah Mineral System...” – Tom Pickett, Cannindah Resources Managing Director

Mineral exploration business Cannindah Resources (ASX: CAE) has delivered an “outstanding” copper intercept from its first hole in a recently commenced drilling campaign at its Mt Cannindah project in Queensland.
🟠 The 71m hit grading 0.95% copper equivalent extends the known mineralisation at the project
🪨 Contained within a larger 274m mineralised zone grading 0.49% copper equivalent, with parts of the hole returning high-grade gold including 1m at 31 g/t
⚒️ Ongoing drilling campaign seeks to grow the current resource consisting of 14.5Mt at 1.09% copper equivalent, and to test other nearby targets
“These outstanding results further demonstrate the continuity of the high grade zone and support the clear upside potential of the Cannindah Mineral System...” – Tom Pickett, Cannindah Resources Managing Director
Australian fertility technology business Memphasys (ASX:MEM) has unveiled positive results from a key clinical trial on its Felix System which is designed to improve sperm selection for assisted reproduction. The outcome could pave the way for global commercial expansion.
🧬 Results from the trial indicate that the Felix System improves embryo utilisation rates and matches or outperforms industry benchmarks
⚡ The trail confirmed Felix to be faster at selecting high-quality sperm compared to traditional methods, whilst also being a preferred method of use by laboratory staff
🌏 Memphasys is now actively pursuing a path to global commercial expansion in Japan, China, and a host of other international markets
"With our existing distribution agreements in place and growing interest from strategic partners, Memphasys is now in a strong position to drive market expansion. The validation of our technology is expected to translate into accelerated sales, particularly in Japan, where Vitrolife has been conducting utilisation testing for over a year.” – Dr David Ali, Memphasys Chief Executive Officer

Australian fertility technology business Memphasys (ASX:MEM) has unveiled positive results from a key clinical trial on its Felix System which is designed to improve sperm selection for assisted reproduction. The outcome could pave the way for global commercial expansion.
🧬 Results from the trial indicate that the Felix System improves embryo utilisation rates and matches or outperforms industry benchmarks
⚡ The trail confirmed Felix to be faster at selecting high-quality sperm compared to traditional methods, whilst also being a preferred method of use by laboratory staff
🌏 Memphasys is now actively pursuing a path to global commercial expansion in Japan, China, and a host of other international markets
"With our existing distribution agreements in place and growing interest from strategic partners, Memphasys is now in a strong position to drive market expansion. The validation of our technology is expected to translate into accelerated sales, particularly in Japan, where Vitrolife has been conducting utilisation testing for over a year.” – Dr David Ali, Memphasys Chief Executive Officer
Digital human software developer Unith (ASX: UNT) has materially progressed a range of growth initiatives in its Digital Humans and Subscription divisions over the last few months, which help to enhance the sustainability of its business in the longer term.
🤖 Signed a one year initial agreement with significant global pharmaceutical enterprise client to deploy Unith’s range of Digital Humans in multiple languages
👩 Unith’s recently launched interFace self-service platform continues to penetrate target markets, including 11 new signings in February alone
🧠 Delivered several key security upgrades to its core platform to help its Digital Human product better compete for targeted enterprise business clients
🔁 The company’s Subscription division continued to grow with its subscriber base now surpassing 885,000 users
🗣️ Unith’s recent entry into new markets has significantly expanded its geographic footprint to 36 countries, helping to drive subscriber numbers and revenue

Digital human software developer Unith (ASX: UNT) has materially progressed a range of growth initiatives in its Digital Humans and Subscription divisions over the last few months, which help to enhance the sustainability of its business in the longer term.
🤖 Signed a one year initial agreement with significant global pharmaceutical enterprise client to deploy Unith’s range of Digital Humans in multiple languages
👩 Unith’s recently launched interFace self-service platform continues to penetrate target markets, including 11 new signings in February alone
🧠 Delivered several key security upgrades to its core platform to help its Digital Human product better compete for targeted enterprise business clients
🔁 The company’s Subscription division continued to grow with its subscriber base now surpassing 885,000 users
🗣️ Unith’s recent entry into new markets has significantly expanded its geographic footprint to 36 countries, helping to drive subscriber numbers and revenue
Kaiser Reef (ASX: KAU) has struck a $32 million deal to acquire the Henty gold mine in Tasmania from fellow mining company Catalyst Metals (ASX:CYL)
#finance #stocks #gold #mining #miners #ASXstocks #news

Kaiser Reef (ASX: KAU) has struck a $32 million deal to acquire the Henty gold mine in Tasmania from fellow mining company Catalyst Metals (ASX:CYL)
#finance #stocks #gold #mining #miners #ASXstocks #news
Mining company Hillgrove Resources (ASX: HGO) has delivered high-grade copper and gold intercepts from an ongoing drilling campaign at its Kanmantoo copper mine in South Australia, with new extensional drill results from the Nugent prospect pointing to a strong continuity of mineralisation.
🪨 Hillgrove is fast-tracking Nugent towards production with first ore expected to be processed in the December quarter this year
🟠 New hits include 21.4m at 1.79% copper and 0.65 g/t gold, with another hole returning 5.5m at 1.2% copper which marks the deepest intercept at Nugent so far
⚒️ Reinforces potential for resource growth with the mineralised footprint remaining open down plunge
“The recent drilling results further confirm the continuity and depth potential of the Nugent copper-gold mineralisation system. The results continue to be higher than the Resource grade at Nugent, which is of course one of the reasons why we are fast tracking production from Nugent.” – Bob Fulker, Hillgrove Chief Executive Officer and Managing Director

Mining company Hillgrove Resources (ASX: HGO) has delivered high-grade copper and gold intercepts from an ongoing drilling campaign at its Kanmantoo copper mine in South Australia, with new extensional drill results from the Nugent prospect pointing to a strong continuity of mineralisation.
🪨 Hillgrove is fast-tracking Nugent towards production with first ore expected to be processed in the December quarter this year
🟠 New hits include 21.4m at 1.79% copper and 0.65 g/t gold, with another hole returning 5.5m at 1.2% copper which marks the deepest intercept at Nugent so far
⚒️ Reinforces potential for resource growth with the mineralised footprint remaining open down plunge
“The recent drilling results further confirm the continuity and depth potential of the Nugent copper-gold mineralisation system. The results continue to be higher than the Resource grade at Nugent, which is of course one of the reasons why we are fast tracking production from Nugent.” – Bob Fulker, Hillgrove Chief Executive Officer and Managing Director
Australian clean energy business GreenHy2 (ASX:H2G) has entered a deal to provide its advanced energy storage solutions for European technology supplier H2Core. The agreement entails access to supercapacitor battery and low-pressure hydrogen technologies which could offer significant benefits over current lithium-ion and hydrogen technologies.
🔋 GreenHy2’s new supercapacitor batteries could deliver longer life, faster charge times, and improved safety compared to lithium-ion solutions
🌱 Low-pressure hydrogen storage is being implemented on GreenHy2’s Telstra contract, with the company expecting more than 50% cost savings
🏭 Manufacturing advances in graphene have made large-scale supercapacitor battery solutions commercially competitive

Australian clean energy business GreenHy2 (ASX:H2G) has entered a deal to provide its advanced energy storage solutions for European technology supplier H2Core. The agreement entails access to supercapacitor battery and low-pressure hydrogen technologies which could offer significant benefits over current lithium-ion and hydrogen technologies.
🔋 GreenHy2’s new supercapacitor batteries could deliver longer life, faster charge times, and improved safety compared to lithium-ion solutions
🌱 Low-pressure hydrogen storage is being implemented on GreenHy2’s Telstra contract, with the company expecting more than 50% cost savings
🏭 Manufacturing advances in graphene have made large-scale supercapacitor battery solutions commercially competitive
Panther Metals (ASX:PNT) is a mineral exploration business advancing its highly prospective portfolio of gold, nickel, and cobalt projects located across Tier 1 mining districts in Western Australia and the Northern Territory. Panther Metals Managing Director and CEO, Daniel Tuffin, joins Lel Smits from The Stock Network and highlights:
⚒️ Bonanza grade gold hits at the company`s Burtville East prospect in WA
⛏️ Exploration upside at the group`s tenure in the Laverton region

Panther Metals (ASX:PNT) is a mineral exploration business advancing its highly prospective portfolio of gold, nickel, and cobalt projects located across Tier 1 mining districts in Western Australia and the Northern Territory. Panther Metals Managing Director and CEO, Daniel Tuffin, joins Lel Smits from The Stock Network and highlights:
⚒️ Bonanza grade gold hits at the company`s Burtville East prospect in WA
⛏️ Exploration upside at the group`s tenure in the Laverton region
Did you know EVs can have up to six times more minerals than petrol vehicles?
#finance #stocks #EVs #tech #techstocks #minerals #mining #miners

Did you know EVs can have up to six times more minerals than petrol vehicles?
#finance #stocks #EVs #tech #techstocks #minerals #mining #miners
Australian artificial intelligence (AI) security firm icetana AI (ASX:ICE) has secured its largest-ever contract with a $1.7 million order from new Iraq-based partner, High Tech. The company will now supply its advanced AI video analytics software to Iraq’s Baghdad Safe City project.
💻 icetana AI’s software successfully completed proof-of-concept trials in Iraq, showcasing features such as facial recognition and Arabic licence plate detection
🛡️ The deal is structured as a perpetual licence with a first-year maintenance agreement that could add $344,000 in recurring annual revenue
🗓️ Deployment is expected in Q4 FY25, with software licensing to begin around May this year
“We are delighted to welcome High Tech as a new partner in the Iraq market. This initial sale is the largest value contract in icetana AI’s listed history and represents a significant milestone for our company.” – Kevin Brown, icetana Chief Executive Officer

Australian artificial intelligence (AI) security firm icetana AI (ASX:ICE) has secured its largest-ever contract with a $1.7 million order from new Iraq-based partner, High Tech. The company will now supply its advanced AI video analytics software to Iraq’s Baghdad Safe City project.
💻 icetana AI’s software successfully completed proof-of-concept trials in Iraq, showcasing features such as facial recognition and Arabic licence plate detection
🛡️ The deal is structured as a perpetual licence with a first-year maintenance agreement that could add $344,000 in recurring annual revenue
🗓️ Deployment is expected in Q4 FY25, with software licensing to begin around May this year
“We are delighted to welcome High Tech as a new partner in the Iraq market. This initial sale is the largest value contract in icetana AI’s listed history and represents a significant milestone for our company.” – Kevin Brown, icetana Chief Executive Officer
Digital healthcare solutions provider Beamtree (ASX: BMT) has locked in a $4 million agreement to provide its PICQ clinical data auditing platform to the Healthcare Pricing Office (HPO) in Ireland, following a tender process across the European Union.
🧪 Represents a continuation of the duo’s partnership for a further five years
💊 PICQ is a SaaS based product that automates the audit of classification and helps support clinical record coders in improving the quality of coding data
🧬 PICQ has been utilised by clinical coders in Ireland since 2018 and is also implemented in Australia, New Zealand, Saudi Arabia, and Canada
“We are proud of this important recognition of the value of PICQ from one of longstanding national customers. It is our great privilege to continue to support the HPO as they work to deliver coding excellence for the Republic of Ireland.” – Marek Stepniak, Beamtree Chief Executive Officer

Digital healthcare solutions provider Beamtree (ASX: BMT) has locked in a $4 million agreement to provide its PICQ clinical data auditing platform to the Healthcare Pricing Office (HPO) in Ireland, following a tender process across the European Union.
🧪 Represents a continuation of the duo’s partnership for a further five years
💊 PICQ is a SaaS based product that automates the audit of classification and helps support clinical record coders in improving the quality of coding data
🧬 PICQ has been utilised by clinical coders in Ireland since 2018 and is also implemented in Australia, New Zealand, Saudi Arabia, and Canada
“We are proud of this important recognition of the value of PICQ from one of longstanding national customers. It is our great privilege to continue to support the HPO as they work to deliver coding excellence for the Republic of Ireland.” – Marek Stepniak, Beamtree Chief Executive Officer
The Stock Network is pleased to support the Sydney Mining Club and interview Larvotto Resources (ASX:LRV) Managing Director Ron Heeks, who will be presenting at the Sydney Mining Club Event. Hear how Larvotto Resources is on the verge of becoming a world-leading antimony producer at its Hillgrove project in New South Wales, which hosts the largest antinomy deposit in Australia and the eighth biggest in the world. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Larvotto Resources (ASX:LRV) Managing Director Ron Heeks.
🗓 Thursday 1 May 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Larvotto Resources (ASX:LRV) Managing Director Ron Heeks, who will be presenting at the Sydney Mining Club Event. Hear how Larvotto Resources is on the verge of becoming a world-leading antimony producer at its Hillgrove project in New South Wales, which hosts the largest antinomy deposit in Australia and the eighth biggest in the world. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Larvotto Resources (ASX:LRV) Managing Director Ron Heeks.
🗓 Thursday 1 May 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
We all know silver is in jewellery, coins and tableware - but why are investors pushing up demand?
#silver #mining #stocks #silverstocks #finance #ASX #solar #green #tech

We all know silver is in jewellery, coins and tableware - but why are investors pushing up demand?
#silver #mining #stocks #silverstocks #finance #ASX #solar #green #tech
Infection prevention specialist Nanosonics (ASX: NAN) has been granted ‘De Novo’ clearance by the US Food and Drug Administration (FDA) for its innovative CORIS system designed to improve cleaning outcomes for flexible endoscopes.
🧪 Establishes CORIS as a completely new category for endoscope cleaning technology in the US
💊 Marks a key step in the company’s commercialisation efforts for CORIS in the lucrative American market
🧬 First phase of commercialisation push remains on track for the first quarter of FY26
“CORIS represents a significant opportunity for the organisation and the FDA de novo clearance marks a key milestone for the Company and an important step in bringing this much needed innovation to market.” – Michael Kavanagh, Nanosonics Chief Executive Officer and President

Infection prevention specialist Nanosonics (ASX: NAN) has been granted ‘De Novo’ clearance by the US Food and Drug Administration (FDA) for its innovative CORIS system designed to improve cleaning outcomes for flexible endoscopes.
🧪 Establishes CORIS as a completely new category for endoscope cleaning technology in the US
💊 Marks a key step in the company’s commercialisation efforts for CORIS in the lucrative American market
🧬 First phase of commercialisation push remains on track for the first quarter of FY26
“CORIS represents a significant opportunity for the organisation and the FDA de novo clearance marks a key milestone for the Company and an important step in bringing this much needed innovation to market.” – Michael Kavanagh, Nanosonics Chief Executive Officer and President
Medical device business EMVision (ASX: EMV) has successfully tested its ‘First Responder’ brain scanner in aeromedical conditions, marking a key step toward faster stroke and traumatic brain injury diagnosis for patients in remote and rural areas.
🚁 Testing performed in collaboration with the Royal Flying Doctor Service (RFDS) and the Australian Stroke Alliance, with scans successfully completed in-flight
🏥 Demonstrates ability for the scanner to withstand physical stress, environmental conditions, and operational constraints unique to aeromedical retrieval
🩺 Planning separate study with the Melbourne Mobile Stroke Unit (MSU) to test the device alongside standard CT scans during emergency stroke response
“These studies are a key step in the development program of the EMVision First Responder device and learnings generated will inform progress from the current advanced prototype to production equivalent commercial units. We are excited by the opportunity to have a substantial positive impact in the reduction of the global burden of stroke.” — Scott Kirkland, EMVision Chief Executive Officer

Medical device business EMVision (ASX: EMV) has successfully tested its ‘First Responder’ brain scanner in aeromedical conditions, marking a key step toward faster stroke and traumatic brain injury diagnosis for patients in remote and rural areas.
🚁 Testing performed in collaboration with the Royal Flying Doctor Service (RFDS) and the Australian Stroke Alliance, with scans successfully completed in-flight
🏥 Demonstrates ability for the scanner to withstand physical stress, environmental conditions, and operational constraints unique to aeromedical retrieval
🩺 Planning separate study with the Melbourne Mobile Stroke Unit (MSU) to test the device alongside standard CT scans during emergency stroke response
“These studies are a key step in the development program of the EMVision First Responder device and learnings generated will inform progress from the current advanced prototype to production equivalent commercial units. We are excited by the opportunity to have a substantial positive impact in the reduction of the global burden of stroke.” — Scott Kirkland, EMVision Chief Executive Officer
Biotechnology business AdAlta (ASX:1AD) has secured its first external investment for the group’s ‘East to West’ growth strategy centred on in-licensing immunotherapies for solid cancers from the ‘East’ (Asia) and providing a pathway for these products to reach ‘Western’ markets.
🧬 SYNthesis BioVentures Fund (SYNBV) is investing up to $2 million in seed financing in AdCella, an unlisted subsidiary of AdAlta
💊 Facilitates accelerated planning and preparation for three previously announced cellular immunotherapy assets being considered for licensing by AdCella
🩺 SYNBV has a right to invest a further $5.5 million in the newly launched Series A funding round for AdCella
⚕️ AdAlta will own at least 75% of AdCella immediately prior to the Series A funding round
“This Agreement between AdAlta and SYNBV is a watershed event for our Company, with it being a clear vote of confidence in our “East to West” cellular immunotherapy strategy. The seed financing provided by SYNBV to our AdCella subsidiary represents AdCella’s first instalment of external funding and is the outcome we anticipated when we first signed our Memorandum of Understanding with SYNBV." - Tim Oldham, AdAlta Chief Executive Officer and Managing Director

Biotechnology business AdAlta (ASX:1AD) has secured its first external investment for the group’s ‘East to West’ growth strategy centred on in-licensing immunotherapies for solid cancers from the ‘East’ (Asia) and providing a pathway for these products to reach ‘Western’ markets.
🧬 SYNthesis BioVentures Fund (SYNBV) is investing up to $2 million in seed financing in AdCella, an unlisted subsidiary of AdAlta
💊 Facilitates accelerated planning and preparation for three previously announced cellular immunotherapy assets being considered for licensing by AdCella
🩺 SYNBV has a right to invest a further $5.5 million in the newly launched Series A funding round for AdCella
⚕️ AdAlta will own at least 75% of AdCella immediately prior to the Series A funding round
“This Agreement between AdAlta and SYNBV is a watershed event for our Company, with it being a clear vote of confidence in our “East to West” cellular immunotherapy strategy. The seed financing provided by SYNBV to our AdCella subsidiary represents AdCella’s first instalment of external funding and is the outcome we anticipated when we first signed our Memorandum of Understanding with SYNBV." - Tim Oldham, AdAlta Chief Executive Officer and Managing Director
Shares in Aussie retailer Myer (ASX:MYR) have been moving lower, but why?
#myer #shopping #stocks #finktock #finance #ASX #ASXstocks

Shares in Aussie retailer Myer (ASX:MYR) have been moving lower, but why?
#myer #shopping #stocks #finktock #finance #ASX #ASXstocks
Clinical stage drug development company Syntara (ASX: SNT) has unveiled its next-generation topical anti-fibrotic drug known as SNT-9465, which is designed to improve the appearance and structure of skin scars. The company is now planning clinical trials in 2025 with results expected early next year.
💊 Seeks to provide easier and more effective daily treatment option compared to expensive and painful existing standards of care for scar treatment
🧪 Phase 1a/b clinical trials to commence in Q2 2025 to assess safety and early effectiveness in treating hypertrophic scars
💉 Results will support an FDA Investigational New Drug (IND) application,
paving the way for a global development program
“With a cost-effective and efficient clinical development strategy, we aim to deliver an IND ready program with evidence supporting safety and efficacy in 2026. The work underway with UWA and the Fiona Wood Foundation will allow us to expand the label indications into other scar types” – Gary Phillips, Syntara Chief Executive Officer

Clinical stage drug development company Syntara (ASX: SNT) has unveiled its next-generation topical anti-fibrotic drug known as SNT-9465, which is designed to improve the appearance and structure of skin scars. The company is now planning clinical trials in 2025 with results expected early next year.
💊 Seeks to provide easier and more effective daily treatment option compared to expensive and painful existing standards of care for scar treatment
🧪 Phase 1a/b clinical trials to commence in Q2 2025 to assess safety and early effectiveness in treating hypertrophic scars
💉 Results will support an FDA Investigational New Drug (IND) application,
paving the way for a global development program
“With a cost-effective and efficient clinical development strategy, we aim to deliver an IND ready program with evidence supporting safety and efficacy in 2026. The work underway with UWA and the Fiona Wood Foundation will allow us to expand the label indications into other scar types” – Gary Phillips, Syntara Chief Executive Officer
Tesla’s (NASDAQ: TSLA) share price is down by nearly 40% since the start of the year and things might have just gotten worse.
#Tesla #Elon #EVs #BYD #stocks #fintok #finance #techstocks

Tesla’s (NASDAQ: TSLA) share price is down by nearly 40% since the start of the year and things might have just gotten worse.
#Tesla #Elon #EVs #BYD #stocks #fintok #finance #techstocks
Cleo Diagnostics (ASX: COV) is advancing the commercialisation push for its ovarian cancer detection test with technology transfer activities taking the group closer to FDA approval in the US. The group is concluding negotiations with Contract Manufacturing Organisations (CMOs) as it assesses the optimal option for bringing the test to market.
🧪 Marks a critical milestone for the manufacturing pathway of the diagnostic test
💊 Cleo is now aiming to bring to market a diagnostic test kit which is compliant with the US Food and Drug Administration (FDA)
🧬 Negotiations with CMOs are in advances stages as Cleo weighs up the most suitable commercialisation option based on manufacturing capability, regulatory compliance, and ability to scale
“The commencement of technology transfer marks a pivotal milestone in CLEO`s strategic pathway toward commercialisation. During this phase, we refine and scale our assay technology, to ensure the Company is well positioned to progress its Ovarian Cancer test from prototype production to a commercially available, FDA-compliant diagnostic kit.” – Dr Richard Allman, Cleo Diagnostics Chief Executive Officer

Cleo Diagnostics (ASX: COV) is advancing the commercialisation push for its ovarian cancer detection test with technology transfer activities taking the group closer to FDA approval in the US. The group is concluding negotiations with Contract Manufacturing Organisations (CMOs) as it assesses the optimal option for bringing the test to market.
🧪 Marks a critical milestone for the manufacturing pathway of the diagnostic test
💊 Cleo is now aiming to bring to market a diagnostic test kit which is compliant with the US Food and Drug Administration (FDA)
🧬 Negotiations with CMOs are in advances stages as Cleo weighs up the most suitable commercialisation option based on manufacturing capability, regulatory compliance, and ability to scale
“The commencement of technology transfer marks a pivotal milestone in CLEO`s strategic pathway toward commercialisation. During this phase, we refine and scale our assay technology, to ensure the Company is well positioned to progress its Ovarian Cancer test from prototype production to a commercially available, FDA-compliant diagnostic kit.” – Dr Richard Allman, Cleo Diagnostics Chief Executive Officer
There could be a new massive gold company in town, that is if a newly proposed $2.4 billion acquisition gets shareholder approval....
#finance #stocks #copper #mining #copperminers #ASX #ASXstocks #miners

There could be a new massive gold company in town, that is if a newly proposed $2.4 billion acquisition gets shareholder approval....
#finance #stocks #copper #mining #copperminers #ASX #ASXstocks #miners
Australian clean-tech business Hazer Group (ASX: HZR) has strengthened its intellectual property (IP) portfolio with the approval of a key US patent that protects the company’s innovative process for hydrogen and graphitic carbon production.
📜 Lifts Hazer’s registered patents in the US to four, spanning several distinct technology families that underpin the group’s production process
🗽 Reinforces the company’s competitive position and marks a milestone in its efforts to tap into the targeted North American market
💧 Continues to pursue patent filings across multiple jurisdictions in line with its strategic intellectual property roadmap and commercialisation push
“The US and North America more broadly are strategic markets for clean energy innovation, and our proprietary technology provides an attractive pathway for locally produced low-cost, clean hydrogen and graphite utilising existing natural gas infrastructure and supply chains.” – Glenn Corrie, Hazer Group Chief Executive Officer and Managing Director

Australian clean-tech business Hazer Group (ASX: HZR) has strengthened its intellectual property (IP) portfolio with the approval of a key US patent that protects the company’s innovative process for hydrogen and graphitic carbon production.
📜 Lifts Hazer’s registered patents in the US to four, spanning several distinct technology families that underpin the group’s production process
🗽 Reinforces the company’s competitive position and marks a milestone in its efforts to tap into the targeted North American market
💧 Continues to pursue patent filings across multiple jurisdictions in line with its strategic intellectual property roadmap and commercialisation push
“The US and North America more broadly are strategic markets for clean energy innovation, and our proprietary technology provides an attractive pathway for locally produced low-cost, clean hydrogen and graphite utilising existing natural gas infrastructure and supply chains.” – Glenn Corrie, Hazer Group Chief Executive Officer and Managing Director
Sustainable energy specialist Renergen (ASX:RLT) has commenced commercial liquid helium sales by successfully filling and delivering its first container to a customer. The company previously faced challenges with cooling large iso-containers to the extreme temperatures needed for liquid helium storage.
❄️Implements alternate solution by regularly filling smaller Dewar containers (250-500 litres) with liquid helium until plant nears nameplate capacity
🎯 Both liquefied natural gas (LNG) and helium now exceed minimum design specifications
🔥 Remains focused on scaling up its Virginia Gas Project in South Africa
" Our operations team has poured their hearts and souls into overcoming these technical challenges. Successfully managing cryogenic liquid at -269 degrees Celsius is a remarkable accomplishment achieved by very few companies worldwide." – Stefano Marani, Renergen Chief Executive Officer

Sustainable energy specialist Renergen (ASX:RLT) has commenced commercial liquid helium sales by successfully filling and delivering its first container to a customer. The company previously faced challenges with cooling large iso-containers to the extreme temperatures needed for liquid helium storage.
❄️Implements alternate solution by regularly filling smaller Dewar containers (250-500 litres) with liquid helium until plant nears nameplate capacity
🎯 Both liquefied natural gas (LNG) and helium now exceed minimum design specifications
🔥 Remains focused on scaling up its Virginia Gas Project in South Africa
" Our operations team has poured their hearts and souls into overcoming these technical challenges. Successfully managing cryogenic liquid at -269 degrees Celsius is a remarkable accomplishment achieved by very few companies worldwide." – Stefano Marani, Renergen Chief Executive Officer
The copper price has been rising, but could this trend continue in the longer term?
#finance #stocks #copper #mining #copperminers #ASX #ASXstocks #miners

The copper price has been rising, but could this trend continue in the longer term?
#finance #stocks #copper #mining #copperminers #ASX #ASXstocks #miners
Mineral exploration business G50 Corp (ASX: G50) has launched a Phase 2 reverse circulation drilling campaign to follow up on the group’s high-grade gallium, gold, and silver discoveries at its Golconda project in the US state of Arizona.
⚒️ Builds on the company’s 2023 exploration drilling which intercepted multiple broad zones of gallium, gold, and silver across a 250m by 1,500m area
🪨 Designed to grow the understanding of depth and strike extensions of existing mineralisation and explore new targets, including gallium
⛏️ Gallium is a strategic metal utilised in semiconductors, solar panels, and other high-tech industries
“We are excited to be back in the field at Golconda, following up on our maiden high grade gallium, gold and silver discoveries. We have significantly increased our understanding of the geological model at Golconda and the current drilling will aim to add further knowledge to both depth and strike potential to this treasure chest of opportunity.” – Mark Wallace, G50 Corp Managing Director

Mineral exploration business G50 Corp (ASX: G50) has launched a Phase 2 reverse circulation drilling campaign to follow up on the group’s high-grade gallium, gold, and silver discoveries at its Golconda project in the US state of Arizona.
⚒️ Builds on the company’s 2023 exploration drilling which intercepted multiple broad zones of gallium, gold, and silver across a 250m by 1,500m area
🪨 Designed to grow the understanding of depth and strike extensions of existing mineralisation and explore new targets, including gallium
⛏️ Gallium is a strategic metal utilised in semiconductors, solar panels, and other high-tech industries
“We are excited to be back in the field at Golconda, following up on our maiden high grade gallium, gold and silver discoveries. We have significantly increased our understanding of the geological model at Golconda and the current drilling will aim to add further knowledge to both depth and strike potential to this treasure chest of opportunity.” – Mark Wallace, G50 Corp Managing Director
Race Oncology (ASX:RAC) has received ethics approval from the Bellberry Human Research Ethics Committee (HREC) to initiate a Phase 1 clinical trial on its RC220 cancer treatment product for adult patients with solid tumours. The trial will begin at Southside Cancer Care Centre with up to nine additional sites expected to follow.
🧪 The Phase 1 trial will assess the safety, tolerability, and pharmacokinetics of RC220, alone and in combination with doxorubicin
🏥 Institutional approval and site activation are expected in March 2025, enabling patient enrolment
🌏 Expansion to international sites in Hong Kong and South Korea is planned after regulatory approvals
"Receiving human ethics approval for the first RC220 trial is a significant milestone for Race, in line with our vision to improve cancer patient treatment by developing new cardioprotective therapies with anticancer benefits." – Dr Daniel Tillett, Race Oncology Chief Executive Officer and Managing Director

Race Oncology (ASX:RAC) has received ethics approval from the Bellberry Human Research Ethics Committee (HREC) to initiate a Phase 1 clinical trial on its RC220 cancer treatment product for adult patients with solid tumours. The trial will begin at Southside Cancer Care Centre with up to nine additional sites expected to follow.
🧪 The Phase 1 trial will assess the safety, tolerability, and pharmacokinetics of RC220, alone and in combination with doxorubicin
🏥 Institutional approval and site activation are expected in March 2025, enabling patient enrolment
🌏 Expansion to international sites in Hong Kong and South Korea is planned after regulatory approvals
"Receiving human ethics approval for the first RC220 trial is a significant milestone for Race, in line with our vision to improve cancer patient treatment by developing new cardioprotective therapies with anticancer benefits." – Dr Daniel Tillett, Race Oncology Chief Executive Officer and Managing Director
Global Uranium and Enrichment (ASX: GUE) has teamed up with Nasdaq-listed Snow Lake Energy to acquire the Pine Ridge uranium project in Wyoming’s heralded Powder River Basin in a “transformational” US$22.5 million deal.
⚒️ Pine Ridge is considered an advanced uranium project with an established Exploration Target of between 24.4 million and 51.3 million pounds of uranium
⚛️ Boasts suitable geological foundation to bring Pine Ridge to production with historical drilling having significantly de-risked the project
⛏️ Plans to launch an accelerated work program to define a maiden mineral resource estimate and move Pine Ridge towards production
“This Project has the potential to be a game-changer for Global Uranium. The Exploration Target identified at Pine Ridge highlights the significant opportunity for further development at the Project, and we are now planning for the execution of that alongside Snow Lake.” – Andrew Ferrier, Global Uranium and Enrichment Managing Director

Global Uranium and Enrichment (ASX: GUE) has teamed up with Nasdaq-listed Snow Lake Energy to acquire the Pine Ridge uranium project in Wyoming’s heralded Powder River Basin in a “transformational” US$22.5 million deal.
⚒️ Pine Ridge is considered an advanced uranium project with an established Exploration Target of between 24.4 million and 51.3 million pounds of uranium
⚛️ Boasts suitable geological foundation to bring Pine Ridge to production with historical drilling having significantly de-risked the project
⛏️ Plans to launch an accelerated work program to define a maiden mineral resource estimate and move Pine Ridge towards production
“This Project has the potential to be a game-changer for Global Uranium. The Exploration Target identified at Pine Ridge highlights the significant opportunity for further development at the Project, and we are now planning for the execution of that alongside Snow Lake.” – Andrew Ferrier, Global Uranium and Enrichment Managing Director
The price of gold is at record highs - why? There are lots of reasons the price of gold goes up. Firstly, it`s the traditional store of value, a safe haven investment in times of uncertainty. This uncertainty has been made worse as recently elected Trump talks up tariffs and everyone`s talking about a possible tariff war. Why would a tariff war be bad? Well, this is because increased tariffs stoke inflation. Concerns about inflation come following a period where inflation cooled which prompting some central bank rate cuts. Also, ongoing armed conflicts like Ukraine/Russia and the Middle East have gold bulls feeling bullish.
#Gold #Finance #Mining #Miners #GoldStocks #Stocks #Trump

The price of gold is at record highs - why? There are lots of reasons the price of gold goes up. Firstly, it`s the traditional store of value, a safe haven investment in times of uncertainty. This uncertainty has been made worse as recently elected Trump talks up tariffs and everyone`s talking about a possible tariff war. Why would a tariff war be bad? Well, this is because increased tariffs stoke inflation. Concerns about inflation come following a period where inflation cooled which prompting some central bank rate cuts. Also, ongoing armed conflicts like Ukraine/Russia and the Middle East have gold bulls feeling bullish.
#Gold #Finance #Mining #Miners #GoldStocks #Stocks #Trump
Victory Metals (ASX: VTM) has revealed “outstanding” results from a scoping study gauging the merits of bringing to production its North Stanmore rare earths project in the ‘Tier 1’ mining jurisdiction of Western Australia.
⚒️ Delivers robust economic profile across multiple pricing scenarios for North Stanmore, including post-tax NPV of $1.2 billion and IRR of 52%
⛏️ Reinforces the project`s strong financial viability and low-cost advantage
🔋 Points to potential for long-term and low-cost supply of critical minerals for high-growth industries such as renewable energy, electric vehicles, and defence
“The combination of a globally significant resource, low CAPEX and strong market fundamentals sets North Stanmore apart as a unique and highly strategic project. We are now focused on advancing towards production while continuing discussions with potential partners to further de-risk development and maximise shareholder value." - Brendan Clark, Victory Metals Chief Executive Officer and Executive Director

Victory Metals (ASX: VTM) has revealed “outstanding” results from a scoping study gauging the merits of bringing to production its North Stanmore rare earths project in the ‘Tier 1’ mining jurisdiction of Western Australia.
⚒️ Delivers robust economic profile across multiple pricing scenarios for North Stanmore, including post-tax NPV of $1.2 billion and IRR of 52%
⛏️ Reinforces the project`s strong financial viability and low-cost advantage
🔋 Points to potential for long-term and low-cost supply of critical minerals for high-growth industries such as renewable energy, electric vehicles, and defence
“The combination of a globally significant resource, low CAPEX and strong market fundamentals sets North Stanmore apart as a unique and highly strategic project. We are now focused on advancing towards production while continuing discussions with potential partners to further de-risk development and maximise shareholder value." - Brendan Clark, Victory Metals Chief Executive Officer and Executive Director
Proteomics International (ASX: PIQ) has reported the publication of a “landmark” study showing that its PromarkerD test used to predict future kidney function decline in patients with type 2 diabetes significantly outperforms current standard-of-care.
🧪 The study found participants classified as high risk by PromarkerD had significantly higher odds of experiencing kidney function decline
💊 Highlights the potential for PromarkerD to revolutionise diabetic kidney disease (DKD) risk assessment, improve patient outcomes, and reduce healthcare costs
🧬 Findings point to the test’s potential to transform DKD management by enabling earlier and more accurate risk assessment
“This peer-reviewed comparison against standard of care is critical in proving the power of PromarkerD to the medical community. As we acknowledge Kidney Health month in the US, we want to provide healthcare professionals with the best tools available to combat this debilitating disease.” – Dr Richard Lipscombe, Proteomics Managing Director

Proteomics International (ASX: PIQ) has reported the publication of a “landmark” study showing that its PromarkerD test used to predict future kidney function decline in patients with type 2 diabetes significantly outperforms current standard-of-care.
🧪 The study found participants classified as high risk by PromarkerD had significantly higher odds of experiencing kidney function decline
💊 Highlights the potential for PromarkerD to revolutionise diabetic kidney disease (DKD) risk assessment, improve patient outcomes, and reduce healthcare costs
🧬 Findings point to the test’s potential to transform DKD management by enabling earlier and more accurate risk assessment
“This peer-reviewed comparison against standard of care is critical in proving the power of PromarkerD to the medical community. As we acknowledge Kidney Health month in the US, we want to provide healthcare professionals with the best tools available to combat this debilitating disease.” – Dr Richard Lipscombe, Proteomics Managing Director
Why did Tesla Inc (NASDAQ:TSLA) fall 15% overnight and why is it down 40% this year? Well let`s get to some possible reasons... People are saying Tesla prices are not competitive. This has also been called "the BYD effect". BYD is a car manufacturer from China. There is growing resistance about EVs. You`ve had the early adopters but momentum is slowing for further uptake. Also, the Musk effect, and association to Trump, hasn`t been positive for the stock. There were even protestors this week in Tesla stores. And finally, the momentum effect - once stocks start to go down some people can say, "it`s going down so I`m taking profits". Elon is not concerned long term, but are you still a Tesla fan?
#Tesla #TSLA #fintok #stocks #finance #elonmusk #nasdaq #techstocks #trump

Why did Tesla Inc (NASDAQ:TSLA) fall 15% overnight and why is it down 40% this year? Well let`s get to some possible reasons... People are saying Tesla prices are not competitive. This has also been called "the BYD effect". BYD is a car manufacturer from China. There is growing resistance about EVs. You`ve had the early adopters but momentum is slowing for further uptake. Also, the Musk effect, and association to Trump, hasn`t been positive for the stock. There were even protestors this week in Tesla stores. And finally, the momentum effect - once stocks start to go down some people can say, "it`s going down so I`m taking profits". Elon is not concerned long term, but are you still a Tesla fan?
#Tesla #TSLA #fintok #stocks #finance #elonmusk #nasdaq #techstocks #trump
Wide Open Agriculture (ASX:WOA) has secured commercial sales and purchase orders for more than five metric tonnes for its lupin protein isolate across five continents, marking a significant step in the commercialisation push for its innovative plant-based protein.
🌍 Initial orders from European health food brand Tarwi, an Australian food manufacturer, and distributors in Latin America
🌱 Validates the high-quality taste, functionality, health benefits, and sustainability credentials of the company’s lupin protein isolates
🫘 Sales traction paves the way for negotiations with major distributors and food and beverage brands in China, Europe, North America, Australia, and South Korea
"As a small company operating with a semi-commercial plant, our strategy has always been to showcase the global potential of our breakthrough lupin proteins, rather than produce volume non-commercially. And now, we’ve clearly demonstrated that potential!” – Yaxi Zhan, Wide Open Agriculture Chairperson

Wide Open Agriculture (ASX:WOA) has secured commercial sales and purchase orders for more than five metric tonnes for its lupin protein isolate across five continents, marking a significant step in the commercialisation push for its innovative plant-based protein.
🌍 Initial orders from European health food brand Tarwi, an Australian food manufacturer, and distributors in Latin America
🌱 Validates the high-quality taste, functionality, health benefits, and sustainability credentials of the company’s lupin protein isolates
🫘 Sales traction paves the way for negotiations with major distributors and food and beverage brands in China, Europe, North America, Australia, and South Korea
"As a small company operating with a semi-commercial plant, our strategy has always been to showcase the global potential of our breakthrough lupin proteins, rather than produce volume non-commercially. And now, we’ve clearly demonstrated that potential!” – Yaxi Zhan, Wide Open Agriculture Chairperson
Meeka Metals (ASX: MEK) has unearthed a new shallow and high grade gold zone at its Murchison project in WA which could improve the economics of a mining operation. First gold pour at the project is expected in the coming months.
🌟 New gold zone lies to the west of the company’s ‘stage 1’ oxide pit design at Turnberry South, which could now be set for an expansion
⚒️ Prioritising further drill testing to define the extent of this gold zone through an ongoing drilling campaign at Murchison
💎 First gold production at Muchison is projected for mid-2025
“We had not previously intersected this high-grade gold zone on the western side of Turnberry South due to the orientation of prior drilling. We are now prioritising drill delineation along strike to incorporate into an expanded grade control model and updated stage 1 open pit design.” – Tim Davidson, Meeka Metals Managing Director

Meeka Metals (ASX: MEK) has unearthed a new shallow and high grade gold zone at its Murchison project in WA which could improve the economics of a mining operation. First gold pour at the project is expected in the coming months.
🌟 New gold zone lies to the west of the company’s ‘stage 1’ oxide pit design at Turnberry South, which could now be set for an expansion
⚒️ Prioritising further drill testing to define the extent of this gold zone through an ongoing drilling campaign at Murchison
💎 First gold production at Muchison is projected for mid-2025
“We had not previously intersected this high-grade gold zone on the western side of Turnberry South due to the orientation of prior drilling. We are now prioritising drill delineation along strike to incorporate into an expanded grade control model and updated stage 1 open pit design.” – Tim Davidson, Meeka Metals Managing Director
Global medical device business OncoSil Medical (ASX:OSL) has successfully performed its first OncoSil treatment for pancreatic cancer at Manchester University NHS Foundation Trust (MFT) in the UK.
🩺 Marks a significant step forward in providing innovative treatment options for patients with locally advanced pancreatic cancer in the UK
💉 MFT provides hospital care to about 750,000 people across 10 hospitals in Manchester and Trafford
⚕️ MFT is the single biggest provider of specialised services in the North West region of England with more than 28,000 staff
🩻 The OncoSil device is a single-use brachytherapy mechanism used to deliver a pre-determined dose of beta radiation directly into cancerous tissue

Global medical device business OncoSil Medical (ASX:OSL) has successfully performed its first OncoSil treatment for pancreatic cancer at Manchester University NHS Foundation Trust (MFT) in the UK.
🩺 Marks a significant step forward in providing innovative treatment options for patients with locally advanced pancreatic cancer in the UK
💉 MFT provides hospital care to about 750,000 people across 10 hospitals in Manchester and Trafford
⚕️ MFT is the single biggest provider of specialised services in the North West region of England with more than 28,000 staff
🩻 The OncoSil device is a single-use brachytherapy mechanism used to deliver a pre-determined dose of beta radiation directly into cancerous tissue
Renewable energy and waste management specialist Delorean Corporation (ASX:DEL) has sealed a $6.08 million grant funding agreement with the Australian Renewable Energy Agency (ARENA) to enhance its SA1 bioenergy facility in South Australia.
🏗️ Funding will support the production of renewable biomethane, food-grade liquid carbon dioxide (LCO2), and Renewable Gas Certificates of Origin (RGGOs)
🔋 Reinforces the company`s role in Australia`s clean energy transition with the renewable biomethane to be injected into Adelaide’s gas network
🌱 Supports decarbonisation efforts of industrial gas users and offers long-term environmental and financial benefits
"This significant grant investment from ARENA is a game-changer for Delorean and the Australian energy sector. It not only enables us to achieve a major milestone with the SA1 project, but it also creates long-term, sustainable revenue streams that will underwrite the viability of the project." - Joseph Oliver, Delorean Corporation Managing Director

Renewable energy and waste management specialist Delorean Corporation (ASX:DEL) has sealed a $6.08 million grant funding agreement with the Australian Renewable Energy Agency (ARENA) to enhance its SA1 bioenergy facility in South Australia.
🏗️ Funding will support the production of renewable biomethane, food-grade liquid carbon dioxide (LCO2), and Renewable Gas Certificates of Origin (RGGOs)
🔋 Reinforces the company`s role in Australia`s clean energy transition with the renewable biomethane to be injected into Adelaide’s gas network
🌱 Supports decarbonisation efforts of industrial gas users and offers long-term environmental and financial benefits
"This significant grant investment from ARENA is a game-changer for Delorean and the Australian energy sector. It not only enables us to achieve a major milestone with the SA1 project, but it also creates long-term, sustainable revenue streams that will underwrite the viability of the project." - Joseph Oliver, Delorean Corporation Managing Director
Health food and beverage business Forbidden Foods (ASX: FFF) has clinched its largest purchase order from major retailer Costco Australia for the company’s Blue Dinosaur snack products, valued at $133,000.
🧃 Highlights the strong demand for Blue Dinosaur ‘Bites’ range which previously sold out across Costco stores
🧋 Builds on the company’s strategy to develop an expanded distribution footprint for its multi-brand portfolio
🥛 Continues sales momentum so far in 2025 after net sales for the first two months of the year jumped by 147% from the previous corresponding period
“The latest purchase order from Costco is another positive step in our strategy to establish Forbidden Foods as a leading multi-brand FMCG business, with a diversified distribution footprint and strong partnerships with major Australian retailers.” – Alex Aleksic, Forbidden Foods Chief Executive Officer

Health food and beverage business Forbidden Foods (ASX: FFF) has clinched its largest purchase order from major retailer Costco Australia for the company’s Blue Dinosaur snack products, valued at $133,000.
🧃 Highlights the strong demand for Blue Dinosaur ‘Bites’ range which previously sold out across Costco stores
🧋 Builds on the company’s strategy to develop an expanded distribution footprint for its multi-brand portfolio
🥛 Continues sales momentum so far in 2025 after net sales for the first two months of the year jumped by 147% from the previous corresponding period
“The latest purchase order from Costco is another positive step in our strategy to establish Forbidden Foods as a leading multi-brand FMCG business, with a diversified distribution footprint and strong partnerships with major Australian retailers.” – Alex Aleksic, Forbidden Foods Chief Executive Officer
MA Credit Income Trust (ASX:MA1) has listed on the ASX with a ticker code of MA1. This listed fund provides exposure to a portfolio of Australian, New Zealand and global credit investments covering three core private credit market segments: direct asset lending, asset backed lending, and direct corporate lending. It offers portfolio diversification for investors seeking income and capital preservation and aims to deliver consistent monthly distributions with a target return of the RBA Cash Rate plus 4.25% per annum.

MA Credit Income Trust (ASX:MA1) has listed on the ASX with a ticker code of MA1. This listed fund provides exposure to a portfolio of Australian, New Zealand and global credit investments covering three core private credit market segments: direct asset lending, asset backed lending, and direct corporate lending. It offers portfolio diversification for investors seeking income and capital preservation and aims to deliver consistent monthly distributions with a target return of the RBA Cash Rate plus 4.25% per annum.
Gold explorer James Bay Minerals (ASX: JBY) has joined the one million ounce club after unveiling a maiden 1.37 million ounce JORC compliant mineral resource estimate (MRE) for its Independence gold project in Nevada.
🌟 Reveals a deeper high-grade skarn component containing about 984,000 ounces of gold grading 6.67 grams per tonne
⚒️ The resource also includes a near-surface epithermal component taking in nearly 400,000 ounces of gold
💎 Identifies further exploration upside with known gold mineralisation sitting outside of the resource estimate
“Notably, significant mineralisation exists beyond both the skarn and near-surface epithermal models, remaining open in all directions. These factors strongly suggest a connection between the surface mineralisation and deeper skarn material, indicating substantial resource growth ahead.” – Matthew Hayes, James Bay Minerals Executive Director

Gold explorer James Bay Minerals (ASX: JBY) has joined the one million ounce club after unveiling a maiden 1.37 million ounce JORC compliant mineral resource estimate (MRE) for its Independence gold project in Nevada.
🌟 Reveals a deeper high-grade skarn component containing about 984,000 ounces of gold grading 6.67 grams per tonne
⚒️ The resource also includes a near-surface epithermal component taking in nearly 400,000 ounces of gold
💎 Identifies further exploration upside with known gold mineralisation sitting outside of the resource estimate
“Notably, significant mineralisation exists beyond both the skarn and near-surface epithermal models, remaining open in all directions. These factors strongly suggest a connection between the surface mineralisation and deeper skarn material, indicating substantial resource growth ahead.” – Matthew Hayes, James Bay Minerals Executive Director
Emerging gold producer Brightstar Resources (ASX: BTR) has delivered a series of significant gold hits from its maiden drilling campaign at the Lord Nelson deposit, located within the company’s 1.5 million ounce Sandstone gold project in WA.
🌟 Confirms continuity of high grade gold mineralisation within the optimised pit shell at Lord Nelson, as well as extensions of the mineralisation at depth
⚒️ Results bode well for potential upgrades of the mineral resource at Lord Nelson
💎 Ongoing drilling campaign seeks at upgrade and extend Sandstone’s existing mineral resource base with 80,000m of drilling planned for this year
“The results from our first drill program at the Lord Nelson deposit within our Sandstone Gold Project are significant, highlighting the continuity of the high-grade mineralisation and the robustness of the current mineral resource.” – Alex Rovira, Brightstar Resources Managing Director

Emerging gold producer Brightstar Resources (ASX: BTR) has delivered a series of significant gold hits from its maiden drilling campaign at the Lord Nelson deposit, located within the company’s 1.5 million ounce Sandstone gold project in WA.
🌟 Confirms continuity of high grade gold mineralisation within the optimised pit shell at Lord Nelson, as well as extensions of the mineralisation at depth
⚒️ Results bode well for potential upgrades of the mineral resource at Lord Nelson
💎 Ongoing drilling campaign seeks at upgrade and extend Sandstone’s existing mineral resource base with 80,000m of drilling planned for this year
“The results from our first drill program at the Lord Nelson deposit within our Sandstone Gold Project are significant, highlighting the continuity of the high-grade mineralisation and the robustness of the current mineral resource.” – Alex Rovira, Brightstar Resources Managing Director
Dominion Income Trust (ASX: DN1) has listed on the ASX with a ticker code of DN1. This Trust has invested in a Note with exposure to debt instruments such as loans and bank facilities issued by corporates, banks, and non-bank financial debt institutions with a demonstrated financial performance. The Note seeks to generate regular monthly interest income and to provide portfolio diversification with lower correlation to listed equity markets and a greater correlation to credit markets.
Directors: Michael J. O`Brien, Managing Director, CEO, Director
Andrew Godfrey, Director, Investor Relations
Mary O`Connor Director
Johanna Platt Director, CFO
David WarrenDirector
Media: The Stock Network @lelsmits

Dominion Income Trust (ASX: DN1) has listed on the ASX with a ticker code of DN1. This Trust has invested in a Note with exposure to debt instruments such as loans and bank facilities issued by corporates, banks, and non-bank financial debt institutions with a demonstrated financial performance. The Note seeks to generate regular monthly interest income and to provide portfolio diversification with lower correlation to listed equity markets and a greater correlation to credit markets.
Directors: Michael J. O`Brien, Managing Director, CEO, Director
Andrew Godfrey, Director, Investor Relations
Mary O`Connor Director
Johanna Platt Director, CFO
David WarrenDirector
Media: The Stock Network @lelsmits
Aquaculture business New Zealand King Salmon (ASX: NZK) has inked a five year funding partnership with the New Zealand government in the duo’s efforts to drive the future of the salmon farming industry in the country.
🐟 NZ government will invest up to NZ$11.7 million into a program designed to establish viability of open ocean farming for the King salmon species
🎣 The company is progressing New Zealand’s first open ocean salmon farm at its Blue Endeavour pilot project
🌊 The collaboration seeks to advance the technologies that will provide a blueprint for substantive and sustainable salmon farming growth in New Zealand
“Having the world’s first King salmon open ocean aquaculture site at Blue Endeavour is a big responsibility – while we are confident it will be successful, there will be some significant lessons learned along the way. This funding partnership will enable us to share these learnings and build industry and investor confidence.” – Carl Carrington, New Zealand King Salmon Chief Executive Officer

Aquaculture business New Zealand King Salmon (ASX: NZK) has inked a five year funding partnership with the New Zealand government in the duo’s efforts to drive the future of the salmon farming industry in the country.
🐟 NZ government will invest up to NZ$11.7 million into a program designed to establish viability of open ocean farming for the King salmon species
🎣 The company is progressing New Zealand’s first open ocean salmon farm at its Blue Endeavour pilot project
🌊 The collaboration seeks to advance the technologies that will provide a blueprint for substantive and sustainable salmon farming growth in New Zealand
“Having the world’s first King salmon open ocean aquaculture site at Blue Endeavour is a big responsibility – while we are confident it will be successful, there will be some significant lessons learned along the way. This funding partnership will enable us to share these learnings and build industry and investor confidence.” – Carl Carrington, New Zealand King Salmon Chief Executive Officer
The Stock Network is pleased to support the Sydney Mining Club and interview Auric Mining (ASX:AWJ) Managing Director Mark English, who will be presenting at the Sydney Mining Club Event. Hear about Auric Mining’s gold production plans for its Jeffreys Find and Munda gold projects located in the heart of Western Australia’s renowned Goldfields region.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Auric Mining (ASX:AWJ) Managing Director Mark English, who will be presenting at the Sydney Mining Club Event. Hear about Auric Mining’s gold production plans for its Jeffreys Find and Munda gold projects located in the heart of Western Australia’s renowned Goldfields region.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
Ahead of appearing at the Stocks On Track event, LTR Pharma (ASX:LTP) Executive Chairman, Lee Rodne speaks with The Stock Network`s Lel Smits and highlights:
🔹Market opportunity for SPONTAN nasal spray used to treat erectile dysfunction
🔹Advantages of SPONTAN over competitor products
🔹Commercialisation push for SPONTAN in Australia and the US

Ahead of appearing at the Stocks On Track event, LTR Pharma (ASX:LTP) Executive Chairman, Lee Rodne speaks with The Stock Network`s Lel Smits and highlights:
🔹Market opportunity for SPONTAN nasal spray used to treat erectile dysfunction
🔹Advantages of SPONTAN over competitor products
🔹Commercialisation push for SPONTAN in Australia and the US
Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The company has just delivered a robust performance in the first half of the 2025 financial year (H1 FY25) showcased by a substantial jump in revenue, operating earnings, and profit. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🥁 Revenue and other income up by 32%
🧑💼 Industry acknowledgements
🗓️ Spectrum Growth plans
“This is an outstanding continuation of the momentum built through the 2024 financial year. We have greatly improved our organic growth, repriced our core SMA to reflect its top tier market position, rebounded from the impact of adviser exits, launched a market leading IDPS with Spectrum, restructured operations offshore and returned earnings to shareholders." - Praemium’s Chief Executive Officer, Mr. Anthony Wamsteker

Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The company has just delivered a robust performance in the first half of the 2025 financial year (H1 FY25) showcased by a substantial jump in revenue, operating earnings, and profit. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🥁 Revenue and other income up by 32%
🧑💼 Industry acknowledgements
🗓️ Spectrum Growth plans
“This is an outstanding continuation of the momentum built through the 2024 financial year. We have greatly improved our organic growth, repriced our core SMA to reflect its top tier market position, rebounded from the impact of adviser exits, launched a market leading IDPS with Spectrum, restructured operations offshore and returned earnings to shareholders." - Praemium’s Chief Executive Officer, Mr. Anthony Wamsteker
Land and marine transport specialist Kelsian Group (ASX:KLS) has delivered healthy revenue growth in the first half of the 2025 financial year (H1 FY25), with the group now targeting a lift in free cash flow generation through reduced capital expenditure.
🚍 Revenue of $1.07 billion up by 9.1% from same time last year with the company on track to meet full-year earnings guidance
🛳️ Delivers a series of significant new and renewed contract wins including in key US growth market
🛣️ Majority of FY25 capital expenditure incurred in H1 FY25, positioning the company for higher free cash flow generation
“The result reflects the strength of our diversified, global business with a strong track record of growth, underpinned by a majority of highly defensive long-term service contracts with high quality counterparties as well as cost base protection in most contracts.” – Clint Feuerherdt, Kelsian Group Managing Director and Chief Executive Officer

Land and marine transport specialist Kelsian Group (ASX:KLS) has delivered healthy revenue growth in the first half of the 2025 financial year (H1 FY25), with the group now targeting a lift in free cash flow generation through reduced capital expenditure.
🚍 Revenue of $1.07 billion up by 9.1% from same time last year with the company on track to meet full-year earnings guidance
🛳️ Delivers a series of significant new and renewed contract wins including in key US growth market
🛣️ Majority of FY25 capital expenditure incurred in H1 FY25, positioning the company for higher free cash flow generation
“The result reflects the strength of our diversified, global business with a strong track record of growth, underpinned by a majority of highly defensive long-term service contracts with high quality counterparties as well as cost base protection in most contracts.” – Clint Feuerherdt, Kelsian Group Managing Director and Chief Executive Officer
The Stock Network is pleased to support the Sydney Mining Club and interview Barton Gold (ASX:BGD) Managing Director Alexander Scanlon, who will be presenting at the Sydney Mining Club Event. Hear Barton Gold accelerating gold development at Tunkillia project, Gawler Craton, South Australia. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Barton Gold (ASX:BGD), Managing Director Alexander Scanlon.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Barton Gold (ASX:BGD) Managing Director Alexander Scanlon, who will be presenting at the Sydney Mining Club Event. Hear Barton Gold accelerating gold development at Tunkillia project, Gawler Craton, South Australia. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Barton Gold (ASX:BGD), Managing Director Alexander Scanlon.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
Ahead of appearing at the Stocks On Track event, Amplia Therapeutics (ASX:ATX) CEO & Managing Director, Chris Burns speaks with The Stock Network`s Lel Smits and highlights:
🩻 Amplia’s role in improving cancer treatment
💉 The company’s upcoming clinical trial in pancreatic cancer
🩺 The global addressable market for pancreatic cancer treatment

Ahead of appearing at the Stocks On Track event, Amplia Therapeutics (ASX:ATX) CEO & Managing Director, Chris Burns speaks with The Stock Network`s Lel Smits and highlights:
🩻 Amplia’s role in improving cancer treatment
💉 The company’s upcoming clinical trial in pancreatic cancer
🩺 The global addressable market for pancreatic cancer treatment
Ahead of appearing at the Stocks On Track event, AdAlta (ASX:1AD) CEO & Managing Director, Tim Oldham speaks with The Stock Network`s Lel Smits and highlights:
🩺 Progress and potential of “East to West” strategy
💉 Strategy momentum and future goals

Ahead of appearing at the Stocks On Track event, AdAlta (ASX:1AD) CEO & Managing Director, Tim Oldham speaks with The Stock Network`s Lel Smits and highlights:
🩺 Progress and potential of “East to West” strategy
💉 Strategy momentum and future goals
3D metal printing specialist AML3D (ASX:AL3) has released its half yearly report for the first half of the 2025 financial year (H1 FY25), headlined by the commercialisation push of its patented Wire Additive Manufacturing technology known as ARCEMY.
Highlights for the half-year include:
🥁 Delivers $4.63 million in revenue in H1 FY25, up by 206% from the previous corresponding period
🏭 Opens US technology centre with immediate plans for expansion and an initial $2.27 million utilities contract
🔑 Seals $30 million in funding to facilitate expansion in the US and Europe
🚢 Strengthens partnership with BlueForge Alliance to support US Navy submarine program

3D metal printing specialist AML3D (ASX:AL3) has released its half yearly report for the first half of the 2025 financial year (H1 FY25), headlined by the commercialisation push of its patented Wire Additive Manufacturing technology known as ARCEMY.
Highlights for the half-year include:
🥁 Delivers $4.63 million in revenue in H1 FY25, up by 206% from the previous corresponding period
🏭 Opens US technology centre with immediate plans for expansion and an initial $2.27 million utilities contract
🔑 Seals $30 million in funding to facilitate expansion in the US and Europe
🚢 Strengthens partnership with BlueForge Alliance to support US Navy submarine program
Mexican restaurant business Guzman Y Gomez (ASX: GYG) has served up a strong set of numbers in the first half of the 2025 financial year (H1 FY25) headlined by a strong jump in global sales as its ongoing network expansion marches on.
🌮 Delivers 23% year-on-year improvement in global network sales as total number of restaurants rises to 239
🌶️ EBITDA of $32 million in the half-year up by 28% with NPAT of $7.3 million nearly doubling
🥑 Pipeline of more than 100 future restaurants to help drive growth

Mexican restaurant business Guzman Y Gomez (ASX: GYG) has served up a strong set of numbers in the first half of the 2025 financial year (H1 FY25) headlined by a strong jump in global sales as its ongoing network expansion marches on.
🌮 Delivers 23% year-on-year improvement in global network sales as total number of restaurants rises to 239
🌶️ EBITDA of $32 million in the half-year up by 28% with NPAT of $7.3 million nearly doubling
🥑 Pipeline of more than 100 future restaurants to help drive growth
Food and beverage business Retail Food Group (ASX: RFG) has delivered a strong set of numbers in the first half of the 2025 financial year whilst also announcing plans to introduce and expand American premium sandwich brand Firehouse Subs within Australia.
🍩 Underlying revenue of $66.5 million up by 24.7% from the previous corresponding period, driven by core brands such as Gloria Jean’s, Donut King, and Brumby’s
🍕 Statutory net profit after tax of $7.3 million up by nearly 74% year-on-year
🥪 Plans to open 165 Firehouse Subs outlets in Australia over the next decade
“Firehouse Subs is a key pillar of our ambitious growth strategy and we are confident consumers will be excited by the brand’s high-quality sandwich product together with an excellent guest experience.” – Matt Marshall, Retail Food Group Chief Executive Officer

Food and beverage business Retail Food Group (ASX: RFG) has delivered a strong set of numbers in the first half of the 2025 financial year whilst also announcing plans to introduce and expand American premium sandwich brand Firehouse Subs within Australia.
🍩 Underlying revenue of $66.5 million up by 24.7% from the previous corresponding period, driven by core brands such as Gloria Jean’s, Donut King, and Brumby’s
🍕 Statutory net profit after tax of $7.3 million up by nearly 74% year-on-year
🥪 Plans to open 165 Firehouse Subs outlets in Australia over the next decade
“Firehouse Subs is a key pillar of our ambitious growth strategy and we are confident consumers will be excited by the brand’s high-quality sandwich product together with an excellent guest experience.” – Matt Marshall, Retail Food Group Chief Executive Officer
Optiscan Imaging (ASX:OIL) has unveiled its next generation microscopic medical imaging device known as InForm, specifically designed to transform pathology workflows by delivering real-time digital insights at point of contact with a tissue sample.
🔹Improves efficiency and accuracy of analysis and diagnosis across all pathology workflows.
🔹Expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the company`s strategic objectives.
🔹Enhances the entire pathology workflow across a range of settings, enabling efficiencies and on-the-spot digital decision making for pathologists to improve diagnostic capabilities.
“The reveal of our revolutionary InForm™ device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. InForm™ has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis." - Optiscan CEO and Managing Director, Dr Camile Farah

Optiscan Imaging (ASX:OIL) has unveiled its next generation microscopic medical imaging device known as InForm, specifically designed to transform pathology workflows by delivering real-time digital insights at point of contact with a tissue sample.
🔹Improves efficiency and accuracy of analysis and diagnosis across all pathology workflows.
🔹Expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the company`s strategic objectives.
🔹Enhances the entire pathology workflow across a range of settings, enabling efficiencies and on-the-spot digital decision making for pathologists to improve diagnostic capabilities.
“The reveal of our revolutionary InForm™ device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. InForm™ has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis." - Optiscan CEO and Managing Director, Dr Camile Farah
Baby goods retailer Baby Bunting (ASX: BBN) has reported a boost in profitability in the first half of the 2025 financial year driven by an uptick in sales, a rise in new customer acquisitions, and gross margin expansion. The company is implementing a series of strategic initiatives to fuel further growth.
👶 Net profit after tax (NPAT) of $4.8 million on a pro-forma basis up by 37% from same time last year as new customer acquisitions rise by 12%
🍼 Gross margin expands by 260 basis points to 39.8 per cent with the company on track to meet its margin target for the full financial year
🧸 Progresses new store rollout and refurbishment of existing shops to fuel growth
“Our focus on driving sales through range innovation and new customer acquisition is delivering results. Newness in our ranges continues to resonate, with new customer acquisition up 12% on the prior period. Our exclusive branded products remain a key traffic driver and, with a strong pipeline of exclusive launches in the second half, we expect this momentum to continue.” – Mark Teperson, Baby Bunting Chief Executive Officer

Baby goods retailer Baby Bunting (ASX: BBN) has reported a boost in profitability in the first half of the 2025 financial year driven by an uptick in sales, a rise in new customer acquisitions, and gross margin expansion. The company is implementing a series of strategic initiatives to fuel further growth.
👶 Net profit after tax (NPAT) of $4.8 million on a pro-forma basis up by 37% from same time last year as new customer acquisitions rise by 12%
🍼 Gross margin expands by 260 basis points to 39.8 per cent with the company on track to meet its margin target for the full financial year
🧸 Progresses new store rollout and refurbishment of existing shops to fuel growth
“Our focus on driving sales through range innovation and new customer acquisition is delivering results. Newness in our ranges continues to resonate, with new customer acquisition up 12% on the prior period. Our exclusive branded products remain a key traffic driver and, with a strong pipeline of exclusive launches in the second half, we expect this momentum to continue.” – Mark Teperson, Baby Bunting Chief Executive Officer
Australian retailer Adore Beauty (ASX: ABY) has reported a sharp rise in profitability and margin growth in the first half of FY25 as its refreshed operational strategy focused on disciplined cost management and the expansion of its retail network begins to take shape.
💄 Operating earnings (EBIT) of $2.8 million in H1 FY25 up by 126% from same time last year
🧴 Delivers cash flow positive half-year and record gross margin of 36.2%
💅 Launches physical store roll out with opening of first shop in Victoria as it targets national retail network of 25 shops
“Our half-year results demonstrate the strength of the Adore Beauty brand and the early momentum of our strategy refresh focusing in the near-term on enhancing quality of earnings and optimising our operating model. I am delighted with the demonstrated gains in gross margin which delivered material improvement and the subsequent 126% growth in EBIT in the half.” – Sacha Laing, Adore Beauty Chief Executive Officer

Australian retailer Adore Beauty (ASX: ABY) has reported a sharp rise in profitability and margin growth in the first half of FY25 as its refreshed operational strategy focused on disciplined cost management and the expansion of its retail network begins to take shape.
💄 Operating earnings (EBIT) of $2.8 million in H1 FY25 up by 126% from same time last year
🧴 Delivers cash flow positive half-year and record gross margin of 36.2%
💅 Launches physical store roll out with opening of first shop in Victoria as it targets national retail network of 25 shops
“Our half-year results demonstrate the strength of the Adore Beauty brand and the early momentum of our strategy refresh focusing in the near-term on enhancing quality of earnings and optimising our operating model. I am delighted with the demonstrated gains in gross margin which delivered material improvement and the subsequent 126% growth in EBIT in the half.” – Sacha Laing, Adore Beauty Chief Executive Officer
Ahead of appearing at the Stocks On Track event, Kingston Resources (ASX:KSN) Managing Director Andrew Corbett speaks with The Stock Network`s Lel Smits and highlights:
⛏️ Rising gold price and operations
⚒️ Maiden underground Ore Reserve at Mineral Hill
⛰️ Mineral Hill upside

Ahead of appearing at the Stocks On Track event, Kingston Resources (ASX:KSN) Managing Director Andrew Corbett speaks with The Stock Network`s Lel Smits and highlights:
⛏️ Rising gold price and operations
⚒️ Maiden underground Ore Reserve at Mineral Hill
⛰️ Mineral Hill upside
Medical technology business Artrya (ASX: AYA) has pocketed $15 million from a placement as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
⚕️ Proceeds will be used to accelerate regulatory approvals in the lucrative US market, as well as customer implementation, clinical studies, and regulatory costs
🧑⚕️ Clearance from the US Food and Drug Administration (FDA) expected soon
🏥 Adds to recent contract win with Australia’s second largest diagnostic imaging provider, Sonic Healthcare
“The Company continues the regulatory pathway to expand FDA approvals this year with a portion of Placement proceeds applied to accelerate regulatory applications for our SCP & SCF products, along with customer implementation costs including the Sonic Healthcare Australia Radiology commercial agreement announced on 12 February 2025.” – Mathew Regan, Artrya Chief Executive Officer

Medical technology business Artrya (ASX: AYA) has pocketed $15 million from a placement as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
⚕️ Proceeds will be used to accelerate regulatory approvals in the lucrative US market, as well as customer implementation, clinical studies, and regulatory costs
🧑⚕️ Clearance from the US Food and Drug Administration (FDA) expected soon
🏥 Adds to recent contract win with Australia’s second largest diagnostic imaging provider, Sonic Healthcare
“The Company continues the regulatory pathway to expand FDA approvals this year with a portion of Placement proceeds applied to accelerate regulatory applications for our SCP & SCF products, along with customer implementation costs including the Sonic Healthcare Australia Radiology commercial agreement announced on 12 February 2025.” – Mathew Regan, Artrya Chief Executive Officer
Health and fitness club provider Viva Leisure (ASX: VVA) has delivered a strong set of numbers for the first half of the 2025 financial year with membership growth and network expansion propelling revenue and profitability to record levels.
🏋️ Revenue up by 25% from the same time last year as memberships soar by 72%
💪 Operating earnings (EBITDA) up by 26% year-on-year with net profit after tax up by 15%
🏃♀️ Prioritising free cash flow generation, network optimisation, and expansion of technology-driven offerings to drive further growth
“1H FY25 has been a phenomenal period for Viva Leisure, with record-breaking results reflecting the strength of our diversified strategy and the resilience of our business model. Our expanding corporate and franchise network, combined with our high-margin technology and payments division, continues to drive sustainable and profitable growth.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director

Health and fitness club provider Viva Leisure (ASX: VVA) has delivered a strong set of numbers for the first half of the 2025 financial year with membership growth and network expansion propelling revenue and profitability to record levels.
🏋️ Revenue up by 25% from the same time last year as memberships soar by 72%
💪 Operating earnings (EBITDA) up by 26% year-on-year with net profit after tax up by 15%
🏃♀️ Prioritising free cash flow generation, network optimisation, and expansion of technology-driven offerings to drive further growth
“1H FY25 has been a phenomenal period for Viva Leisure, with record-breaking results reflecting the strength of our diversified strategy and the resilience of our business model. Our expanding corporate and franchise network, combined with our high-margin technology and payments division, continues to drive sustainable and profitable growth.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director
If you like to buy at Chemist Warehouse you may be interested to know that from today, it today became part of a listed company. Sigma Healthcare is the listed company that merged with Chemist Warehouse, debuting today as a merged entity trading under the code SIG.

If you like to buy at Chemist Warehouse you may be interested to know that from today, it today became part of a listed company. Sigma Healthcare is the listed company that merged with Chemist Warehouse, debuting today as a merged entity trading under the code SIG.
Diversified digital health platform business Vitura Health (ASX: VIT) has sealed $5.1 million from a strategic placement to fund its new acquisition of leading Australian medicinal cannabis clinic business, Candor Medical.
🧑⚕️ Propels Vitura into one of Australia’s largest medicinal cannabis clinic providers by growing its consolidated consultation numbers to more than 100,000 each year
💊 Expands Vitura’s specialty healthcare division with the deal expected to deliver a material boost to revenue and operating earnings (EBITDA)
🥼 Backed by $5.1 million placement to an entity associated with renowned high-net-worth businessman, Professor Khalil Shahin
“We are very excited by the opportunities unlocked by this acquisition which we see as a great opportunity to bring together two leaders in the field, both of whom have a deep alignment on the commitment to providing patients with personalised care and which reinforces our goal to make specialty healthcare product and service verticals more accessible to millions of patients across Australia.” – Geoff Cockerill, Vitura Health Chief Executive Officer

Diversified digital health platform business Vitura Health (ASX: VIT) has sealed $5.1 million from a strategic placement to fund its new acquisition of leading Australian medicinal cannabis clinic business, Candor Medical.
🧑⚕️ Propels Vitura into one of Australia’s largest medicinal cannabis clinic providers by growing its consolidated consultation numbers to more than 100,000 each year
💊 Expands Vitura’s specialty healthcare division with the deal expected to deliver a material boost to revenue and operating earnings (EBITDA)
🥼 Backed by $5.1 million placement to an entity associated with renowned high-net-worth businessman, Professor Khalil Shahin
“We are very excited by the opportunities unlocked by this acquisition which we see as a great opportunity to bring together two leaders in the field, both of whom have a deep alignment on the commitment to providing patients with personalised care and which reinforces our goal to make specialty healthcare product and service verticals more accessible to millions of patients across Australia.” – Geoff Cockerill, Vitura Health Chief Executive Officer
BTC Health (ASX:BTC) has appointed Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. It has also appointed its current Head of Finance, Josh Kahanovitz, into the role of Chief Operating Officer.
🥼 Mr Balak joins BTC Health from Universal Biosensors Australia where he was the Chief Financial Officer and Company Secretary for more than 18 years
🩺 He is a member of the Institute of Chartered Accountants and Certified Practicing Accountants
💉 The appointment reflects the underlying expansion of the BTC Health business
“I am delighted to welcome Salesh to BTC. He brings significant international experience applicable to high-growth companies in the healthcare and medical sectors. He joins us at an exciting time in BTC’s growth journey and he will be a valuable addition to the leadership team.” - BTC Health Executive Chairman Dr Richard Treagus

BTC Health (ASX:BTC) has appointed Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. It has also appointed its current Head of Finance, Josh Kahanovitz, into the role of Chief Operating Officer.
🥼 Mr Balak joins BTC Health from Universal Biosensors Australia where he was the Chief Financial Officer and Company Secretary for more than 18 years
🩺 He is a member of the Institute of Chartered Accountants and Certified Practicing Accountants
💉 The appointment reflects the underlying expansion of the BTC Health business
“I am delighted to welcome Salesh to BTC. He brings significant international experience applicable to high-growth companies in the healthcare and medical sectors. He joins us at an exciting time in BTC’s growth journey and he will be a valuable addition to the leadership team.” - BTC Health Executive Chairman Dr Richard Treagus
Healthcare technology business Alcidion (ASX: ALC) has sealed a $5.5 million agreement with the Hywel Dda University Health Board in Wales for the provision of its Miya Precision Platform.
⚕️ Represents Alcidion’s first contract win with a Health Board in Wales
🧑⚕️ Hywel Dda provides primary, secondary and community and dental health services to about 380,000 people in Wales
🏥 Miya Precision Platform helps optimise resource allocation, provides clearer insights into vital signs in patients, and streamlines their journeys
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients.” – Kate Quirke, Alcidion Chief Executive Officer and Managing Director

Healthcare technology business Alcidion (ASX: ALC) has sealed a $5.5 million agreement with the Hywel Dda University Health Board in Wales for the provision of its Miya Precision Platform.
⚕️ Represents Alcidion’s first contract win with a Health Board in Wales
🧑⚕️ Hywel Dda provides primary, secondary and community and dental health services to about 380,000 people in Wales
🏥 Miya Precision Platform helps optimise resource allocation, provides clearer insights into vital signs in patients, and streamlines their journeys
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients.” – Kate Quirke, Alcidion Chief Executive Officer and Managing Director
Medication management specialist Careteq (ASX: CTQ) has entered a strategic partnership with MedicAlert Foundation Australia designed to improve medication safety for Australians living with complex health conditions.
⚕️ Enhances access to critical healthcare services offered by both organisations, including Careteq`s Home Medication Reviews (HMRs)
🧑⚕️ Careteq`s clients to benefit from MedicAlert`s life-saving medical identification products and around-the-clock emergency response hotline
💊 Addresses shortfall of more than 500,000 at-risk individuals who don’t receive the medication reviews they require
“Our partnership with MedicAlert aligns perfectly with our goal of preventing medication-related harm. By raising awareness of the benefits of HMRs, we hope to enhance health outcomes for all Australians.” – Mark Simari, Careteq Executive Chairman

Medication management specialist Careteq (ASX: CTQ) has entered a strategic partnership with MedicAlert Foundation Australia designed to improve medication safety for Australians living with complex health conditions.
⚕️ Enhances access to critical healthcare services offered by both organisations, including Careteq`s Home Medication Reviews (HMRs)
🧑⚕️ Careteq`s clients to benefit from MedicAlert`s life-saving medical identification products and around-the-clock emergency response hotline
💊 Addresses shortfall of more than 500,000 at-risk individuals who don’t receive the medication reviews they require
“Our partnership with MedicAlert aligns perfectly with our goal of preventing medication-related harm. By raising awareness of the benefits of HMRs, we hope to enhance health outcomes for all Australians.” – Mark Simari, Careteq Executive Chairman
PARKD (ASX: PKD) has sealed an exclusive licencing agreement with Fielders Steel Roofing - a division of BlueScope Steel - for the IP related to its innovative metal decking support bracket (MDSB) and metal deck support system (MDSS) used in the construction of car parks and other commercial structures.
🏗️ Grants Fielders an exclusive five year licence to manufacture, market, distribute, and sell the MDSB and MDSS within Australia
🧱 Creates confidence for immediate go-to-market strategy in Australia and expands PARKD’s addressable market and possible applications of its IP
🔨 Fielders has first right to negotiate additional licences for targeted international markets including the US, New Zealand, Indonesia, Japan, and India
“PARKD recognised the potential, its simple, yet ingenious connection system could present to the broader construction market. This small yet critical invention is the key to unlock the aspirations of the construction sector to meaningfully improve safety, productivity, costs and particularly sustainability goals of the government and private sectors.” – Peter McUtchen, PARKD Managing Director

PARKD (ASX: PKD) has sealed an exclusive licencing agreement with Fielders Steel Roofing - a division of BlueScope Steel - for the IP related to its innovative metal decking support bracket (MDSB) and metal deck support system (MDSS) used in the construction of car parks and other commercial structures.
🏗️ Grants Fielders an exclusive five year licence to manufacture, market, distribute, and sell the MDSB and MDSS within Australia
🧱 Creates confidence for immediate go-to-market strategy in Australia and expands PARKD’s addressable market and possible applications of its IP
🔨 Fielders has first right to negotiate additional licences for targeted international markets including the US, New Zealand, Indonesia, Japan, and India
“PARKD recognised the potential, its simple, yet ingenious connection system could present to the broader construction market. This small yet critical invention is the key to unlock the aspirations of the construction sector to meaningfully improve safety, productivity, costs and particularly sustainability goals of the government and private sectors.” – Peter McUtchen, PARKD Managing Director
Digital payments and financial services provider Findi Limited (ASX: FND) has locked in a seven year deal with Union Bank of India (UBI) for the deployment of an additional 900 ATMs across India.
🏧 Lifts the number of brown label ATMs operated by Findi in India to nearly 9,000
🏦Delivers more than $75 million in revenue and up to $38 million in operating earnings (EBITDA) for the company
💳 Findi will also hold close to 5,000 white label ATMs in India once its acquisition of Tata Communications Payment is concluded
“Findi is delighted to deepen the long-term relationship we have with Union Bank of India, and it is pleasing that we have again been entrusted by one of India’s largest banks to continue providing ATMs.” – Nicholas Smedley, Findi Limited Executive Chairman

Digital payments and financial services provider Findi Limited (ASX: FND) has locked in a seven year deal with Union Bank of India (UBI) for the deployment of an additional 900 ATMs across India.
🏧 Lifts the number of brown label ATMs operated by Findi in India to nearly 9,000
🏦Delivers more than $75 million in revenue and up to $38 million in operating earnings (EBITDA) for the company
💳 Findi will also hold close to 5,000 white label ATMs in India once its acquisition of Tata Communications Payment is concluded
“Findi is delighted to deepen the long-term relationship we have with Union Bank of India, and it is pleasing that we have again been entrusted by one of India’s largest banks to continue providing ATMs.” – Nicholas Smedley, Findi Limited Executive Chairman
Vection Technologies (ASX: VR1), a specialist in artificial intelligence (AI) and extended reality (XR) solutions, has sealed a $4 million contract extension with an existing defence sector client, adding to two other contract wins with the customer.
🥽 Highlights the group’s ability to enhance national security efforts by integrating cutting-edge AI capabilities
🤖 Enables real-time data processing and analysis for the client’s large-scale distributed infrastructure design projects
🧠 Builds momentum for Vection’s new AI capability and its partnership with global IT heavyweight Dell Technologies
“Our alignment with Dell Technologies further exemplifies the value of collaborative partnerships with industry leaders. Together, we are dedicated to pushing the boundaries of real-time data processing and driving meaningful innovation for high-performance intelligence and law enforcement operations.” – Gianmarco Biagi, Vection Technologies Managing Director
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250205/pdf/06f67yfwj74tzw.pdf

Vection Technologies (ASX: VR1), a specialist in artificial intelligence (AI) and extended reality (XR) solutions, has sealed a $4 million contract extension with an existing defence sector client, adding to two other contract wins with the customer.
🥽 Highlights the group’s ability to enhance national security efforts by integrating cutting-edge AI capabilities
🤖 Enables real-time data processing and analysis for the client’s large-scale distributed infrastructure design projects
🧠 Builds momentum for Vection’s new AI capability and its partnership with global IT heavyweight Dell Technologies
“Our alignment with Dell Technologies further exemplifies the value of collaborative partnerships with industry leaders. Together, we are dedicated to pushing the boundaries of real-time data processing and driving meaningful innovation for high-performance intelligence and law enforcement operations.” – Gianmarco Biagi, Vection Technologies Managing Director
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250205/pdf/06f67yfwj74tzw.pdf
A study testing the efficacy of Argenica Therapeutics’ (ASX: AGN) leading drug known as ARG-007 has displayed significant neuroprotection in traumatic brain injury (TBI). The broadened pre-clinical rat study measuring axonal injury and neuroinflammation has shown ARG-007 to significantly reduce brain cell damage.
💊 Results suggest ARG-007 reduces axonal injury and neuroinflammation following TBI to similar levels seen in non-injured animals
🧪 ARG-007 could be effective treatment strategy for preserving normal motor coordination and hold other benefits like restoring normal body weight in recipients
🧬 Argenica estimates the addressable market for treatment of TBI with ARG-007 could reach US$18.6 billion by 2031
“We are extremely pleased with the results from this larger preclinical study in a moderate TBI animal model. The study confirms previously generated data, indicating that ARG-007 consistently reduces axonal injury and neuroinflammation following TBI, and encouragingly to levels similar to non-injured animals.”
Dr Liz Dallimore, Argenica Therapeutics Managing Director

A study testing the efficacy of Argenica Therapeutics’ (ASX: AGN) leading drug known as ARG-007 has displayed significant neuroprotection in traumatic brain injury (TBI). The broadened pre-clinical rat study measuring axonal injury and neuroinflammation has shown ARG-007 to significantly reduce brain cell damage.
💊 Results suggest ARG-007 reduces axonal injury and neuroinflammation following TBI to similar levels seen in non-injured animals
🧪 ARG-007 could be effective treatment strategy for preserving normal motor coordination and hold other benefits like restoring normal body weight in recipients
🧬 Argenica estimates the addressable market for treatment of TBI with ARG-007 could reach US$18.6 billion by 2031
“We are extremely pleased with the results from this larger preclinical study in a moderate TBI animal model. The study confirms previously generated data, indicating that ARG-007 consistently reduces axonal injury and neuroinflammation following TBI, and encouragingly to levels similar to non-injured animals.”
Dr Liz Dallimore, Argenica Therapeutics Managing Director
Motion analysis device specialist @dorsavi (ASX: DVL) has entered a commercial research project with heralded American physician Dr Chiarg Patel to study athlete movement patterns using the company’s wearable sensor technology.
🏈 The study will assess patterns and traits that could increase the risk of foot and ankle injury in elite athletes
🦶 Dr Patel is regarded as a global authority in lower extremity sports medicine, specialising in injury prevention, performance optimisation, and athlete longevity
🏀 Expected to generate close to US$50,000 in revenue for the company, with potential for a broadened collaboration
🛡️ Integration of blockchain technology to enhance security and compliance could benefit data generated in the study

Motion analysis device specialist @dorsavi (ASX: DVL) has entered a commercial research project with heralded American physician Dr Chiarg Patel to study athlete movement patterns using the company’s wearable sensor technology.
🏈 The study will assess patterns and traits that could increase the risk of foot and ankle injury in elite athletes
🦶 Dr Patel is regarded as a global authority in lower extremity sports medicine, specialising in injury prevention, performance optimisation, and athlete longevity
🏀 Expected to generate close to US$50,000 in revenue for the company, with potential for a broadened collaboration
🛡️ Integration of blockchain technology to enhance security and compliance could benefit data generated in the study
Leading Australian home builder Simonds Group (ASX: SIO) has entered an agreement to acquire Dennis Family Homes in a $10 million deal from respected property development company owned by the Dennis family.
🏡 The deal is set to double Simonds Group’s existing product portfolio and significantly expand its market reach in Australia
🛠️ Expected to deliver $200 million in additional revenue for Simonds Group by FY26
🏗️ Could support future sales by expanding Simonds Group’s footprint across Victoria by about 40%
“In a time of increasing demand for accessible housing options, this acquisition enables us to scale up with a robust product line that meets the needs of first-time buyers, growing families, and downsizers alike.” – David McKeown, Simonds Group Chief Executive Officer

Leading Australian home builder Simonds Group (ASX: SIO) has entered an agreement to acquire Dennis Family Homes in a $10 million deal from respected property development company owned by the Dennis family.
🏡 The deal is set to double Simonds Group’s existing product portfolio and significantly expand its market reach in Australia
🛠️ Expected to deliver $200 million in additional revenue for Simonds Group by FY26
🏗️ Could support future sales by expanding Simonds Group’s footprint across Victoria by about 40%
“In a time of increasing demand for accessible housing options, this acquisition enables us to scale up with a robust product line that meets the needs of first-time buyers, growing families, and downsizers alike.” – David McKeown, Simonds Group Chief Executive Officer
Australia’s leading online pet ecosystem Mad Paws (ASX: MPA) has reported a strong lift in earnings in the second quarter of the 2025 financial year (FY25) as its recently launched promotional campaign in the mainstream media gathers traction.
🐶 Cash operating earnings (EBITDA) up by more than 300% from the same time last year as maiden brand campaign shifts up a gear
🐱 Operating cash flow up by 81 per cent from previous corresponding period
🐰 Retains healthy media budget to build awareness and accelerate growth for its wide array of pet services and products
“Our unwavering focus on profitability has delivered a Cash EBITDA of $0.3 million for the quarter — a 328% improvement compared to the prior corresponding period. This milestone also positions the Mad Paws Group as Cash EBITDA positive for the first half of FY25.” – Justus Hammer, Mad Paws Co-founder and Chief Executive Officer

Australia’s leading online pet ecosystem Mad Paws (ASX: MPA) has reported a strong lift in earnings in the second quarter of the 2025 financial year (FY25) as its recently launched promotional campaign in the mainstream media gathers traction.
🐶 Cash operating earnings (EBITDA) up by more than 300% from the same time last year as maiden brand campaign shifts up a gear
🐱 Operating cash flow up by 81 per cent from previous corresponding period
🐰 Retains healthy media budget to build awareness and accelerate growth for its wide array of pet services and products
“Our unwavering focus on profitability has delivered a Cash EBITDA of $0.3 million for the quarter — a 328% improvement compared to the prior corresponding period. This milestone also positions the Mad Paws Group as Cash EBITDA positive for the first half of FY25.” – Justus Hammer, Mad Paws Co-founder and Chief Executive Officer
AML3D (ASX: AL3), a leader in large scale Wire Additive Manufacturing technology and 3D metal printing solutions, has reported a series of key outcomes during the December quarter of the 2025 financial year (FY25) as its commercialisation push targeting the defence sector accelerates.
🏭 Opened US manufacturing facility for its advanced manufacturing technology solutions targeting the defence sector, with immediate plans for expansion
🔑 Locked in $30 million in funding to facilitate increased production of its specialist metal products and drive the company’s next growth phase
🚢 Nailed down a series of key US Navy and Australian defence contracts
🛡️ Initiated plans to enter European market targeting significant contract growth across defence, utility, oil & gas, marine and aerospace sectors

AML3D (ASX: AL3), a leader in large scale Wire Additive Manufacturing technology and 3D metal printing solutions, has reported a series of key outcomes during the December quarter of the 2025 financial year (FY25) as its commercialisation push targeting the defence sector accelerates.
🏭 Opened US manufacturing facility for its advanced manufacturing technology solutions targeting the defence sector, with immediate plans for expansion
🔑 Locked in $30 million in funding to facilitate increased production of its specialist metal products and drive the company’s next growth phase
🚢 Nailed down a series of key US Navy and Australian defence contracts
🛡️ Initiated plans to enter European market targeting significant contract growth across defence, utility, oil & gas, marine and aerospace sectors
Adventure tourism specialist Experience Co (ASX: EXP) has served up a strong set of numbers in Q2 FY25, showcased by robust revenue growth across both its operating segments and improved earnings stemming from cost optimisation initiatives.
🪂 Revenue for the quarter up by 14% from same time last year on the back of rising volumes for the company’s wide range of adventure experiences
🤿 Operating earnings (EBITDA) in Q2 FY25 up by 46% from a year ago as cost optimisation initiatives gain traction
✈️ EBITDA in the first half of FY25 up by 51 per cent, with the business free cash flow positive during the period
🏖️ Solid start to calendar year with recovery in international tourists to Australia expected to benefit volumes across the business

Adventure tourism specialist Experience Co (ASX: EXP) has served up a strong set of numbers in Q2 FY25, showcased by robust revenue growth across both its operating segments and improved earnings stemming from cost optimisation initiatives.
🪂 Revenue for the quarter up by 14% from same time last year on the back of rising volumes for the company’s wide range of adventure experiences
🤿 Operating earnings (EBITDA) in Q2 FY25 up by 46% from a year ago as cost optimisation initiatives gain traction
✈️ EBITDA in the first half of FY25 up by 51 per cent, with the business free cash flow positive during the period
🏖️ Solid start to calendar year with recovery in international tourists to Australia expected to benefit volumes across the business
Orthopedic imaging specialist CurveBeam AI (ASX: CVB) has locked in a commercial agreement with leading medical technology business Stryker Australia, designed to boost awareness and understanding of the company’s innovative weight bearing CT (WBCT) imaging equipment within its target markets.
🩻 Stryker to educate surgeons about benefits of WBCT scans and help to drive demand for the technology in Australia and New Zealand
🏥 Stryker also tasked with generating sales leads for CurveBeam’s flagship HiRise scanning equipment as part of initial three year deal
🦴 HiRise has unique ability to scan a patient’s hip, pelvis or foot in a weight bearing position, enabling medical professionals to gain detailed insight into bone and joint alignment under natural load conditions
“Stryker’s scale, resources and reach, along with the fact that the collaboration is very synergistic, will be all instrumental in driving surgeon demand for WBCT. We see this demand being met through placing HiRise WBCT scanners with imaging centres and hospitals.” – Greg Brown, CurveBeam AI Chief Executive Officer

Orthopedic imaging specialist CurveBeam AI (ASX: CVB) has locked in a commercial agreement with leading medical technology business Stryker Australia, designed to boost awareness and understanding of the company’s innovative weight bearing CT (WBCT) imaging equipment within its target markets.
🩻 Stryker to educate surgeons about benefits of WBCT scans and help to drive demand for the technology in Australia and New Zealand
🏥 Stryker also tasked with generating sales leads for CurveBeam’s flagship HiRise scanning equipment as part of initial three year deal
🦴 HiRise has unique ability to scan a patient’s hip, pelvis or foot in a weight bearing position, enabling medical professionals to gain detailed insight into bone and joint alignment under natural load conditions
“Stryker’s scale, resources and reach, along with the fact that the collaboration is very synergistic, will be all instrumental in driving surgeon demand for WBCT. We see this demand being met through placing HiRise WBCT scanners with imaging centres and hospitals.” – Greg Brown, CurveBeam AI Chief Executive Officer
4DMedical (ASX: 4DX) has sealed a significant commercial agreement for its respiratory care solutions with leading provider of diagnostic imaging services in Queensland, Qscan Radiology Clinics. The deal follows a successful pilot program.
🩻 Qscan will provide clinicians with access to 4DMedical’s lung function products in select Brisbane practices
🩺 Qscan is regarded as one of Australia’s leading medical imaging providers with 40 clinics across the nation
🧬 The deal adds to a series of other recent contract wins in Australia and the US
“Momentum continues to build with the commercialisation of our technology across the US and Australia. With the addition of Qscan to our network of providers in Australia, I am excited to see our footprint expand to ensure our cutting-edge technology is now becoming more readily available to all Australians.” – Andreas Fouras, 4DMedical Managing Director and Founder

4DMedical (ASX: 4DX) has sealed a significant commercial agreement for its respiratory care solutions with leading provider of diagnostic imaging services in Queensland, Qscan Radiology Clinics. The deal follows a successful pilot program.
🩻 Qscan will provide clinicians with access to 4DMedical’s lung function products in select Brisbane practices
🩺 Qscan is regarded as one of Australia’s leading medical imaging providers with 40 clinics across the nation
🧬 The deal adds to a series of other recent contract wins in Australia and the US
“Momentum continues to build with the commercialisation of our technology across the US and Australia. With the addition of Qscan to our network of providers in Australia, I am excited to see our footprint expand to ensure our cutting-edge technology is now becoming more readily available to all Australians.” – Andreas Fouras, 4DMedical Managing Director and Founder
Hearing health specialist Audeara (ASX: AUA) has launched its co-branded Clinico Sound Earbuds in Taiwan as the group’s strategy of penetrating international markets gathers momentum.
🎧 Successful launch of Clinico Sound Earbuds builds on Audeara`s strategic partnership with Taiwan`s largest hearing aid retailer Clinico
🎶 Clinico Sound Earbuds incorporate Audeara’s proprietary technology which provides tailored soundscapes that meet the unique needs of every individual
🔊 Lays the foundation for Audeara`s strategic expansion into other Asian markets including China
“As the largest hearing aid retailer in Taiwan, Clinico provides the Company with a unique distribution advantage which is expected to expand further now that the product is officially in-market. With this product launch, we have established a strong platform for growth in major Asian markets, further complementing our broader international momentum.” – Dr James Fielding, Audeara Chief Executive Officer and Founder

Hearing health specialist Audeara (ASX: AUA) has launched its co-branded Clinico Sound Earbuds in Taiwan as the group’s strategy of penetrating international markets gathers momentum.
🎧 Successful launch of Clinico Sound Earbuds builds on Audeara`s strategic partnership with Taiwan`s largest hearing aid retailer Clinico
🎶 Clinico Sound Earbuds incorporate Audeara’s proprietary technology which provides tailored soundscapes that meet the unique needs of every individual
🔊 Lays the foundation for Audeara`s strategic expansion into other Asian markets including China
“As the largest hearing aid retailer in Taiwan, Clinico provides the Company with a unique distribution advantage which is expected to expand further now that the product is officially in-market. With this product launch, we have established a strong platform for growth in major Asian markets, further complementing our broader international momentum.” – Dr James Fielding, Audeara Chief Executive Officer and Founder
Biotechnology business Zoono (ASX: ZNO) is advancing numerous significant sale prospects as the group continues to prioritise the development of commercial opportunities in its selected niche markets. More specifically, the company is reporting further strong interest in its technology designed to extend the shelf-life of fresh produce.
🍎 Eight additional supermarket groups and packaging companies joining shelf-life extensions trials being held across 12 countries, lifting the total to 21
🥒 Trials involve a diverse range of customers including supermarket chains, food producers, packaging companies and exporters
🫐 Zoono in discussions with more than 40 supermarket and packaging companies about the adoption of its shelf-life technology
🥦 Shelf-life technology could help reduce food waste globally

Biotechnology business Zoono (ASX: ZNO) is advancing numerous significant sale prospects as the group continues to prioritise the development of commercial opportunities in its selected niche markets. More specifically, the company is reporting further strong interest in its technology designed to extend the shelf-life of fresh produce.
🍎 Eight additional supermarket groups and packaging companies joining shelf-life extensions trials being held across 12 countries, lifting the total to 21
🥒 Trials involve a diverse range of customers including supermarket chains, food producers, packaging companies and exporters
🫐 Zoono in discussions with more than 40 supermarket and packaging companies about the adoption of its shelf-life technology
🥦 Shelf-life technology could help reduce food waste globally
Traffic Technologies (ASX: TTI), an Australian manufacturer of traffic related products and services, has locked in a five year contract with the City of Sydney Council for the provision of its innovative ‘Smart City IoT’ ready LED streetlights.
🚦 Five year deal worth up to $3 million with an option to extend to $5 million over nine years
💡 Traffic Technologies to replace existing streetlights along roads, parks, plazas, laneways, and footways in the City of Sydney
🏢 Agreement covers the Sydney CBD and surrounding inner suburbs of the greater metropolitan area which host more than 16,000 streetlights
“The award of this contract to one of the most prestigious local government areas in Australia is a fantastic vote of confidence in the Company’s state of the art LED streetlights. The length of the contract provides an opportunity for the Company to supply a range of additional products throughout the Sydney area.” – Con Liostas, Traffic Technologies Managing Director

Traffic Technologies (ASX: TTI), an Australian manufacturer of traffic related products and services, has locked in a five year contract with the City of Sydney Council for the provision of its innovative ‘Smart City IoT’ ready LED streetlights.
🚦 Five year deal worth up to $3 million with an option to extend to $5 million over nine years
💡 Traffic Technologies to replace existing streetlights along roads, parks, plazas, laneways, and footways in the City of Sydney
🏢 Agreement covers the Sydney CBD and surrounding inner suburbs of the greater metropolitan area which host more than 16,000 streetlights
“The award of this contract to one of the most prestigious local government areas in Australia is a fantastic vote of confidence in the Company’s state of the art LED streetlights. The length of the contract provides an opportunity for the Company to supply a range of additional products throughout the Sydney area.” – Con Liostas, Traffic Technologies Managing Director
Biopharmaceutical business Immuron (ASX:IMC) has served up a stellar set of numbers for the December quarter of the 2025 financial year, showcased by surging sales in Australia and North America for its Travelan product used to treat mild gastro-intestinal disorders.
📢 Total Travelan sales during the quarter up by nearly 250% from a year ago
⚕️Travelan sales in Australia up by more than 300% on the back of broadened product ranging in pharmacy chains
💊 Travelan sales in North America up by 130% following robust growth online and in physical retail stores
“We are achieving strong growth in both Australia and North America reflecting the core ranging we secured in another nine pharmacy banner groups in Australia, distribution in ten pharmacy/grocery retailers in Canada and sales growth on amazon.com in the US.” – Flavio Palumbo, Immuron Chief Commercial Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250117/pdf/06dm5s0svt54n4.pdf

Biopharmaceutical business Immuron (ASX:IMC) has served up a stellar set of numbers for the December quarter of the 2025 financial year, showcased by surging sales in Australia and North America for its Travelan product used to treat mild gastro-intestinal disorders.
📢 Total Travelan sales during the quarter up by nearly 250% from a year ago
⚕️Travelan sales in Australia up by more than 300% on the back of broadened product ranging in pharmacy chains
💊 Travelan sales in North America up by 130% following robust growth online and in physical retail stores
“We are achieving strong growth in both Australia and North America reflecting the core ranging we secured in another nine pharmacy banner groups in Australia, distribution in ten pharmacy/grocery retailers in Canada and sales growth on amazon.com in the US.” – Flavio Palumbo, Immuron Chief Commercial Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250117/pdf/06dm5s0svt54n4.pdf
FY26 Stocks & sectors to watch as rate cuts set to fuel the next stock market rally